<SEC-DOCUMENT>0001193125-17-109612.txt : 20170404
<SEC-HEADER>0001193125-17-109612.hdr.sgml : 20170404
<ACCEPTANCE-DATETIME>20170404110105
ACCESSION NUMBER:		0001193125-17-109612
CONFORMED SUBMISSION TYPE:	DEF 14A
PUBLIC DOCUMENT COUNT:		5
CONFORMED PERIOD OF REPORT:	20170518
FILED AS OF DATE:		20170404
DATE AS OF CHANGE:		20170404
EFFECTIVENESS DATE:		20170404

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MACROGENICS INC
		CENTRAL INDEX KEY:			0001125345
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEF 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36112
		FILM NUMBER:		17736653

	BUSINESS ADDRESS:	
		STREET 1:		9704 MEDICAL CENTER DRIVE
		CITY:			Rockville
		STATE:			MD
		ZIP:			20850
		BUSINESS PHONE:		301-251-5172

	MAIL ADDRESS:	
		STREET 1:		9704 MEDICAL CENTER DRIVE
		CITY:			ROCKVILLE
		STATE:			MD
		ZIP:			20850
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEF 14A
<SEQUENCE>1
<FILENAME>d337004ddef14a.htm
<DESCRIPTION>DEF 14A
<TEXT>
<HTML><HEAD>
<TITLE>DEF 14A</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Washington, D.C. 20549 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SCHEDULE 14A INFORMATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Proxy Statement Pursuant to Section&nbsp;14(a) of the </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Securities Exchange Act of 1934 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>(Amendment No. &nbsp;&nbsp;&nbsp;&nbsp;) </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Filed by the
Registrant&nbsp;&nbsp;&#9746;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Filed by a Party other than the
Registrant&nbsp;&nbsp; &#9744; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="95%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Preliminary Proxy Statement</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#9746;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Definitive Proxy Statement</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Definitive Additional Materials</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Soliciting Material under &#167; 240.14a-12</TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:22pt; font-family:Times New Roman" ALIGN="center"><B>MACROGENICS, INC. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Name of Registrant as Specified In Its Charter) </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Name of Person(s) Filing Proxy Statement, if other than the Registrant) </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Payment of Filing Fee (Check the appropriate box): </P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="90%"></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#9746;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">No fee required.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">(1)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Title of each class of securities to which transaction applies:</P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">(2)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Aggregate number of securities to which transaction applies:</P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">(3)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing
fee is calculated and state how it was determined):</P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">(4)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Proposed maximum aggregate value of transaction:</P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">(5)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Total fee paid:</P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="10"></TD>
<TD HEIGHT="10" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Fee paid previously with preliminary materials.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="10"></TD>
<TD HEIGHT="10" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement
number, or the Form or Schedule and the date of its filing.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">(1)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Amount Previously Paid:</P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">(2)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Form, Schedule or Registration Statement No.:</P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">(3)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Filing Party:</P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">(4)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Date Filed:</P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
</TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>MacroGenics, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>9704 Medical Center Drive </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Rockville, Maryland 20850 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTICE OF ANNUAL MEETING OF STOCKHOLDERS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TO BE HELD ON MAY 18, 2017 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To the Stockholders of MacroGenics, Inc.: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>NOTICE IS HEREBY GIVEN</B> that the Annual Meeting of Stockholders (the &#147;Annual Meeting&#148;) of MacroGenics, Inc., a Delaware
corporation, will be held on May&nbsp;18, 2017, at 9:00 a.m. local time, at the Hilton Garden Inn Rockville-Gaithersburg, 14975 Shady Grove Road, Rockville, Maryland 20850, for the following purposes: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">1. To elect two Class I directors listed in these proxy materials to hold office until the 2020 Annual Meeting of Stockholders or until their
successors are elected and qualified or until their earlier death, resignation or removal; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">2. To ratify the selection by the Audit
Committee of our Board of Directors of Ernst&nbsp;&amp; Young LLP as the independent registered public accounting firm of the Company for its fiscal year ending December&nbsp;31, 2017; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">3. To approve, on an advisory basis, the compensation of our named executive officers as disclosed in these proxy materials; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">4. To approve the 2016 Employee Stock Purchase Plan; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">5. To transact such other business as may properly come before the Annual Meeting or any adjournment or postponement thereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The foregoing items of business are more fully described in the Proxy Statement accompanying this Notice. Only stockholders who owned our
common stock at the close of business on March&nbsp;24, 2017, the record date, can vote at the Annual Meeting or any adjournment or postponement thereof. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Board of Directors recommends that you vote <B>FOR</B> the election of the director nominees and <B>FOR</B> Proposals 2, 3 and 4. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Your vote is important. Whether or not you plan to attend the meeting in person, please vote by internet, by telephone or by completing,
signing and dating the accompanying proxy card and returning it as soon as possible. If you have received and are using an enclosed return envelope, no postage need be affixed if it is mailed in the United States. If you receive more than one notice
or more than one proxy card because your shares are registered in different names or addresses, you should vote each set of shares separately to ensure that all of your shares will be voted. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Important Notice Regarding the Availability of Proxy Materials for the Stockholder Meeting to be Held on May&nbsp;18, 2017: Our proxy
materials and annual report to stockholders are available at www.proxydocs.com/MGNX. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:54%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">By Order of the Board of
Directors </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt; margin-left:54%; text-indent:-2%">


<IMG SRC="g337004g99b25.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:54%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">James Karrels </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:54%; text-indent:-2%; font-size:10pt; font-family:Times New Roman"><I>Corporate Secretary</I> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Rockville, Maryland </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">April&nbsp;4, 2017 </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc"></A>TABLE OF CONTENTS </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="96%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc337004_1">Information About the Proxy Process and Voting</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc337004_2">Proposal No.&nbsp;1. Election of Directors</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc337004_3">Director Compensation</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc337004_4">Proposal No.&nbsp;
2. Ratification of Selection of Independent Registered Public Accounting Firm</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc337004_5">Audit Committee Report</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc337004_6">Proposal No.&nbsp;3. Advisory Vote on Executive
Compensation</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc337004_7">Proposal No.&nbsp;4. Approval of the 2016 Employee Stock Purchase
Plan</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc337004_8">Corporate Governance</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc337004_9">Certain Relationships and Related Party Transactions</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">23</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc337004_10">Executive Officers</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">24</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc337004_11">Executive Compensation</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc337004_12">Security Ownership</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">44</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>MacroGenics, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>9704 Medical Center Drive </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Rockville, Maryland 20850 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PROXY STATEMENT FOR THE 2017 ANNUAL MEETING </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>OF STOCKHOLDERS TO BE HELD MAY 18, 2017 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have made available to you this proxy statement and the accompanying proxy card because the Board of Directors (the &#147;Board&#148;) of
MacroGenics, Inc. (referred to herein as the &#147;Company&#148;, &#147;MacroGenics&#148;, &#147;we&#148;, &#147;us&#148; or &#147;our&#148;) is soliciting your proxy to vote at our 2017 Annual Meeting of Stockholders (the &#147;Annual
Meeting&#148;) to be held on Thursday, May&nbsp;18, 2017, at 9:00 a.m. local time, at the Hilton Garden Inn Rockville-Gaithersburg, 14975 Shady Grove Road, Rockville, Maryland 20850. </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">This proxy statement summarizes information about the proposals to be considered at the Annual Meeting and other information you may find useful in determining how to vote. </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">The proxy card is the means by which you actually authorize another person to vote your shares in accordance with your instructions. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition to solicitations by mail, our directors, officers and regular employees, without additional remuneration, may solicit proxies by
telephone and by e-mail. All costs of the solicitation of proxies will be borne by us. Brokers, custodians and fiduciaries will be requested to forward proxy soliciting material to the owners of stock held in their names, and we will reimburse them
for their reasonable out-of-pocket expenses incurred in connection with the distribution of proxy materials. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are mailing the Notice of
Annual Meeting of Stockholders and the proxy card to our stockholders of record as of March&nbsp;24, 2017, the record date, for the first time on or about April&nbsp;4, 2017. In this mailing, we are also including instructions on how to access our
proxy statement and Annual Report on Form 10-K <FONT STYLE="white-space:nowrap">(&#147;Form&nbsp;10-K&#148;)</FONT> for the year ended December&nbsp;31, 2016, which Form 10-K, together with the additional cover materials, constitutes our 2016 Annual
Report to Stockholders (&#147;2016 Annual Report&#148;). In addition, we have provided brokers, dealers, banks, voting trustees and their nominees, at our expense, with additional copies of our proxy materials and the 2016 Annual Report so that our
record holders can supply these materials to the beneficial owners of shares of our common stock as of the record date upon request. The Form 10-K is also available in the &#147;Financials&nbsp;&amp; Filings&#148; section of our website at
http://ir.macrogenics.com/financials.cfm. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The only voting securities of MacroGenics are shares of our common stock, of which there were
34,977,771 shares outstanding as of the record date. We need the holders of a majority in voting power of these shares of common stock to be present in person or represented by proxy at the Annual Meeting to have a quorum and conduct business at the
Annual Meeting. </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc337004_1"></A>INFORMATION ABOUT THE PROXY PROCESS AND VOTING </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Why am I receiving these materials? </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You
are receiving notice of Annual Meeting and related proxy materials from us because you owned shares of our common stock as of March&nbsp;24, 2017, the record date for the Annual Meeting. The MacroGenics Board of Directors (the &#147;Board&#148;) has
made these materials available to you in connection with the Board&#146;s solicitation of proxies for use at our Annual Meeting. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This
proxy statement describes matters on which you may vote and provides you with other important information so that you can make informed decisions about such matters. You are requested to vote on the proposals described in this proxy statement and
are invited to attend the Annual Meeting. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We intend to make our Annual Report, this proxy statement and accompanying proxy card available
on or about April&nbsp;4, 2017, to all stockholders of record entitled to vote at the Annual Meeting. Beneficial owners will receive notice and electronic access to these materials, and may request physical copies from their respective brokers,
custodians or fiduciaries who are holding the shares on their behalf. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Who can vote at the Annual Meeting? </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Only stockholders of record at the close of business on March&nbsp;24, 2017, the record date, will be entitled to vote at the Annual Meeting.
At the close of business on the record date, there were 34,977,771 shares of our common stock issued and outstanding and entitled to vote. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Stockholder of Record: Shares Registered in Your Name </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If, on the record date, your shares were registered directly in your name with the transfer agent for our common stock, Computershare Trust
Company, N.A. (&#147;Computershare&#148;), then you are a stockholder of record. As a stockholder of record, you may vote in person at the Annual Meeting or vote by proxy. Whether or not you plan to attend the Annual Meeting, we urge you to fill out
and return the enclosed proxy card or vote by proxy over the telephone or on the internet as instructed below to ensure your vote is counted. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Beneficial Owner: Shares Registered in the Name of a Broker, Bank or Other Agent </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If, on the record date, your shares were held in an account at a brokerage firm, bank, dealer or other similar organization, then you are the
beneficial owner of shares held in &#147;street name&#148; and these proxy materials are being forwarded to you by that organization. The organization holding your account is considered the stockholder of record for purposes of voting at the Annual
Meeting. As a beneficial owner, you have the right to direct your broker or other agent regarding how to vote the shares in your account. You are also invited to attend the Annual Meeting. However, since you are not the stockholder of record, you
may not vote your shares in person at the Annual Meeting unless you request and obtain a valid proxy card from your broker or other agent. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>What are the voting requirements to elect directors and approve the other proposals described in the proxy
statement? </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The vote required to elect directors and approve each of the matters scheduled for a vote at the Annual Meeting is set
forth below: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="57%"></TD>
<TD VALIGN="bottom" WIDTH="10%"></TD>
<TD WIDTH="19%"></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:30.20pt; font-size:8pt; font-family:Times New Roman"><B>Proposal</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Vote Required</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Board&nbsp;Recommendation</B></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Election of Class I directors</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Plurality&nbsp;of&nbsp;votes&nbsp;cast</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>FOR</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Ratification of appointment of Ernst &amp; Young LLP
(&#147;Ernst &amp; Young&#148;)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Majority&nbsp;of&nbsp;votes&nbsp;cast</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>FOR</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Advisory vote to approve compensation of named executive
officers as disclosed in this proxy statement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Majority of votes cast</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>FOR</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Approval of the 2016 Employee Stock Purchase Plan (the
&#147;Plan&#148;)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Majority of votes cast</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>FOR</B></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Shares voted &#147;Abstain&#148; will be counted for the purposes of determining whether a quorum has been
reached, but will have no effect on the approval of matters considered at the Annual Meeting. Votes may be cast by proxy or in person. A &#147;plurality&#148; of the votes cast at the meeting for the election of directors means that the nominees who
receive the most votes will be the nominees elected by stockholders. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>How do I vote? </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Even if you plan to attend the Annual Meeting, we recommend that you vote before the meeting, as described below, so that your vote will be
counted if you later decide not to attend the meeting. Voting by internet or by telephone is fast and convenient, and your vote is immediately confirmed and tabulated. Submitting a proxy by internet, telephone or mail prior to the Annual Meeting
will not affect your right to attend the Annual Meeting and vote in person. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>If you hold shares in your own name as a stockholder of
record</I>, regardless of whether you received your Annual Meeting materials through the mail or via the internet, you may vote before the Annual Meeting: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><B>By Internet</B>. To vote by internet, go to www.proxypush.com/MGNX and follow the instructions you find on this website. Your proxy will be voted according to your instructions. If you vote by internet, you do not
need to mail in a proxy card. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><B>By Telephone</B>. To vote by phone, call 1-866-284-4925 toll-free from the United States and follow the instructions. If you vote by telephone, you do not need to mail in a proxy card. </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"><B>By Mail</B>. To vote by mail, complete, sign and return our proxy card in the enclosed postage-paid envelope. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If you vote by internet or by telephone, please do not mail in your proxy card (unless you intend for it to revoke your prior internet or
telephone vote). Your internet or telephone vote will authorize the named proxies to vote your shares in the same manner as if you completed, signed and returned your proxy card. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If you hold shares in street name, please refer to the information provided by the institution that holds our shares regarding how to provide
them with voting instructions. If you beneficially hold your shares in street name and you do not submit specific voting instructions to your broker, your broker may generally vote your shares in its discretion on matters designated as
&#147;routine&#148; under rules applicable to broker-dealers. However, a broker cannot vote shares held in street name on matters designated by these rules as &#147;non-routine,&#148; unless the broker receives specific voting instructions from the
beneficial holder. See &#147;What are &#145;broker non-votes&#146;?&#148; and &#147;Which ballot measures are considered &#145;routine&#146; and &#145;non-routine&#146;?&#148; below for additional information. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Who counts the votes? </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Mediant Communications, Inc. (&#147;Mediant&#148;) has been engaged as our independent agent to tabulate stockholder votes as the Inspector of
Elections. If you are a stockholder of record, your executed proxy card should be returned directly to Mediant for tabulation. As noted above, if you hold your shares through a broker, your broker will return one proxy card to Mediant on behalf of
all its clients. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>How are votes counted? </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Votes will be counted by the Inspector of Election, who will separately count &#147;For&#148; and &#147;Against&#148; votes, abstentions and
broker non-votes. In addition, with respect to the election of directors, the Inspector of Elections will count the number of &#147;Withheld&#148; votes received for the nominees. If your shares are held in street name, you will need to obtain a
voting instruction form from the institution that holds your shares and follow the instructions included on that form regarding how to instruct the institution that holds your shares to vote your shares. If you do not give instructions to the
institution that holds your shares, the institution that holds your shares can vote your shares with respect to &#147;routine&#148; items, but not with respect to &#147;non-routine&#148; items. See &#147;What are &#145;broker non-votes&#146;?&#148;
and &#147;Which ballot measures are considered &#145;routine&#146; and &#145;non-routine&#146;?&#148; for more information. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>What are &#147;broker
non-votes&#148;? </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Broker non-votes occur when a beneficial owner of shares held in street name does not give instructions to the broker
or nominee holding the shares as to how to vote on matters deemed &#147;non-routine.&#148; Generally, if shares are held in street name, the beneficial owner of the shares is entitled to give voting instructions to the broker or nominee holding the
shares. If the beneficial owner does not provide voting instructions, the broker or nominee can still vote the shares with respect to matters that are considered to be &#147;routine,&#148; but not with respect to &#147;non-routine&#148; matters. In
the event that a broker, bank, custodian, nominee or other record holder of common stock indicates on a proxy that it does not have discretionary authority to vote certain shares on a particular proposal, then those shares will be treated as broker
non-votes with respect to that proposal. Accordingly, if you own shares through a nominee, such as a broker or bank, please be sure to instruct your nominee how to vote to ensure that your vote is counted on each of the proposals. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Which ballot measures are considered &#147;routine&#148; or &#147;non-routine&#148;? </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The ratification of the appointment of Ernst&nbsp;&amp; Young as our independent registered public accounting firm for the year ending
December&nbsp;31, 2017 (Proposal 2) is considered routine under applicable rules. A broker or other nominee may generally vote on routine matters, and therefore no broker non-votes are expected to occur in connection with Proposal 2. The election of
directors (Proposal 1), the advisory vote approving compensation of the named executive officers (Proposal 3) and the approval of the Company&#146;s Plan (Proposal 4) are considered non-routine matters under applicable rules. A broker or other
nominee cannot vote without instructions from the beneficial owners on non-routine matters, and therefore we expect there will be broker non-votes on Proposals 1, 3 and 4. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>How many votes do I have? </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On each matter
to be voted upon, you have one vote for each share of common stock you own as of the record date. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>What is the quorum requirement? </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A quorum of stockholders is necessary to hold a valid meeting. Our by-laws provide that a quorum will exist if stockholders holding a majority
of the shares of stock issued and outstanding and entitled to vote are present at </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the meeting in person or by proxy. Abstentions and broker non-votes count as present for establishing a quorum but will not be counted as votes cast. If a quorum is not present, the meeting may
be adjourned or postponed until a quorum is obtained. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>What if I return a proxy card but do not make specific choices? </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If we receive a signed and dated proxy card or receive your instructions by internet or by telephone and your instructions do not specify how
your shares are to be voted, your shares will be voted &#147;For&#148; the election of each of the two nominees for director, &#147;For&#148; the ratification of the appointment of Ernst&nbsp;&amp; Young as our independent registered public
accounting firm, &#147;For&#148; the approval of the compensation of named executive officers, and &#147;For&#148; the approval of the Plan. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>What if
other matters not on the proxy card are brought before the Annual Meeting for action by the stockholders? </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of the date of this proxy
statement, our Board of Directors does not intend to present any matters other than those described in this proxy statement at the Annual Meeting and is not aware of any matters to be presented by other parties. If other matters are properly brought
before the Annual Meeting for action by the stockholders, proxies will be voted in accordance with the recommendation of the Board or, in the absence of such a recommendation, in accordance with the judgment of the proxy holder. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Who is paying for this proxy solicitation? </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We will pay for the entire cost of soliciting proxies. In addition to these mailed proxy materials, our directors, officers and employees may
also solicit proxies in person, by telephone or by other means of communication. Directors, officers and employees will not be paid any additional compensation for soliciting proxies. We may also reimburse brokerage firms, banks and other agents for
the cost of forwarding proxy materials to beneficial owners. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>What does it mean if I receive more than one notice or more than one set of materials?
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">It means that you have more than one account for your MacroGenics shares. Please vote by internet or telephone using each of the
identification numbers marked on each notice of Annual Meeting, or complete and submit all proxies by mail to ensure that all of your shares are voted. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Can I change my vote after submitting my proxy? </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Yes. You can revoke your proxy at any time before the Annual Meeting. If you are the record holder of your shares, you may revoke your proxy in
any one of three ways: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">You may submit another properly completed proxy with a later date by internet, telephone or mail. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">You may send a written notice that you are revoking your proxy to our Corporate Secretary at 9704 Medical Center Drive, Rockville, Maryland 20850. </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">You may attend the Annual Meeting and vote in person. Please note, however, that simply attending the Annual Meeting will not, by itself, revoke your proxy. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If your shares are held by your broker, bank or other nominee, you should follow the instructions provided by such nominee. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>When are stockholder proposals or director nominations due for next year&#146;s Annual Meeting? </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To be considered for inclusion in the proxy materials for the 2018 Annual Meeting of stockholders, your stockholder proposals must be submitted
in writing by December&nbsp;5, 2017, to our Corporate Secretary at </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
9704&nbsp;Medical Center Drive, Rockville, Maryland 20850. However, if the date of the 2018 Annual Meeting is more than 30 days from May&nbsp;18, 2018, the deadline is a reasonable time before we
begin to print and send our proxy materials for next year&#146;s Annual Meeting. If you wish to submit a proposal that is not to be included in our proxy materials for next year&#146;s Annual Meeting or to nominate a director pursuant to our
by-laws, you must do so not less than 90 days and no more than 120 days prior to the first anniversary of the preceding year&#146;s Annual Meeting (February 17, 2018 and January&nbsp;18, 2018, respectively); provided, that if the date of that Annual
Meeting is more than 20 days before or more than 60 days after the first anniversary of the preceding year&#146;s Annual Meeting, you must give notice not earlier than the 120th day prior to such Annual Meeting and not later than the close of
business on the later of (a)&nbsp;the 90th day prior to such Annual Meeting and (b)&nbsp;the tenth day following the day on which notice of the date of such Annual Meeting was mailed or public disclosure of the date of such Annual Meeting was made,
whichever first occurs. You are also advised to review our by-laws, which contain additional requirements about advance notice of stockholder proposals and director nominations. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>How can I find out the results of the voting at the Annual Meeting? </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Voting results will be announced by the Company pursuant to the filing of a Current Report on Form 8-K within four business days after the
Annual Meeting. If final voting results are unavailable at that time, we will file an amended Current Report on Form 8-K within four business days of the day the final results become available. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc337004_2"></A>PROPOSAL NO. 1 ELECTION OF DIRECTORS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Background </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Board of Directors is
divided into three classes. Each class consists, as nearly as possible, of one-third of the total number of directors, and each class has a three-year term. Unless the Board determines that vacancies (including vacancies created by increases in the
number of directors) will be filled by the stockholders, and except as otherwise provided by law, vacancies on the Board may be filled only by the affirmative vote of a majority of the remaining directors. A director elected by the Board to fill a
vacancy (including a vacancy created by an increase in the number of directors) shall serve for the remainder of the term of the class of directors in which the vacancy occurred, subject to the election and qualification of such director&#146;s
successor, or until such director&#146;s earlier death, resignation or removal. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At the 2017 Annual Meeting, stockholders will have an
opportunity to vote for the re-election of Scott Koenig, M.D., Ph.D. and Matthew Fust to serve as Class I directors, the class that is due for election this year. Each director to be elected will hold office from the date of his election by the
stockholders until the 2020&nbsp;Annual Meeting of Stockholders or until his successor is elected and has been qualified, or until such director&#146;s earlier death, resignation or removal. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In January 2017, the Board voted to increase the size of the Board from six to eight, creating two new vacancies. Karen Ferrante, M.D. and
Scott Jackson have been appointed to fill those vacancies and have been designated as Class III and Class II directors, respectively. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Board
Recommendation </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>The Board of Directors recommends a vote </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>&#147;FOR&#148; the election of each of the Class I director nominees. </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>DIRECTORS AND NOMINEES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This section provides information as of the date of this proxy statement about each Class I director nominee as well as those directors whose
terms continue after the Annual Meeting. The information includes age, all positions and offices held with us, length of service as a director, principal occupation and employment for the past five years and the names of other publicly held
companies of which s/he has served as a director during the past five years. For information about the number of shares of common stock beneficially owned by our directors as of March&nbsp;24, 2017, please see &#147;Information About Stock
Ownership&#148; beginning on page 39. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Shares represented by executed proxies will be voted, if authority to do so is not withheld, for
the election of the two nominees named below. Each of Dr.&nbsp;Koenig and Mr.&nbsp;Fust has agreed to serve if elected, and management has no reason to believe that either nominee will be unable to serve. Directors are elected by a plurality of the
votes cast at the Annual Meeting. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Class I Nominees for Election to a Three-Year Term Expiring at the 2020 Annual Meeting of Stockholders </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Scott Koenig, M.D., Ph.D., age 64 </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Dr.&nbsp;Koenig has been our President, Chief Executive Officer and a director since September 2001 and was one of our co-founders. Prior to
joining us, Dr.&nbsp;Koenig served as Senior Vice President of Research at MedImmune, Inc., where he participated in the selection and maturation of their product pipeline. From 1984 to 1990, he worked in the Laboratory of Immunoregulation at the
National Institute of Allergy and Infectious </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Diseases at the National Institutes of Health, where he investigated the immune response to retroviruses and studied the pathogenesis of AIDS. Dr.&nbsp;Koenig currently serves as Chairman of the
Board of Directors of Applied Genetic Technologies Corporation, and is on the Board of Directors for GlycoMimetics, both publicly held companies. Additionally, Dr.&nbsp;Koenig serves on the Board of Directors of the International Biomedical Research
Alliance, and the Biotechnology Innovation Organization (BIO) and is Co-Chairman of the Scientific Advisory Board of the Institute for Bioscience and Biotechnology Research at the University of Maryland. We believe that Dr.&nbsp;Koenig&#146;s
detailed knowledge of our company and his over 30 years in research and the biotechnology industry provide a valuable contribution to our Board. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Matthew Fust, age 52 </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Matthew Fust has served as a director since 2014. He served as Executive Vice President and Chief Financial Officer of Onyx Pharmaceuticals,
Inc., an oncology-focused biopharmaceutical company, from January 2009 until its acquisition by Amgen Inc. in October 2013. From May 2003 to December 2008, Mr.&nbsp;Fust served as Chief Financial Officer of Jazz Pharmaceuticals, Inc. From 2002 to
2003, Mr.&nbsp;Fust served as Chief Financial Officer of Perlegen Sciences, a biopharmaceutical company. Previously, he was Senior Vice President and Chief Financial Officer of ALZA Corporation, where he was an executive from 1996 until 2002.
Mr.&nbsp;Fust serves as a director of Atara Biotherapeutics, Inc., Dermira, Inc., Sunesis Pharmaceuticals and Ultragenyx Pharmaceutical, which are publicly held companies. Based on Mr.&nbsp;Fust&#146;s depth of experience in the biotechnology
industry, ranging from executive officer to director roles, the Board of Directors believes Mr.&nbsp;Fust has the appropriate set of skills to serve as a member of our Board of Directors. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Class II Directors Continuing in Office Until the 2018 Annual Meeting of Stockholders </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Kenneth Galbraith, age 54 </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Mr.&nbsp;Galbraith has served as a director since July 2008. Mr.&nbsp;Galbraith joined Ventures West Capital in 2007 and founded Five Corners
Capital Inc. in 2013 to manage the continued operations of the Ventures West Investment Funds. Mr.&nbsp;Galbraith has over 25 years of experience serving as an executive, director, investor and adviser to companies in the biotechnology, medical
device, pharmaceutical and healthcare sectors. In addition, Mr.&nbsp;Galbraith serves as a director of several privately held companies. Based on Mr.&nbsp;Galbraith&#146;s depth of experience in the biotechnology industry, ranging from executive
officer to director roles, the Board believes Mr.&nbsp;Galbraith has the appropriate set of skills to serve as a member of our Board. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Scott Jackson, age 52 </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Mr.&nbsp;Jackson has served as a director since January 2017. Mr.&nbsp;Jackson served as Chief Executive Officer and as a member of the Board
of Directors of Celator Pharmaceuticals, Inc. from April 2008 until July 2016, when the company was acquired by Jazz Pharmaceuticals plc. Mr.&nbsp;Jackson has more than 25 years of experience in the pharmaceutical and biotechnology industry and has
held positions of increasing responsibility in sales, marketing and commercial development at Eli Lilly&nbsp;&amp; Co., SmithKline Beecham, ImClone Systems Inc., Centocor Inc., a division of Johnson&nbsp;&amp; Johnson, Eximias Pharmaceutical and YM
BioSciences. Mr.&nbsp;Jackson holds a B.S. in pharmacy from the Philadelphia College of Pharmacy and Science and an M.B.A. from the University of Notre&nbsp;Dame. Mr.&nbsp;Jackson serves as chairman of the board of trustees of the Eastern
Pennsylvania Chapter of The Leukemia and Lymphoma Society<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP>. Based on Mr.&nbsp;Jackson&#146;s depth of experience in the biotechnology industry ranging from executive officer to director roles
and experience with commercial development, the Board believes Mr.&nbsp;Jackson has the appropriate set of skills to serve as a member of our Board. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>David Stump, M.D., age 67 </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Dr.&nbsp;Stump has served as a director since September 2013. Dr.&nbsp;Stump was most recently Executive Vice President, Research and
Development at Human Genome Sciences, Inc. (&#147;HGS&#148;), where he was employed from </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
November 1999 until his retirement in December 2012. Dr.&nbsp;Stump also serves as a director of Sunesis Pharmaceuticals, Inc., Portola Pharmaceuticals, Inc., and REGENXBIO, Inc., which are
publicly held companies. The Board believes that Dr.&nbsp;Stump&#146;s medical training and 23 years of experience in research and development and operations in the biotechnology industry as well as his public company board service qualify him to
serve as a member of our Board. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Class III Directors Continuing in Office Until the 2019 Annual Meeting of Stockholders </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Paulo Costa, age 66 </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Mr.&nbsp;Costa has served as a director since June 2009. Mr.&nbsp;Costa served as President and Chief Executive Officer of Novartis U.S.
Corporation, from October 2005 to August 2008. Prior to his work at Novartis U.S. Corporation, Mr.&nbsp;Costa was President and Chief Executive Officer of Novartis Pharmaceuticals, US from July 1999 to September 2005. From August 2009 to August
2012, Mr.&nbsp;Costa served as chairman of the Board of Directors of Amylin Pharmaceuticals Inc., a publicly held company, and currently serves as a director of two privately held, life science companies. Based on Mr.&nbsp;Costa&#146;s diverse
experience in the pharmaceutical industry, ranging from successful product development, launch and commercialization and his extensive senior management experience within the industry, as well as his experience serving on numerous boards, our Board
believes Mr.&nbsp;Costa has the appropriate set of skills to serve as a member of our Board. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Karen Ferrante, M.D., age 59
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Dr.&nbsp;Ferrante has served as a director since January 2017. Dr.&nbsp;Ferrante, a hematologist-oncologist, most recently served
as Chief Medical Officer and Head of Research and Development at Tokai Pharmaceuticals and brings over 20 years of oncology drug development experience to the Board. Prior to Tokai, Dr.&nbsp;Ferrante held several senior level positions at Millennium
Pharmaceuticals and parent company Takeda Pharmaceuticals, including Oncology Therapeutic Area Head, Takeda Cambridge Site Head and Chief Medical Officer. Dr.&nbsp;Ferrante previously held positions of increasing responsibility at Pfizer Global
Research and Development and Bristol-Myers Squibb. Dr.&nbsp;Ferrante holds an M.D. from Georgetown University and completed her internship and residency in internal medicine at New England Deaconess Hospital (now part of Beth Israel Deaconess
Medical Center) followed by a fellowship in hematology and oncology. She currently serves as a member of the boards of Chi-Med, a publicly traded biopharmaceutical company, Progenics Pharmaceuticals, and the New&nbsp;England Women in Science
Executives Club. Based on Dr.&nbsp;Ferrante&#146;s depth of experience in the biotechnology industry, ranging from executive officer to director roles, the Board believes Dr.&nbsp;Ferrante has the appropriate set of skills to serve as a member of
our Board. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Edward Hurwitz, age 53 </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Mr.&nbsp;Hurwitz has served as a director since October 2004. Mr.&nbsp;Hurwitz is a Managing Director of MPM Capital, a venture capital firm.
From January 2015 through December 2016, Mr.&nbsp;Hurwitz was a Managing Director of Precision BioVentures, LLC, a consulting and investment advisory firm. He was a director of Alta BioPharma III, L.P., and Alta Partners VIII, funds affiliated with
Alta Partners, a venture capital firm, from 2002 through December 2014. Mr.&nbsp;Hurwitz also serves as a director of Applied Genetic Technologies Corporation. The Board believes that Mr.&nbsp;Hurwitz&#146;s financial and scientific expertise, as
well as his deep understanding of the biotechnology industry, makes him an important asset to our Board as it assesses both financial and strategic decisions. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc337004_3"></A>DIRECTOR COMPENSATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have adopted a Director Compensation Program (the &#147;Director Plan&#148;) for our non-employee directors. Our directors who are
employees are compensated for their service as employees and do not receive any additional compensation for their service on our Board. Pursuant to the Director Plan, our non-employee directors receive an annual retainer of $35,000. If our Chairman
is a non-employee director, the Chairman receives an additional annual retainer of $27,500. In addition, all non-employee directors who serve on one or more committees are eligible to receive the following committee fees: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="61%"></TD>
<TD VALIGN="bottom" WIDTH="13%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="13%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:35.45pt; font-size:8pt; font-family:Times New Roman">Committee</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Member&nbsp;Annual<BR>Retainer</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Chair&nbsp;Additional<BR>Retainer</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Audit Committee</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">7,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">15,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Compensation Committee</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">5,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">10,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Nominating and Corporate Governance Committee</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">4,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">7,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our directors may elect to receive these retainer amounts in cash or stock options based on the <FONT
STYLE="white-space:nowrap">Black-Scholes</FONT> value of the dollar amount of the retainer as of the date of grant. Other than the annual retainers and committee fees paid pursuant to our Director Plan described above, non-employee directors are not
entitled to receive any cash fees in connection with their service on our Board. In addition, non-employee directors are entitled to receive an option to purchase shares of our common stock upon initial election or appointment to the Board (the
&#147;Initial Option&#148;) and an option to purchase shares of our common stock annually thereafter (the &#147;Annual Option&#148;). The amount of shares subject to the Initial Option and Annual Option for 2016 were 17,000 and 8,500, respectively.
For 2017, those amounts have been increased to 20,000 and 10,000 shares, respectively. Director compensation is reviewed regularly, generally on an annual basis, by our Compensation Committee. In setting director compensation, including any
modifications to the Director Plan, the Compensation Committee considers several factors including the Company&#146;s size and stage of development and market data of the Company&#146;s peer group. The Compensation Committee also considers
recommendations from its independent consultant in making these determinations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Options granted to non-employee directors have a per
share exercise price equal to the per share fair market value of our common stock as of the date of grant and vest as to 1/12th of the shares of our common stock underlying such option monthly, beginning on the first monthly anniversary of the
applicable grant date, subject to the director&#146;s continued service on our Board through each vesting date. The Initial Option is granted on the date the director first joins the Board and the Annual Option is granted on the date of the first
Board meeting held after each Annual Meeting of stockholders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table sets forth information concerning the compensation
earned by our non-employee directors during the year ended December&nbsp;31, 2016. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="54%"></TD>
<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:19.10pt; font-size:8pt; font-family:Times New Roman">Name</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Fees&nbsp;Earned&nbsp;or<BR>Paid in Cash</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Option&nbsp;Awards&nbsp;(1)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Total</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Paulo Costa (2)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">17,125</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">179,079</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">196,204</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Matthew Fust</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">61,375</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">107,392</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">168,767</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Kenneth Galbraith</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">53,750</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">107,392</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">161,142</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Edward Hurwitz</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">57,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">107,392</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">164,892</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">David Stump, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">40,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">107,392</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">147,392</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top">Amount reflects the aggregate grant date fair value of options granted during 2016 computed in accordance with ASC Topic 718 <I>Stock Compensation</I>, as used by analogy for non-employees. The assumptions used in the
valuation of these awards are set forth in Note 6 to our financial statements, which are included in our Form 10-K. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top">Mr.&nbsp;Costa elected to receive his 2016 fees in stock options. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of December&nbsp;31, 2016, each of our non-employee directors held the following outstanding
options: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="82%"></TD>
<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:19.10pt; font-size:8pt; font-family:Times New Roman">Name</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Shares<BR>Subject to<BR>Outstanding<BR>Options</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Paulo Costa</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">46,760</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Matthew Fust</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">37,773</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Kenneth Galbraith</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">37,773</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Edward Hurwitz</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">37,773</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">David Stump, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">37,773</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc337004_4"></A>PROPOSAL NO. 2 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>RATIFICATION OF SELECTION OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Ernst&nbsp;&amp; Young LLP currently serves as our independent registered public accounting firm. After consideration of the firm&#146;s
qualifications and past performance, the Audit Committee of our Board of Directors has appointed Ernst&nbsp;&amp; Young LLP as our independent registered public accounting firm for the fiscal year ending December&nbsp;31, 2017. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In accordance with the rules of the Securities and Exchange Commission and our Audit Committee&#146;s charter, the Audit Committee is directly
responsible for the selection, appointment, compensation, and oversight of the Company&#146;s independent registered public accounting firm and is not required to submit this appointment to a vote of the stockholders. The Board, however, considers
the appointment of the independent registered public accounting firm to be an important matter of stockholder concern and is submitting the appointment of Ernst&nbsp;&amp; Young for ratification by our stockholders as a matter of good corporate
practice. One or more representatives of Ernst&nbsp;&amp; Young is expected to be present at the Annual Meeting and will have an opportunity to make a statement and respond to appropriate questions from stockholders. In the event that our
stockholders fail to ratify the appointment of Ernst&nbsp;&amp; Young, it will be considered as a direction to the Audit Committee to consider the appointment of a different firm. Even if the appointment is ratified, the Audit Committee in its
discretion may select a different independent registered public accounting firm at any time during the year if it determines that such a change would be in the best interests of the Company and its stockholders. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Required Vote and Board Recommendation </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Ratification of the appointment of Ernst&nbsp;&amp; Young as the Company&#146;s independent registered public accounting firm requires the
affirmative vote of a majority of the votes cast on the matter. Abstentions are not considered votes cast and, therefore, will have no effect on the voting outcome. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>The Board of Directors recommends a vote </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>&#147;FOR&#148; the ratification of the appointment of Ernst&nbsp;&amp; Young LLP. </B></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Principal Accountant Fees and Services </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table provides information regarding the fees paid to Ernst&nbsp;&amp; Young LLP during the years ended December&nbsp;31, 2016
and 2015. All fees described below were approved by the Audit Committee. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="66%"></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Year Ended December&nbsp;31,</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">2016</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">2015</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Audit Fees (1)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">850,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">843,999</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Audit-Related Fees (2)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">62,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">114,870</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tax Fees (3)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">115,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">94,299</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">All Other Fees</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total Fees</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,030,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,053,168</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top">Audit fees for 2016 and 2015 were for professional services rendered for the audits of our financial statements, attestation services with respect to our internal control over financial reporting, reviews of quarterly
financial statements and consents related to regulatory filings. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top">Audit-related fees for 2016 and 2015 were for services associated with our follow-on offerings, consultations concerning financial accounting and other audit requirements. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top">Tax fees for 2016 consist of $94,000 for tax compliance, including the preparation, review and filing of tax returns, and $1,500 for tax advice and planning. Tax fees for 2015 consist of $64,500 for tax compliance,
including the preparation, review and filing of tax returns, and $29,799 for tax advice and planning. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Pre-Approval Policies and Procedures </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Audit Committee pre-approves all audit and non-audit services provided by its independent registered public accounting firm. This policy is
set forth in the charter of the Audit Committee and available on the Corporate Governance section of our website at http://ir.macrogenics.com/corporate-governance.cfm. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Audit Committee approved all audit, audit-related, tax and other services provided by Ernst&nbsp;&amp; Young LLP for 2016 and 2015 and the
estimated costs of those services. Actual amounts billed, to the extent in excess of the estimated amounts, were periodically reviewed and approved by the Audit Committee. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc337004_5"></A>AUDIT COMMITTEE REPORT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>The material in this report is not &#147;soliciting material,&#148; is not deemed &#147;filed&#148; with the SEC, and is not to be incorporated by
reference into any filing by MacroGenics under the Securities Act of 1933, as amended (the &#147;Securities Act&#148;), or the Securities Exchange Act of 1934 (the &#147;Exchange Act&#148;), as amended. </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The primary purpose of the Audit Committee is to oversee the Company&#146;s financial reporting processes on behalf of the Board. The Audit
Committee&#146;s functions are more fully described in its charter, which is available on the Corporate Governance section of the Company&#146;s website at http://ir.macrogenics.com/corporate-governance.cfm. Management has the primary responsibility
for the Company&#146;s financial statements and reporting processes, including the Company&#146;s systems of internal controls. In fulfilling its oversight responsibilities, the Audit Committee reviewed and discussed with management
MacroGenics&#146; audited financial statements and the effectiveness of the Company&#146;s internal controls over financial reporting as of and for the year ended December&nbsp;31, 2016. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Audit Committee has discussed with Ernst&nbsp;&amp; Young LLP, the Company&#146;s independent registered public accounting firm, the
matters required to be discussed under generally accepted auditing standards including Auditing Standard No.&nbsp;1301. In addition, the Audit Committee discussed with Ernst&nbsp;&amp; Young LLP its independence, and received from Ernst&nbsp;&amp;
Young LLP the written disclosures and the letter required by Ethics and Independence Rule 3526 of the Public Company Accounting Oversight Board. Finally, the Audit Committee discussed with Ernst&nbsp;&amp; Young LLP, with and without management
present, the scope and results of Ernst&nbsp;&amp; Young LLP&#146;s audit of such financial statements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Based on these reviews and
discussions, the Audit Committee recommended to the Board that such audited financial statements be included in the Company&#146;s Annual Report on Form 10-K for the year ended December&nbsp;31, 2016, for filing with the SEC. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:54%; text-indent:-2%; font-size:10pt; font-family:Times New Roman"><B>Audit Committee </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:54%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Matthew Fust, Chairman </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:54%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Kenneth Galbraith </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:54%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Edward Hurwitz </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc337004_6"></A>PROPOSAL NO. 3 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ADVISORY VOTE ON EXECUTIVE COMPENSATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In 2016, stockholders voted, on an advisory basis, to hold an annual advisory vote on the compensation of our named executive officers.
Pursuant to that guidance and consistent with Section&nbsp;14A of the Exchange Act, our Board of Directors is asking stockholders to approve an advisory vote on the following resolution: <B> </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>RESOLVED</B>, that the compensation paid to MacroGenics&#146; named executive officers, as disclosed pursuant to the compensation disclosure
rules of the SEC, including the compensation discussion and analysis, the compensation tables and any related material disclosed in this proxy statement, is hereby approved. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As an advisory vote, this proposal is not binding. Although the vote is non-binding, our Compensation Committee and Board of Directors value
the opinions expressed by our stockholders in their vote on this proposal and will consider the outcome of the vote when making future compensation decisions for our named executive officers. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our executive compensation programs are designed to attract, motivate, and retain executive officers who are critical to our success. Under
these programs, our named executive officers are rewarded for the achievement of our near-term and longer-term financial and strategic goals and for driving corporate financial performance and stability. The programs contain elements of cash and
equity-based compensation and are designed to align the interests of our executives with those of our stockholders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The &#147;Executive
Compensation&#148; section of this proxy statement beginning on page 23, including &#147;Compensation Discussion and Analysis,&#148; describes in detail our executive compensation programs and the decisions made by the Compensation Committee with
respect to 2016. Highlights of our executive compensation philosophy include the following: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">A significant portion of each senior executive&#146;s compensation should be variable, based on a combination of individual and corporate performance; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Compensation opportunities should be competitive with clinical-stage biopharmaceutical companies of similar size and comparable stage of development, but also should be designed to be flexible enough to attract talent
as needed from other biopharmaceutical companies; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">The equity compensation program should align executive interests with those of stockholders; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Supplemental benefits and perquisites should be limited and used selectively in specific circumstances to attract and retain executives. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As we describe in the &#147;Compensation Discussion and Analysis&#148; section of this proxy statement, our executive compensation program
embodies a pay-for-performance philosophy that we believe supports our business strategy and aligns the interests of our executives with those of our stockholders. The Board of Directors believes this link between compensation and the achievement of
our near- and long-term business goals has helped drive our performance over time. At the same time, we believe our program does not encourage excessive risk-taking by management. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Vote Required and Board Recommendation </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Approval of the advisory vote on the compensation of our named executive officers requires the affirmative vote of a majority of the votes cast
on the proposal. Abstentions are not considered votes cast and, therefore, will have no effect on the vote outcome. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>The Board of
Directors recommends a vote &#147;FOR&#148; the approval of the advisory vote on the compensation of our named executive officers. </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc337004_7"></A>PROPOSAL NO. 4 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>APPROVAL OF THE 2016 EMPLOYEE STOCK PURCHASE PLAN </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are requesting that stockholders vote to approve the Plan, which our Board of Directors adopted on September&nbsp;14, 2016. Subject to
shareholder approval, 800,000 shares of common stock have been reserved for issuance under the Plan. The Plan is intended to qualify as an &#147;employee stock purchase plan&#148; under Section&nbsp;423 of the Internal Revenue Code of 1986 (the
&#147;Code&#148;). The purpose of the Plan is to provide eligible employees with opportunities to purchase shares of the Company&#146;s stock through payroll deductions at a discounted price. A copy of the Plan is attached to this Proxy Statement as
<U>Appendix A</U>. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Summary of the 2016 Employee Stock Purchase Plan </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following is a brief summary of the Plan. This summary is qualified in its entirety by reference to the full text of the Plan, a copy of
which is attached as <U>Appendix A</U>. You are urged to read the text of the Plan in its entirety. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Plan provides eligible employees
of the Company with opportunities to purchase shares of Company common stock at a discounted price. The Company will make one or more offerings to eligible employees to purchase Common Stock under the Plan. In general, each offering will extend for
a six-month period (&#147;Plan Period&#148;), during which the Company will withhold via payroll deduction the amount elected by the eligible employee for purposes of purchasing common stock at the end of the Plan Period. Unless the Board or a
Committee appointed by the Board chooses a different Plan Period of 12 months or less, the Company will have two six-month Plan Periods per year: a June Plan Period commencing on June&nbsp;1 and ending on November&nbsp;30, and a December Plan Period
commencing on December&nbsp;1 and ending on May&nbsp;31 of the following calendar year. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Eligibility to participate in the Plan is
generally determined for each Plan Period. Employees of the Company who were employed not later than the last day of the enrollment period for the next applicable Plan Period, and who customarily work more than twenty hours per week will be eligible
to participate in the Plan for that Plan Period. An employee may not participate in the Plan if he or she would then own 5% or more of the voting power or the value of the Company&#146;s common stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">General terms and features of participation include: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">voluntary participation by employees, with the right to withdraw at any time prior to the close of business on the last business day of the Plan Period. A withdrawing employee may not resume participation during the
remainder of the Plan Period, but may participate in the next Plan Period if the employee continues to meet the eligibility requirements; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">eligible employees may elect to have up to 10% of their eligible compensation withheld on an after-tax basis via payroll deduction for purposes of purchasing shares at the end of the Plan Period; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">purchases of shares are made on the last business day of the Plan Period, subject to the limitations described below; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">purchase price per share is 85% of the closing price of the common stock on the last business day of the Plan Period; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">an employee may not buy more than $25,000 worth of stock in any calendar year, based on the fair market value of the stock for each calendar year in which an Option to purchase shares under the Plan is outstanding;
</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">no employee may purchase more than 800 shares on any purchase date for a Plan Period of six months or less. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Plan provides for certain adjustments to be made to (i)&nbsp;the number and class of securities available under this Plan, (ii)&nbsp;the
share limitations under the Plan, and (iii)&nbsp;the Option Price in the event of any stock split, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
reverse stock split, stock dividend, recapitalization, combination of shares, reclassification of shares, spin-off or other similar change in capitalization or event, or any distribution to
holders of common stock other than an ordinary cash dividend. In addition, the Board has authority under the Plan to take a number of actions with respect to outstanding Options in the event of a merger or consolidation. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Plan is administered by the Board or by a committee appointed by the Board, and the Board has delegated responsibility for its
administration to the Compensation Committee. The Plan may be amended by the Board or a committee appointed by the Board from time to time in any respect, except that (i)&nbsp;if Section&nbsp;423 of the Code requires that such amendment be approved
by the stockholders of the Company, such amendment will not be effected without such approval, and (ii)&nbsp;in no event may any amendment be made which would cause the Plan to fail to comply with Section&nbsp;423 of the Code. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>New Plan Benefits </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">While all employees
eligible to participate in the Plan could purchase as much as $25,000 worth of our common stock in a single year, the actual amount or value of shares purchased by any given employee or group of employees is not determinable because it depends on
the elections of each employee who chooses to participate. Therefore, it is not possible to determine the benefits that will be received in the future by participants in the Plan. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Federal Income Tax Consequences </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
following generally summarizes certain key United States federal income tax consequences that will arise with respect to participation in the Plan and with respect to the sale of common stock acquired under the Plan. This summary is based on the tax
laws in effect as of the date of this proxy statement. Changes to these laws could alter the tax consequences described below. The following summary is not intended to be a complete summary or legal interpretation, and it does not address
consequences other than U.S. federal tax consequences. Eligible employees also might be subject to state or local tax, including tax in jurisdictions outside the U.S., as a result of participating in the Plan. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Tax Consequences to Participants. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Participants do not experience any federal income tax consequences upon enrolling in the Plan. Amounts withheld via payroll deduction for
purposes of purchasing shares under the Plan are included in the participant&#146;s income in accordance with the Company&#146;s regular income and payroll tax withholding and reporting procedures. Because participants use after-tax dollars to
purchase shares at the end of the Plan Period, there is no income tax at the time the participant purchases shares. As a general matter, additional income tax is not realized until the participant sells the shares acquired under the Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A participant may have both ordinary income and capital gain income or both ordinary income and a capital loss upon the sale of common stock
that was acquired under the plan. The amount of each type of income and loss will depend on when the participant sells the common stock and the price at which the participant sells the common stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the participant sells the common stock more than two years after the commencement of the offering during which the common stock was
purchased and more than one year after the date that the participant purchased the common stock, then the participant will have ordinary income equal to the lesser of: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) 15% of the value of the common stock on the day the offering commenced; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) the participant&#146;s profit (the excess of the sales proceeds over the purchase price). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any profits in excess of amounts classified as ordinary income will be taxed as long-term capital gain income. If the participant sells the
common stock at a loss (if sales proceeds are less than the purchase price) </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
after satisfying these waiting periods, there is no ordinary income and the participant will have a long-term capital loss for the difference between the sale price and the purchase price. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the participant sells the common stock prior to satisfying these waiting periods, including by way of gift, then he or she will have
engaged in a disqualifying disposition. Upon a disqualifying disposition, the participant will have ordinary income equal to the value of the common stock on the day he or she purchased the common stock less the purchase price. If the
participant&#146;s profit exceeds the ordinary income, then the excess profit will be a capital gain. If the participant&#146;s profit is less than the ordinary income, then the participant will have a capital loss equal to the value of the common
stock on the day he or she purchased the common stock less the sales proceeds. This capital gain or loss will be long-term if the participant has held the stock for more than one year and otherwise will be short-term. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Tax Consequences to the Company: </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">There will be no tax consequences to the Company except that we will be entitled to a deduction when a participant has ordinary income upon a
disqualifying disposition. Any such deduction will be subject to the limitations of Section&nbsp;162(m) of the Code (&#147;Section 162(m)&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>The Board of Directors deems the Plan to be in the best interest of MacroGenics, Inc. and its stockholders and recommends a vote
&#147;FOR&#148; the approval of the Plan. </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc337004_8"></A>CORPORATE GOVERNANCE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Corporate Policies </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have adopted a
code of business conduct and ethics that applies to all of our employees, officers and directors, including those officers responsible for financial reporting. The code of business conduct and ethics is available under the Corporate Governance
section of our website at http://ir.macrogenics.com/corporate-governance.cfm. We expect that any amendments to the code, or any waivers of its requirements, will be disclosed on our website. The references to our web address in this proxy statement
do not constitute incorporation by reference of the information contained at or available through our website. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Independence of the Board of Directors
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As required under NASDAQ rules and regulations, a majority of the members of our Board of Directors must qualify as
&#147;independent,&#148; as affirmatively determined by the Board. The Board consults with the Company&#146;s counsel to ensure that the Board&#146;s determinations are consistent with all relevant securities and other laws and regulations regarding
the definition of &#147;independent,&#148; including those set forth in pertinent NASDAQ listing standards, as in effect from time to time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The NASDAQ independence definition includes a series of objective tests, such as that the director is not, and has not been for at least three
years, one of our employees and that neither the director nor any of his/her family members has engaged in various types of business dealings with us. In addition, as required by NASDAQ rules, our Board has evaluated, with respect to each of our
directors whether any relationships exist, which, in the opinion of our Board, would interfere with the exercise of independent judgment in carrying out the responsibilities of a director. Consistent with these considerations, our Board has
determined that all of our directors, other than Dr.&nbsp;Koenig, qualify as &#147;independent&#148; directors in accordance with the NASDAQ listing requirements. Dr.&nbsp;Koenig is not considered independent because he is an employee of
MacroGenics. In making these determinations, our Board reviewed and discussed information provided by the directors and us with regard to each director&#146;s business and personal activities and relationships as they may relate to us and our
management. There are no family relationships among any of our directors or executive officers. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As required under NASDAQ rules and
regulations, our independent directors meet in regularly scheduled executive sessions at which only independent directors are present. All of the committees of our Board are comprised entirely of directors determined by the Board to be independent
within the meaning of NASDAQ rules and regulations. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Leadership Structure of the Board </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board of Directors does not have a policy regarding whether the roles of Chief Executive Officer and Chairman of the Board should be
separate and, if they are to be separate, whether the Chairman of the Board should be a non-employee director. Currently, Mr.&nbsp;Costa, a non-employee director, serves as the Chairman of the Board and Dr.&nbsp;Koenig serves as a director and Chief
Executive Officer. The Board will continue to periodically review our leadership structure and may make such changes in the future as it deems appropriate and in the best interests of the Company and its stockholders. However, the Board believes
that separation of the roles of Chief Executive Officer and Chairman of the Board is currently the most appropriate structure for the Company because this structure is consistent with best corporate governance practices. In addition, our Board
believes this structure creates an environment in which there are candid disclosures by management about the Company&#146;s performance and a culture in which directors can regularly engage management and each other in active and meaningful
discussions about various corporate matters. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Role of Board in Risk Oversight Process </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Risk assessment and oversight are an integral part of our governance and management processes. Our Board encourages management to promote a
culture that incorporates risk management into our corporate strategy and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
day-to-day business operations. Management discusses strategic and operational risks at regular management meetings, and conducts specific strategic planning and review sessions during the year
that include a focused discussion and analysis of the risks facing us. Throughout the year, senior management reviews these risks with the Board at regular Board meetings as part of management presentations that focus on particular business
functions, operations or strategies, and presents the steps taken by management to mitigate or eliminate such risks. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Board does not
have a standing risk management committee, but rather administers this oversight function directly through our Board as a whole, as well as through various standing committees of our Board that address risks inherent in their respective areas of
oversight. In particular, our Board is responsible for monitoring and assessing strategic risk exposure and our Audit Committee is responsible for overseeing our major financial risk exposures and the steps our management has taken to monitor and
control these exposures. The Audit Committee also monitors compliance with legal and regulatory requirements and considers and, if appropriate, approves any related-person transactions. Our Nominating and Governance Committee monitors the
effectiveness of our corporate governance. Our Compensation Committee assesses and monitors whether any of our compensation policies and programs has the potential to encourage excessive risk-taking. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Board Committees </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Audit Committee </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Audit Committee oversees the accounting and financial reporting processes of the Company and audits of the Company&#146;s financial
statements. The primary function of the Audit Committee is to provide assistance to the Board of Directors in fulfilling its responsibilities relating to corporate accounting and auditing, reporting practices of the Company, the quality and
integrity of the financial reports of the Company, the Company&#146;s systems of internal controls regarding finance, accounting, legal compliance and ethics that management and the Board have established, the performance of the Company&#146;s
internal audit function, if any, and independent auditor, and the qualifications and independence of the Company&#146;s independent auditor. The Audit Committee also maintains a free and open means of communication between directors, the independent
auditor, the internal auditor, if any, and the management of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The current members of our Audit Committee are Matthew Fust,
Kenneth Galbraith and Edward Hurwitz. Mr.&nbsp;Fust serves as the chair of the Audit Committee. All members of our Audit Committee meet the requirements for financial literacy under the applicable rules and regulations of the SEC and NASDAQ. Our
Board has determined that each of Messrs. Fust, Galbraith and Hurwitz qualifies as an &#147;audit committee financial expert&#148; as defined under the applicable rules of the SEC and has the requisite financial sophistication as defined under the
applicable rules and regulations of NASDAQ. Our Board has determined that each of Messrs. Fust, Galbraith and Hurwitz are independent under the applicable rules of NASDAQ and under the applicable rules of the SEC, in particular, Rule 10A-3 of the
Exchange Act. The Audit Committee operates under a written charter that satisfies the applicable standards of the SEC and NASDAQ and the committee reviews compliance with its charter annually. A copy of the Audit Committee charter is is available on
the Corporate Governance section of the Company&#146;s website at http://ir.macrogenics.com/corporate-governance.cfm. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Compensation Committee
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Compensation Committee reviews and evaluates our compensation philosophy for executive officers. The Compensation Committee
reviews and approves both corporate and individual goals and objectives relevant to compensation of our Chief Executive Officer, evaluates the performance of the Chief Executive Officer in light of those goals and objectives and determines and
approves his compensation based on such evaluations. The Compensation Committee also determines and approves the compensation for all of the Company&#146;s executive officers, and oversees Dr.&nbsp;Koenig&#146;s grant of stock options and other
awards to employees other than executive officers. The Compensation Committee also reviews director compensation, including retainers for committee service at least annually and recommends any changes to the Board. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The current members of our Compensation Committee are Edward Hurwitz, Paulo Costa, Scott Jackson
and David Stump, M.D. Mr.&nbsp;Hurwitz serves as the chair of the Compensation Committee. Each of the members of our Compensation Committee is independent under the applicable rules and regulations of NASDAQ, and under the applicable rules of the
SEC, in particular, Rule 10C-1 under the Exchange Act, is a &#147;non-employee director&#148; as defined in Rule 16b-3 promulgated under the Exchange Act, and is an &#147;outside director&#148; as that term is defined in Section&nbsp;162(m). The
Compensation Committee operates under a written charter and the committee reviews compliance with its charter annually. A copy of the Compensation Committee charter is available on the Corporate Governance section of the Company&#146;s website at
http://ir.macrogenics.com/ corporate-governance.cfm. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Nominating and Corporate Governance Committee </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Nominating and Corporate Governance Committee is responsible for making recommendations to our Board regarding candidates for directorships
and the size and composition of our Board. In addition, the Nominating and Corporate Governance Committee is responsible for overseeing our corporate governance policies and reporting and making recommendations to our Board concerning governance
matters, including, on an annual basis, director independence. The current members of our Nominating and Corporate Governance committee are Kenneth Galbraith, Paulo Costa, Karen Ferrante, M.D. and Matthew Fust. Mr.&nbsp;Galbraith serves as the chair
of the Nominating and Corporate Governance Committee. Each of the members of our Nominating and Corporate Governance Committee is an independent director under the applicable rules and regulations of NASDAQ. The Nominating and Corporate Governance
Committee operates under a written charter and the committee reviews compliance with its charter annually. A copy of the Nominating and Corporate Governance Committee charter is available on the Corporate Governance section of the Company&#146;s
website at http://ir.macrogenics.com/corporate-governance.cfm. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In recommending candidates for election to the Board at the Annual Meeting
or any special meeting of stockholders, the independent members of the Nominating and Corporate Governance Committee may consider such factors as personal and professional integrity, ethics and values, experience in corporate management, experience
in the industries in which we compete, experience as a board member or executive officer of another publicly held company, diversity of expertise and experience in substantive matters pertaining to our business relative to other Board members,
conflicts of interest, practical and mature business judgment and any other areas as may be expected to contribute to an effective Board. With respect to diversity, the Nominating and Corporate Governance Committee may consider such factors as
differences of viewpoint, professional experience, education, skill, and other individual qualities and attributes that contribute to board heterogeneity, including characteristics such as race, gender, and national origin. The Board evaluates each
individual in the context of the Board as a whole, with the objective of assembling a group that can best maximize the success of the business and represent stockholder interests through the exercise of sound judgment using its diversity of
experience in these various areas. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Nominating and Corporate Governance Committee will consider director candidates recommended by
stockholders. For a stockholder to make any nomination for election to the Board at an Annual Meeting, the stockholder must provide notice to the Company in a timely manner. See &#147;When are stockholder proposals or director nominations due for
next year&#146;s Annual Meeting?&#148; for additional information. Our by-laws specify requirements as to the form and content of a stockholder&#146;s notice and updates and supplements to such notice. We recommend that any stockholder wishing to
make a nomination for director review a copy of our by-laws, which is available, without charge, from our Corporate Secretary, at 9704 Medical Center Drive, Rockville, Maryland 20850. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Meetings of the Board of Directors, Board and Committee Member Attendance and Annual Meeting Attendance </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Board met seven times during the last year. The Audit Committee met six times, the Compensation Committee met four times and the Nominating
and Corporate Governance Committee met five times during last </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
year. During 2016, all then current Board members attended 75% or more of the meetings of the Board and of the committees on which they served. We encourage all of our directors and nominees for
director to attend our Annual Meeting, but attendance is not mandatory. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Stockholder Communications with the Board of Directors </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Should stockholders wish to communicate with the Board or any specified individual directors, such correspondence should be sent to the
attention of the Corporate Secretary at 9704 Medical Center Drive, Rockville, Maryland 20850. The Corporate Secretary will forward the communication to the Board members. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Compensation Committee Interlocks and Insider Participation </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">None of the members of our Compensation Committee has at any time been one of our officers or employees. None of our executive officers
currently serves, or in the past fiscal year has served, as a member of the Board of Directors or compensation committee of any entity that has one or more executive officers on our Board or Compensation Committee. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc337004_9"></A>CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Since January&nbsp;1, 2016, there has not been, nor is there any proposed transaction where we were or will be a participant in which the
amount involved exceeded or will exceed $120,000 and in which any director, executive officer, holder of more than 5% of any class of our voting securities, or any member of the immediate family of any of the foregoing persons had or will have a
direct or indirect material interest, other than the compensation agreements and other agreements and transactions which are described in &#147;Executive Compensation&#151;Overview of Employment and Change in Control Agreements&#148; or those
described immediately below. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In December 2014, we entered into a collaboration and license agreement with Janssen Biotech, Inc.
(&#147;Janssen&#148;), relating to one of our programs, designated MGD011, and concurrently entered into a stock purchase agreement and an investor agreement with Johnson&nbsp;&amp; Johnson Innovation&#151;JJDC, Inc. (&#147;JJDC&#148;), an affiliate
of Janssen. The transactions contemplated by these agreements closed in the first quarter of 2015. Under the terms of this stock purchase agreement, JJDC acquired 1,923,077 shares of our common stock, which is approximately 5.5% of our common stock
as of March&nbsp;24, 2017. JJDC has certain rights and is subject to certain restrictions as set forth in greater detail in the above referenced investor agreement. JJDC does not have any rights to appoint individuals to our Board of Directors or
otherwise direct our general operations. There are on-going rights and obligations set forth in the collaboration and license agreement with Janssen, under which Janssen can control and direct the MGD011 program subject to the terms of that
agreement; however, Janssen does not have any rights to direct our general operations. For additional information, see the descriptions of these agreements in our Form 10-K. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In May 2016, we announced a global collaboration and license agreement for MGD015, a preclinical bispecific molecule, with Janssen. Under the
terms of the agreement, the Company received a $75 million upfront license fee. Janssen will complete IND-enabling activities and be fully responsible for future clinical development of MGD015. Assuming successful development and commercialization,
the Company could receive up to an additional $665 million in clinical, regulatory and commercialization milestone payments. The Company may elect to fund a portion of late-stage clinical development in exchange for a profit share in the U.S. and
Canada. If commercialized, the Company would be eligible to receive double-digit royalties on any global net sales and has the option to co-promote MGD015 with Janssen in the U.S. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Policies and Procedures for Related Party Transactions </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Audit Committee is responsible for reviewing and approving, prior to our entry into any related party transactions and potential conflict
of interest situations involving a principal stockholder, a member of the Board of Directors or senior management. With certain exceptions set forth in Item&nbsp;404 of Regulation S-K under the Securities Act, the Audit Committee&#146;s authority
covers any transaction, arrangement or relationship, or any series of similar transactions, arrangements or relationships in which we were or are to be a participant, where the amount involved exceeds $120,000 and a related person had or will have a
direct or indirect material interest, including, without limitation, purchases of goods or services by or from the related person or entities in which the related person has a material interest, indebtedness, guarantees of indebtedness and
employment by us of a related person. In reviewing and approving any such transactions, our Audit Committee considers all relevant facts and circumstances, including, but not limited to, whether the transaction is on terms comparable to those that
could be obtained in an arm&#146;s length transaction and the extent of the related person&#146;s interest in the transaction. In addition, our Company policies require that our officers and employees avoid using their positions for purposes that
are, or give the appearance of being, motivated by a desire for personal gain, and our policies further require that all officers and employees report any potential related party transaction prior to entering into such transaction. All such notices
concerning related party transactions or conflicts of interest are submitted to, and reviewed by, our general counsel, our chief financial officer and our Audit Committee. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc337004_10"></A>EXECUTIVE OFFICERS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following sets forth certain information regarding our current executive officers as of March&nbsp;24, 2017: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="23%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="71%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:19.10pt; font-size:8pt; font-family:Times New Roman">Name</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Age</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:34.55pt; font-size:8pt; font-family:Times New Roman">Position(s)</P></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Scott Koenig, M.D., Ph.D</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">64</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">President, Chief Executive Officer and Director</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">James Karrels</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Senior Vice President, Chief Financial Officer and Corporate Secretary</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Ezio Bonvini, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">63</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Senior Vice President, Research and Chief Scientific Officer</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Eric Risser</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">44</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Senior Vice President, Business Development and Portfolio Management and Chief Business Officer</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Atul Saran</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">43</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Senior Vice President and General Counsel</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Jon Wigginton, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">55</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Senior Vice President, Clinical Development and Chief Medical Officer</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Thomas Spitznagel, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Senior Vice President, BioPharmaceutical Development and Manufacturing</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Lynn Cilinski</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">59</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Vice President, Controller and Treasurer</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Scott Koenig, M.D., Ph.D.,</I></B> President and Chief Executive Officer and a director since September
2001 and was one of our co-founders. See &#147;Directors and Nominees&#151;Class I Nominees for Election; Term Expiring at the 2020 Annual Meeting of Stockholders&#148; for Dr.&nbsp;Koenig&#146;s biography. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>James Karrels,</I></B> Senior Vice President, Chief Financial Officer and Corporate Secretary, joined us in May 2008 and has
approximately 25 years of experience in finance, with a significant portion of those working for, or on behalf of, life sciences companies. Prior to joining us, he served as Executive Director of Finance at Jazz Pharmaceuticals, Inc., where he was
responsible for the company&#146;s financial planning and analysis and investor relations activities. Prior to joining Jazz Pharmaceuticals, Mr.&nbsp;Karrels spent 11 years in the Investment Banking Group at Merrill Lynch, serving as a Director in
the Global Healthcare Group. Mr.&nbsp;Karrels holds an M.B.A. from Stanford University and a B.B.A. from the University of Notre Dame. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Ezio Bonvini, M.D.</I></B>, Senior Vice President, Research and Chief Scientific Officer, joined us in June 2003. From 1985 to 2003,
Dr.&nbsp;Bonvini was with the FDA in the Center for Biologics Evaluation and Research (CBER), which is responsible for regulating therapeutic monoclonal antibodies and other proteins, ultimately serving as Acting Deputy Director, Division of
Monoclonal Antibodies and Chief, Laboratory of Immunobiology. From 1982 to 1984, Dr.&nbsp;Bonvini was a Visiting Fellow at the National Cancer Institute at the National Institutes of Health. Dr.&nbsp;Bonvini received a Diploma in Science from the
Scientific Lyceum in Genoa, Italy, and his M.D. and Specialty Certification in Clinical Hematology from the University of Genoa, School of Medicine. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Eric Risser</I></B><I>,</I> Senior Vice President, Business Development and Portfolio Management and Chief Business Officer, joined us
in March 2009. Prior to joining us, Mr.&nbsp;Risser held the position of Senior Director, Business Development in the pharmaceutical group at Johnson&nbsp;&amp; Johnson, where he worked from 2003 to 2009. Before Johnson&nbsp;&amp; Johnson,
Mr.&nbsp;Risser started and built a consulting practice that provided counsel to emerging life science companies in the United States and Europe. Earlier in his career, Mr.&nbsp;Risser held venture capital and investment banking positions with BA
Venture Partners and Lehman Brothers Holdings Inc., respectively. Mr.&nbsp;Risser holds an M.B.A. from Stanford University and a B.A. from Yale University. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Atul Saran,</I></B> Senior Vice President and General Counsel, joined us in April 2014. Before joining MacroGenics, Mr.&nbsp;Saran spent
over a decade at AstraZeneca and MedImmune. From May 2013 through January 2014, Mr.&nbsp;Saran was Vice President, Corporate Development and Ventures for AstraZeneca PLC. During that time, he was responsible for AstraZeneca&#146;s global corporate
development strategies and also chaired the MedImmune Ventures Investment Committee. From January 2011 through May 2013, Mr.&nbsp;Saran was Senior Vice President, Corporate Development and Ventures for MedImmune, the biologics business for
AstraZeneca. During that time, he was responsible for corporate and business development, government contracting and oversight for MedImmune Ventures. From February 2003 through December 2010, Mr.&nbsp;Saran had positions of increasing
responsibility in the MedImmune legal department, both before and after its acquisition by </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
AstraZeneca, culminating as Vice President and Deputy General Counsel. Before joining MedImmune, Mr.&nbsp;Saran was a practicing attorney in the private equity/emerging business group at
Hogan&nbsp;&amp; Hartson, LLP in Washington, D.C. Mr.&nbsp;Saran holds an M.B.A. from the MIT Sloan School of Management, a J.D. from the University of Illinois College of Law and a B.S. in biological sciences from Stanford University. He is a
member of the bar in the State of California and in the District of Columbia. From August 2011 through January 2014, Mr.&nbsp;Saran served on the Board of Directors of Xencor, Inc., and also served on the Board of Directors of privately held
companies Arriva Pharmaceuticals, Inc., Inotek Pharmaceuticals Corporation and VentiRx Pharmaceuticals, Inc. He is currently a member of the Board of Directors of LogicNets, Inc., a private company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Jon Wigginton, M.D.</I></B>, Senior Vice President, Clinical Development and Chief Medical Officer, joined us in August 2013.
Dr.&nbsp;Wigginton was the Therapeutic Area Head, Immuno-Oncology, Early Clinical Research and Executive Director, Discovery Medicine-Clinical Oncology at Bristol-Myers from October 2008 to August 2013. While there, he led the early clinical
development of the Bristol-Myers&#146; Immuno-Oncology portfolio including anti-PD-1 and anti-PD-L1. Prior to joining Bristol-Myers, Dr.&nbsp;Wigginton was the Director of Clinical Oncology at Merck Research Laboratories from May 2006 to October
2008, where he led early- and late-stage clinical development teams for small molecules and biologics. During his academic career, Dr.&nbsp;Wigginton held several positions at the National Cancer Institute Center for Cancer Research (NCI-CCR),
including Head of Investigational Biologics Section, Pediatric Oncology Branch. Dr.&nbsp;Wigginton received his M.D. and B.S. in Biology from the University of Michigan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Thomas Spitznagel, Ph.D.</I></B>, Senior Vice President, BioPharmaceutical Development and Manufacturing, joined us in 2013. He has
overall responsibility for both biopharmaceutical development and manufacturing of MacroGenics&#146; Fc-optimized monoclonal antibodies and DART<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP> molecules, as well as facilities. Prior to
joining us, he was at Human Genome Sciences, most recently serving as Vice President of BioPharmaceutical Development, where he was responsible for oversight of Analytical Development, Formulation and Drug Delivery, Purification Sciences, and
Fermentation and Cell Culture Sciences. Prior to joining HGS, Dr.&nbsp;Spitznagel was a Senior Scientist at Nabi from 1996-1998, and a Staff Engineer at Genetics Institute from 1992-1996. Dr.&nbsp;Spitznagel earned his S.B. in Chemical Engineering
at MIT, and his Ph.D. in Chemical Engineering at the University of California, Berkeley. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Lynn Cilinski</I></B>, Vice President,
Controller and Treasurer, joined us in October 2003. Prior to joining us, Ms.&nbsp;Cilinski spent a year as a consultant to various companies providing services to the government. Prior to that, she spent more than 20 years with Covanta Energy Inc.
(formerly Ogden Corporation) where she held the position of Corporate Controller for four subsidiary companies that provided services to the federal government. Ms.&nbsp;Cilinski holds a B.S. from Strayer University. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc337004_11"></A>EXECUTIVE COMPENSATION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>COMPENSATION DISCUSSION AND ANALYSIS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Overview </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Compensation
Discussion&nbsp;&amp; Analysis considers the Company&#146;s executive compensation philosophy, the objectives and operation of the compensation program, how compensation was set for 2016 and the various elements of compensation paid to the named
executive officers for services during 2016. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In 2016, MacroGenics&#146; named executive officers consisted of the following people: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="35%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="62%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:20.00pt; font-size:8pt; font-family:Times New Roman"><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:35.90pt; font-size:8pt; font-family:Times New Roman"><B>Position(s)</B></P></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Scott Koenig, M.D., Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">President, Chief Executive Officer and Director (principal&nbsp;executive officer)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">James Karrels</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Senior Vice President, Chief Financial Officer and Corporate Secretary (principal financial officer)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Ezio Bonvini, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Senior Vice President, Research and Chief Scientific Officer</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Eric Risser</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Senior Vice President, Business Development and Portfolio Management and Chief Business Officer</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Jon Wigginton, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Senior Vice President, Clinical Development and Chief Medical Officer</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Executive Compensation Philosophy </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">MacroGenics&#146; executive compensation program, overseen by the Compensation Committee of the Board, is designed to attract, retain and
reward highly qualified talent at the senior executive level, in a very competitive market, while ensuring an individual and corporate accountability to achieve the Company&#146;s mission, vision, and goals. This philosophy is reflected in the
components of the Company&#146;s compensation program, and includes the following principles: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">pay for executives who are responsible for the success of MacroGenics should be linked to individual and corporate performance; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">compensation opportunities should be competitive with comparable biopharmaceutical companies, but also should be designed to be sufficiently flexible to attract talent as needed from other biopharmaceutical companies;
</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">the equity compensation program should align executives&#146; interests with those of stockholders; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">supplemental benefits and perquisites should be limited and used selectively in specific circumstances to attract and retain executives. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Within this overall philosophy, the Compensation Committee&#146;s objectives regarding executive officer compensation are to: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">offer a total compensation program that enables MacroGenics to attract, motivate, and retain individuals who are highly experienced with a proven track record of success, and to provide total compensation that is
competitive with the Company&#146;s peers, as described in more detail below; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">achieve an equitable balance in the compensation offered to the members of the executive team; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">provide annual variable cash incentive awards based on the achievement of individual and corporate performance criteria; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">make a significant portion of named executive officers&#146; compensation dependent on MacroGenics&#146; long-term performance and on enhancing stockholder value by providing appropriate long-term, equity-based
incentives and encouraging stock ownership. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">26 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Attract and Retain Highly Qualified Executives </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Compensation Committee believes that the compensation for MacroGenics&#146; executive officers should be designed to attract, motivate and
retain highly qualified executive officers responsible for the success of MacroGenics and should be determined within a framework that rewards performance and aligns the interests of the named executive officers with the interests of the
Company&#146;s stockholders. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Balance Corporate and Individual Performance </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Compensation Committee believes that a significant portion of an executive officer&#146;s total compensation should be affected by the
overall Company performance as well as that individual&#146;s performance. Incentives are based on meeting criteria in each of these categories and reflect the named executive officer&#146;s overall contributions to the Company. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Reward Named Executive Officers for Meeting MacroGenics&#146; Strategic Goals and Objectives </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The compensation program rewards the Company&#146;s named executive officers for achieving specified performance goals, building stockholder
value, and long-term retention with MacroGenics. The compensation program is designed to reward these three aspects because the Compensation Committee believes it will motivate the executive team to make balanced operational and long-term strategic
decisions resulting in strong financial performance, scientific and product development innovation, and the achievement of the Company&#146;s strategic business objectives. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Align Named Executive Officers&#146; Goals with MacroGenics&#146; Stockholders&#146; Goals </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Compensation Committee believes that MacroGenics&#146; long-term success depends upon aligning executives&#146; and stockholders&#146;
interests. To support this objective, MacroGenics provides the executive officers with equity accumulation opportunities by awarding stock options and, in certain cases, restricted stock. Generally, stock option grants vest over four years, which
supports long-term retention of our executive officers. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Align Named Executive Officers&#146; Compensation with Market Benchmarks </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">With the assistance of an independent compensation consultant, the Compensation Committee evaluates the compensation for each executive
officer&#146;s current position against the compensation data from peer companies, as described below, targeting the 25th to 75th percentiles for base salary, the 50th percentile for annual cash bonus and the 50th to 75th percentile for long-term
(equity) incentives. These are common reference points among biotechnology companies similar in size to the Company and allows the Company&#146;s compensation practices to remain consistent with market data, while allowing for differentiation based
on Company and individual performance. Executive compensation may be positioned above or below the stated philosophy for individual executives based on experience, leadership, the ability to work together with members of the senior leadership team,
scope of position and individual performance. Actual position with respect to these benchmarks also takes into consideration internal pay equity, Company constraints and other internal factors. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Use of Independent Compensation Consultant </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Compensation Committee retained Radford, an Aon Hewitt Company&#151;a business unit of Aon plc, a national executive compensation
consulting firm, to conduct market research and analysis to assist the committee in developing executive compensation levels for 2016, including appropriate base salaries, bonus percentages and equity awards for our executives. After consultation
with Radford, the Compensation Committee determined that Radford was independent and that there was no conflict of interest resulting from retaining Radford for this engagement. In reaching these conclusions, the Compensation Committee considered
the factors set forth in the SEC rules and NASDAQ listing standards. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">27 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Oversight and Operation of the Executive Compensation Program </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Compensation Committee is appointed by the Board to review and approve annually the compensation of the Company&#146;s executive officers,
assist the Board with its responsibilities related to the compensation of the Company&#146;s directors, officers, and employees, and to oversee the development and administration of the Company&#146;s compensation plans. For details regarding the
Compensation Committee&#146;s oversight of the executive compensation program, see the section titled &#147;Corporate Governance&#151;Board Committees&#151;Compensation Committee&#148; beginning on page 17 of this Proxy Statement. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Process for Setting Executive Compensation </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In setting executive base salaries and bonuses and granting equity incentive awards, the Committee considers compensation for comparable
positions in the market, the historical compensation levels of our executives, individual performance as compared to our expectations and objectives, internal pay equity, stockholder advisory votes, if any, on executive compensation, our desire to
motivate our employees to achieve short- and long-term results that are in the best interests of our stockholders and to incentivize a long-term commitment to our Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On an annual basis, the Compensation Committee schedules a series of meetings at which it reviews executive officer compensation. These
meetings are used to establish a set of peer companies to use as a benchmark, review market compensation data from those companies as well as data from the biopharmaceutical sector more broadly, obtain input from the committee&#146;s independent
compensation consultant and obtain input from the Chief Executive Officer and Vice President, Human Resources. The Compensation Committee reviews the peer group annually to ensure that each company remains reasonable and appropriate and makes
changes to the constituent companies as necessary. Selection parameters are determined for each review of the peer group based on the Company&#146;s profile at the time of the review and all companies are evaluated against the selection criteria.
Companies may be removed from the peer group based on falling outside of the selection parameters or due to being acquired while others may be added based on generally meeting the selection parameters and proximity to the Company in terms of
business focus. Ultimately, the Committee strives to select a group of peer companies that is most closely aligned with the Company in terms of size, therapeutic focus and business profile. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As the Compensation&#146;s Committee&#146;s independent compensation consultant, Radford performs an analysis and presents a detailed report
to our Compensation Committee and Chief Executive Officer, and makes recommendations for our executives&#146; compensation. The Chief Executive Officer and Compensation Committee review and discuss compensation for all executives other than the
Chief Executive Officer. The Chief Executive Officer evaluates and provides to the Compensation Committee performance assessments and compensation recommendations for each executive officer other than himself. Dr.&nbsp;Koenig is not present for any
Compensation Committee discussions regarding his compensation. Based on those discussions and its discretion, the Compensation Committee then determines and approves the compensation for each executive officer. MacroGenics&#146; Vice President,
Human Resources is present for a portion of these Compensation Committee discussions and, at the request of the Compensation Committee, supplements information provided by Radford. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Compensation packages for each executive officer are analyzed and discussed by the Compensation Committee at least annually. Prior to that
review, Radford performs an analysis, considering the goals of market competitiveness. The Committee also considers the executive&#146;s performance and contribution to the Company, and internal equity. The results of this analysis are presented to
the Compensation Committee, although at any time, the Compensation Committee may request additional information from the Vice President, Human Resources. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Peer Group and Market Data </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In
conducting its analysis, the Compensation Committee directed Radford to assess the compensation practices of publicly-traded peer companies with a median profile that was substantially similar to that of the
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">28 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Company at the time of review. The peer group was constructed from U.S.-based biopharmaceutical companies of a similar size to the Company, by market capitalization ($300M&#151;$3.0B) and number
of employees (90-800 headcount), with at least one product candidate in Phase 2 or Phase 3 of clinical development. As secondary considerations in selecting this peer group, the Compensation Committee also prioritized selecting companies that were
focused on oncology therapeutics, those that had been public companies for a relatively shorter period of time and those that had similar levels of R&amp;D expenses. This analysis was conducted in 2015 and in 2016 and resulted in the selection of
the following companies: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="51%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="47%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>2015</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>2016</B></P></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="center">Acceleron Pharma Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Acceleron Pharma Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="center">Agenus Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Aduro BioTech, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="center">Alder Biopharmaceuticals Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Agenus Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="center">Array BioPharma Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Agios Pharmaceuticals, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="center">Celldex Therapeutics, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Alder Biopharmaceuticals Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="center">Epizyme, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Array BioPharma Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="center">Five Prime Therapeutics, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Celldex Therapeutics, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="center">ImmunoGen, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">ChemoCentryx, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="center">Infinity Pharmaceuticals, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Curis, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="center">Kite Pharma, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Epizyme, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="center">Merrimack Pharmaceuticals, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Five Prime Therapeutics, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="center">NewLink Genetics Corporation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">ImmunoGen, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="center">Novavax, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Immunomedics, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="center">OncoMed Pharmaceuticals, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Inovio Pharmaceuticals, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="center">Prothena Corporation plc</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Kite Pharma, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="center">Puma Biotechnology, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">NewLink Genetics Corporation</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="center">Sangamo Biosciences Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">OncoMed Pharmaceuticals, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="center">Trevena, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Prothena Corporation plc</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="center">Xencor, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Puma Biotechnology, Inc.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Xencor, Inc.</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, the Compensation Committee reviewed broader market compensation survey data from Radford&#146;s
Global Life Sciences survey reflecting companies of similar size, both in terms of market capitalization and number of employees, operating in the biopharmaceutical industry. The analysis of the 2015 peer companies above and this additional market
data were used in determining salary and non-equity compensation targets for 2016, including in confirming that compensation was competitive both in terms of each element of compensation and total compensation. The Compensation Committee used the
data from the 2016 peer companies to determine appropriate base salary increases and equity grants to award to executive officers who were promoted during the year. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Market data is used to determine whether or not a named executive officer&#146;s salary, bonus opportunity and equity incentives are
competitive both in terms of each element of compensation and total compensation. When setting the compensation for the named executive officers for 2016, Radford prepared an extensive analysis of compensation-related data specific to the life
science industry and recommendations to review prior to making any compensation decisions. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Internal Equity </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Compensation Committee considers internal equity for all employees including, but not limited to, its named executive officers when
determining compensation to ensure that the Company is fair in its compensation practices across all levels and to ensure that there is no discrimination in compensation practices among the protected classes. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">29 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Individual Performance </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In late 2016 and early 2017, the Chief Executive Officer reviewed and evaluated the performance of the other executive officers based on the
Company&#146;s performance in 2016 and each individual&#146;s achievements in 2016 against their established objectives that had been set early in the year. Based on this evaluation, the Chief Executive Officer made recommendations to the
Compensation Committee for each other executive officer regarding base salary adjustments, bonuses to be paid, adjustments to target bonus percentages and equity grants. The Compensation Committee discussed recommendations with the Chief Executive
Officer and evaluated them in light of each individual&#146;s performance as well as benchmark data provided by the committee&#146;s compensation consultant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In late 2016 and early 2017, the Compensation Committee also reviewed and evaluated the performance of the Chief Executive Officer, based on
the Company&#146;s performance in 2016 against its objectives and the overall value of the Chief Executive Officer&#146;s contributions to that effort. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Based on the performance evaluations, each executive officer received a performance rating for his or her 2016 performance. The performance
rating was used to determine base salary adjustments, bonuses to be paid, adjustments to target bonus percentages and equity grants. For 2016, each named executive officer received a performance rating that reflected that they had achieved or
exceeded their target performance. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Elements of Compensation </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Compensation Committee believes that the most effective compensation program is one that provides a competitive base salary, rewards the
achievement of established annual and long-term goals and objectives and provides an incentive for retention. For this reason, the compensation program is comprised of three primary elements: base salary, a performance-based cash incentive bonus
program and equity awards. The Compensation Committee believes that these three elements are the most effective combination to motivate and retain the named executive officers. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Compensation Committee has not adopted any formal guidelines for allocating total compensation between equity compensation and cash
compensation, but generally seeks to provide an overall executive compensation package designed to attract, motivate, and retain highly qualified executive officers, to reward them for performance over time, and to align the interests of the named
executive officers with the interests of the stockholders. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Base Salary </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Compensation Committee&#146;s philosophy is to maintain base salaries at a competitive level sufficient to recruit and retain individuals
possessing the skills and capabilities necessary to achieve the Company&#146;s goals over the long-term. The Company provides an annual salary to each named executive officer designed to reflect that person&#146;s level of responsibility, expertise,
skills, knowledge, and experience. When determining base salaries, the Compensation Committee considered each named executive officer&#146;s performance in light of the individual&#146;s 2015 performance goals and achievement of Company objectives,
as well as the 2015 peer group data described above and made adjustments, as appropriate, to assist the Company in retaining this expertise, skill, and knowledge at the Company. These base salary increases for fiscal year 2016 were effective as of
January&nbsp;1, 2016. In addition, Drs. Bonvini and Wigginton and Mr.&nbsp;Risser were promoted in 2016. At the time of each of their promotions, the Compensation Committee conducted an assessment, including review of market data provided by Radford
to determine whether base salary increases were warranted in conjunction with the promotions. Based on this assessment, the Committee concluded that the adjustments set forth below were appropriate. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">30 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The 2016 base salaries for the named executive officers as of December&nbsp;31, 2016 were: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="73%"></TD>
<TD VALIGN="bottom" WIDTH="10%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:33.30pt; font-size:8pt; font-family:Times New Roman"><B>Executive</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Base</B><br><B>Salary&nbsp;($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Percentage</B><br><B>Increase</B><br><B>in Base</B><br><B>Salary from<BR>December&nbsp;31,</B><br><B>2015&nbsp;(%)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Scott Koenig, M.D., Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">535,600</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">James Karrels</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">344,400</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Ezio Bonvini, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">391,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;(1)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Eric Risser</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">362,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;(2)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Jon Wigginton, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">430,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;(3)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top">Reflects Dr.&nbsp;Bonvini&#146;s promotion in September 2016. His salary prior to his promotion was $360,500 which reflects a 3% increase from his December&nbsp;31, 2015 base salary, and his subsequent promotion
reflects an additional 9% increase. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top">Reflects Mr.&nbsp;Risser&#146;s promotion in September 2016. His salary prior to his promotion was $345,100 which reflects a 3% increase from his December&nbsp;31, 2015 base salary, and his subsequent promotion reflects
an additional 5% increase. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top">Reflects Dr.&nbsp;Wigginton&#146;s promotion in February 2016. His salary prior to his promotion was $390,400 which reflects a 3% increase from his December&nbsp;31, 2015 base salary, and his subsequent promotion
reflects an additional 10% increase. </TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Annual Incentive Cash Bonus </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our bonus plan is designed to motivate and reward our executives for achievements relative to our goals and expectations for each fiscal year.
Each executive officer has a target bonus opportunity, defined as a percentage of his or her earned base salary. Following the end of each year, our Compensation Committee, in its discretion, determines bonuses. Material considerations in
determining bonuses include the overall performance of the Company, the level of achievement of the corporate objectives for the year and an executive officer&#146;s performance against his or her individual objectives for the year; and the
executive&#146;s handling of unplanned events and opportunities. The Compensation Committee considers the Chief Executive Officer&#146;s input with respect to the Company&#146;s performance against our established corporate objectives. Based on
these factors and the judgment of our Compensation Committee, we approved the bonuses in the table below for our named executive officers for the fiscal year ended December&nbsp;31, 2016. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The target bonus is set at a percentage of the named executive officer&#146;s base salary, with such percentages being evaluated in the
context of market data as described above. If the executive was promoted during 2016, the bonus was calculated separately for each position he/she held during the year, based on the corresponding salary and bonus target. Then the two calculations
were added together to form the total bonus for 2016. The Compensation Committee believes that the higher the individual&#146;s position within the Company, the more closely his or her bonus award should be tied to the Company&#146;s success. The
Chief Executive Officer&#146;s bonus is based solely on the achievement of the 2016 corporate objectives described below and the discretion of the Compensation Committee. For other named executive officers, 60% of the bonus for 2016 was based on
corporate achievement and 40% of the bonus was based on individual performance. The Compensation Committee chose this split because it believed that this split recognized the need for executive officers to have a substantial portion of their
compensation tied to Company performance, while also recognizing the need to focus and incentivize executive officers to achieve their individual performance goals. In contrast, given his senior role at the Company, the Compensation Committee
believed that 100% of Dr.&nbsp;Koenig&#146;s bonus compensation should be tied to Company performance, subject to discretionary adjustments by the committee, since he is ultimately responsible for the performance for all aspects of the
Company&#146;s business. The Compensation Committee assesses this split between corporate achievement and individual performance on a periodic basis. The </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">31 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Compensation Committee retains the discretion to make adjustments to the calculated bonus based on unexpected or unplanned events, the overall financial condition of the Company, extraordinary
performance or underperformance or other factors. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>2016 Company Performance Objectives </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">With regard to evaluating Company performance, early in 2016, the Compensation Committee, with management&#146;s input and recommendation,
reviewed and approved a set of Company objectives for 2016 and then evaluated the Company&#146;s performance against those objectives. In setting the 2016 objectives, the Board sought to create targets for management that the Compensation Committee
believed were consistent with the Company&#146;s long-term strategic plan and in the best interests of stockholders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The 2016 objectives
were divided into three categories labeled as Pipeline, Discovery and Infrastructure. The Pipeline objectives related to advancing clinical-stage programs with expected enrollment timing for each ongoing clinical trial, expected initiation timing
for each new clinical trial to be started in 2016 and the expected filing date of an investigational new drug, or IND, application for a new molecular entity entering clinical testing for the first time. The Discovery objectives related to the
identification and testing of potential new molecules expected to enter clinical testing in 2017 through 2019, consistent with the Company&#146;s long-term strategic objective to advance at least one IND for a new molecular entity per year. The
Infrastructure objectives related to compliance, the development of skills, capabilities and talents required for the long-term success of the organization and the management of the Company&#146;s cash and other resources against budget and the
Company&#146;s strategic plan. In addition, while the Compensation Committee retains the discretion to recognize extraordinary performance, the 2016 objectives also included criteria for a transaction that would significantly accelerate the
Company&#146;s long-term strategic plan by providing significant additional funding or meaningfully expanding the Company&#146;s pipeline. In evaluating overall performance, Pipeline objectives were given a 60% weight, Discovery objectives were
given a 25% weight, and Infrastructure objectives were given a 15% weight. Further, if a significant transaction was completed, the executive officers could receive an increase in the overall performance of up to 20%. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In making its assessments of performance at the end of the year, the Board determined that the Pipeline and Infrastructure objectives had been
partially met and that the Discovery objectives had been fully met. Given the weighting of each category, in the aggregate, the Board determined that the Company had achieved 75% of the 100% possible against these objectives. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition to performance against these objectives, the Compensation Committee determined that the transaction with Janssen regarding MGD015
met the criteria for a significant transaction that could accelerate the Company&#146;s long-term strategic plan. Consequently, the Compensation Committee increased the corporate achievement by 10%. Taken collectively with the primary categories,
the Compensation Committee determined that the corporate portion of the bonuses of named executive officers would be paid at the 85% level. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>2016
Individual Performance Objectives </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The individual objectives for each of the named executive officers, other than the Chief Executive
Officer, were established between each such named executive officer and the Chief Executive Officer during 2016. These objectives were established, in the Chief Executive Officer&#146;s judgment, to provide the greatest opportunity for the Company
to meet its annual and long-term objectives. At the end of the year, the Chief Executive Officer evaluated the performance of each such named executive officer and assigned an achievement percentage against the individual objectives for each such
named executive officer. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">32 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For 2016, the bonus targets for each named executive officer, each individual&#146;s achievement
against those targets and the amount paid to those individuals were as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="37%"></TD>
<TD VALIGN="bottom" WIDTH="12%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="12%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="12%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="12%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:33.30pt; font-size:8pt; font-family:Times New Roman"><B>Executive</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Target<BR>Bonus&nbsp;Percentage&nbsp;(%)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Target<BR>Bonus&nbsp;($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Performance<BR>Achievement&nbsp;for&nbsp;2016&nbsp;(%)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Bonus<BR>Amount&nbsp;Paid&nbsp;($)&nbsp;(1)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Scott&nbsp;Koenig,&nbsp;M.D.,&nbsp;Ph.D.&nbsp;(2)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">55</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">294,580</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">82</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">240,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">James Karrels</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">35</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">120,540</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">87</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">105,111</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Ezio Bonvini, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">35</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">136,850</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;(4)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">84</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">115,067</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Eric Risser</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">35</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">126,700</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;(4)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">92</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">116,385</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Jon Wigginton, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">40</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;(3)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">172,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;(4)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">80</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">134,546</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top">Amount paid in the first quarter of 2017. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top">The Chief Executive Officer&#146;s bonus is based solely on the achievements of the 2016 Company objectives and the discretion of the Compensation Committee. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top">Dr.&nbsp;Wigginton&#146;s target bonus percentage increased from 35% to 40% in connection with his promotion in February 2016. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top">Drs. Bonvini and Wigginton and Mr.&nbsp;Risser were each promoted during 2016, and each of their base salaries was increased in connection with their promotions. The target bonus shown is (a)&nbsp;the base salary for
the initial role multiplied by the target bonus percentage for the initial role, added to (b)&nbsp;the base salary for the new role multiplied by the target bonus percentage for the new role, in each case pro rated for the percentage of the year the
applicable role was held. </TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Equity Awards </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We typically grant stock option awards at the start of employment to each employee, including our named executive officers. In addition,
employees, including named executive officers, have typically been granted stock option awards on an annual basis. The Compensation Committee believes these equity awards encourage retention and align compensation for our named executive officers
with the long-term objectives of the Company. The Compensation Committee also retains discretion to make additional targeted equity awards, in the form of options or other types of awards, in certain circumstances. In 2016, such discretionary
additional targeted equity awards were granted to Dr.&nbsp;Bonvini, Mr.&nbsp;Risser, and Dr.&nbsp;Wigginton in connection with their promotions during the year. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The annual stock option grants and any discretionary additional targeted equity awards to our executive officers are evaluated by the
Compensation Committee in the context of each executive officer&#146;s total compensation and takes into account the market data provided by Radford in addition to the individual employment situation of each executive officer. In the case of
executive officers other than the Chief Executive Officer, the Compensation Committee also takes into account the recommendations of the Chief Executive Officer with regards to appropriate grants and any particular individual circumstances. Our
stock option grants to executive officers are awarded on the date that the Compensation Committee approves the grant. We set the option exercise price and grant date fair value based on our per-share closing-price valuation on the date of grant.
Time vested stock option grants to our executives typically vest 12.5% six months after the date of grant with the remainder vesting in equal installments over the following 14 quarters. The Compensation Committee retains discretion to make
adjustments to the vesting schedule and types of awards as may be necessary to meet the Company&#146;s long-term objectives. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
Company&#146;s 2013 Equity Incentive Plan also permits granting specified types of equity incentives other than stock options. The Compensation Committee retains the discretion to issue grants of other types of incentives under this plan based on
market data provided by Radford, the individual employment situation of each named executive officer and the best interests of the Company. Under this authority, in connection with his promotion to Chief Medical Officer in February 2016, the
Compensation Committee issued restricted stock units to Dr.&nbsp;Wigginton under this plan. All of the restricted stock units under that grant will vest two years after </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">33 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
issuance provided that Dr.&nbsp;Wigginton is still employed by the Company at that time or has been terminated other than for &#147;cause&#148; as defined in the applicable restricted stock unit
agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Compensation Committee shifted its annual compensation review cycle to take place in the first quarter of 2017 and expects
that future reviews will similarly occur in the first quarter after the year being reviewed. As a result, there were no equity grants or non-equity compensation payments made in the fourth quarter of 2016, and the awards made in the first quarter of
2017 were adjusted to reflect this change. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table provides certain information as of December&nbsp;31, 2016, with respect to
all of our equity compensation plans in effect on that date. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="27%"></TD>
<TD VALIGN="bottom" WIDTH="16%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="16%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="16%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>Number&nbsp;of&nbsp;Securities</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>Number of</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>Remaining Available</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>Securities&nbsp;to&nbsp;be</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>for&nbsp;Future&nbsp;Issuance&nbsp;Under</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>Issued Upon</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B><FONT STYLE="white-space:nowrap">Weighted-Average</FONT></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>Equity&nbsp;Compensation&nbsp;Plans</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>Exercise of</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>Exercise Price of</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>(Excluding Securities</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>Outstanding&nbsp;Options,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>Outstanding&nbsp;Options,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>Reflected</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:49.10pt; font-size:8pt; font-family:Times New Roman"><B>Plan Category</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Warrants and Rights<BR>(a)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Warrants and Rights<BR>(b)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>in Column (a))</B><br><B>(c)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Equity Compensation Plans Approved by Stockholders (1)(2)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,838,060</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">18.93</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,644,706</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Equity Compensation Plans Not Approved by Stockholders</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,838,060</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,644,706</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top">Includes the MacroGenics, Inc. 2013 Equity Incentive Award Plan, 2003 Equity Incentive Plan and 2000&nbsp;Stock Option and Incentive Plan. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top">Includes 3,838,060 of equity available for issuance under our 2013 Plan. In addition to being available for future issuance upon exercise of stock options and vesting of restricted stock unit awards that have been or
may be granted after December&nbsp;31, 2016, our 2013 Plan provides for the issuance of restricted stock awards and other stock-based awards. The 2013 Plan contains an &#147;evergreen&#148; provision, pursuant to which the number of shares of common
stock reserved for issuance or transfer pursuant to awards under the 2013 Plan shall be increased on the first day of each year beginning in 2014 and ending in 2023, equal to the lesser of (a)&nbsp;1,960,168 shares, (b)&nbsp;4.0% of the shares of
common stock outstanding (on an as converted basis) on the last day of the immediately preceding fiscal year and (c)&nbsp;such smaller number of shares of stock as determined by our Board. As of December&nbsp;31, 2016, 2,644,706 shares were
available for future issuance, which number increased by 1,394,824 shares as of January&nbsp;1, 2017, due to the effect of this evergreen provision. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">34 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Summary Compensation Table </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table sets forth information concerning the compensation earned during the fiscal years ended December&nbsp;31, 2016, 2015, and
2014 by the named executive officers. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="45%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:61.75pt; font-size:8pt; font-family:Times New Roman"><B>Name and Position</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Salary</B><br><B>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Bonus</B><br><B>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Stock<BR>Awards<BR>($)&nbsp;(1)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Option<BR>Awards<BR>($)&nbsp;(2)(3)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Nonequity<BR>Incentive&nbsp;Plan<BR>Compensation<BR>($)&nbsp;(4)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>All Other<BR>Compensation<BR>($)&nbsp;(5)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total</B><br><B>($)&nbsp;(3)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Scott Koenig, M.D., Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">2016</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">535,600</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">240,000</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">7,950</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">783,550</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ROWSPAN="2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">President, Chief Executive Officer and Director</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">2015</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">523,048</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">3,112,995</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">266,000</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">3,975</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">3,906,018</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">2014</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">466,548</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">2,592,296</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">280,000</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">3,900</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">3,342,744</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">James Karrels</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">2016</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">344,400</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">105,111</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">7,950</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">457,461</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ROWSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Senior Vice President,<BR>Chief Financial Officer and Corporate Secretary</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">2015</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">336,518</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">933,899</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">107,600</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">3,975</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">1,381,992</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">2014</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">313,818</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">740,656</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">115,000</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">3,900</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">1,173,374</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Ezio Bonvini, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2016</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">369,627</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">526,149</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">115,067</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,950</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,018,793</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ROWSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Senior Vice President, Research and Chief Scientific</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2015</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">353,048</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,141,432</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">117,400</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,975</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,615,855</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">2014</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">328,048</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">925,820</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">130,000</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">3,900</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">1,387,768</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Eric Risser</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2016</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">350,157</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">438,458</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">116,385</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,950</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">912,950</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ROWSPAN="2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Senior Vice President,<BR>Business Development</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">2015</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">336,518</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">933,899</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">110,000</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">3,975</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">1,384,392</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">2014</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">301,368</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">925,820</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">121,000</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">3,900</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">1,352,088</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Jon Wigginton, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">2016</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">423,400</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">458,400</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">134,556</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">7,950</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">1,024,306</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ROWSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Senior Vice President,<BR>Clinical Development and Chief Medical Officer</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">2015</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">380,758</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">1,141,432</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">127,100</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">3,975</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">1,653,265</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">2014</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">369,699</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">740,656</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">131,000</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">3,900</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">1,245,255</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top">The amounts reflect the grant value for restricted stock units (RSUs) using the Company&#146;s closing stock price on the date of grant. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top">The amounts reflect the grant date fair value for awards granted during the year indicated. The grant date fair value was computed in accordance with Financial Accounting Standards Board Accounting Standards
Codification Topic 718, <I>Compensation&#151;Stock Compensation</I>. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top">For years ended December&nbsp;31, 2015 and 2014, equity grants were made to named executive officers in December of those years. For the year ended December&nbsp;31, 2016, the Company shifted its performance review
cycle and made equity grants to named executive officers in the first calendar quarter of 2017. Since these grants were not made prior to December&nbsp;31, 2016, they are not included in this table, but for comparison with prior periods, in February
2017 stock option awards were granted to named executive officers in the following amounts: Dr.&nbsp;Koenig ($2,623,860); Mr. Karrels ($721,562); Dr.&nbsp;Bonvini ($885,553); Mr.&nbsp;Risser ($721,562); Dr.&nbsp;Wigginton ($885,553). Stock and
option awards shown for Drs.&nbsp;Bonvini and Wigginton and Mr.&nbsp;Risser reflect grants awarded in connection with their respective promotions. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top">The amounts reflect the performance bonuses paid in 2017 for performance during 2016; the performance bonuses paid in 2016 for performance during 2015; and the performance bonuses paid in 2015 for performance during
2014. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top">The amounts reflect $7,950, $3,975 and $3,900 in 401(k) matching in 2016, 2015 and 2014, respectively. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">35 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following tables provide certain information as of December&nbsp;31, 2016, with respect to
equity grants made to our named executive officers. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Grants of Plan-Based Awards </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table sets forth information with respect to all plan-based awards granted during the fiscal year ended December&nbsp;31, 2016 to
the Company&#146;s named executive officers: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="34%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:20.00pt; font-size:8pt; font-family:Times New Roman"><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Grant Date</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Estimated<BR>Possible</B><br><B>Payouts&nbsp;Under<BR>Non-Equity<BR>Incentive Plan<BR>Awards (1)</B><br><B>Target ($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>All&nbsp;Other&nbsp;Stock<BR>Awards:<BR>Number of<BR>Shares of Stock<BR>or Units</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>All&nbsp;Other&nbsp;Option<BR>Awards:&nbsp;Number<BR>of Securities<BR>Underlying<BR>Options (#) (2)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Exercise&nbsp;or Base<BR>Price of<BR>Option&nbsp;Awards<BR>(per&nbsp;share)&nbsp;(2)(3)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Grant&nbsp;Date<BR>Fair&nbsp;Value&nbsp;of<BR>Stock&nbsp;and&nbsp;Option<BR>Awards (2)(4)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Scott&nbsp;Koenig,&nbsp;M.D.,&nbsp;Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">294,580</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">James Karrels</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">120,540</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Ezio Bonvini, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9/14/2016</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30,000&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">(6)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">28.95</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">526,149</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">136,850</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Eric Risser</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9/14/2016</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25,000&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">(6)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">28.95</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">438,458</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">126,700</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Jon Wigginton, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/25/2016</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30,000&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">(5)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">458,400</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">172,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top">Reflects target awards under the Company&#146;s annual incentive cash plan. There are no threshold or maximum award levels under this plan. For information about the actual payouts under the plan, which were determined
by the Compensation Committee on February&nbsp;15, 2017, see &#147;Compensation Discussion and Analysis&#151;Elements of Compensation&#151;Annual Incentive Cash Bonus&#148; and the &#147;Summary Compensation Table.&#148; </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top">Equity grants made to named executive officers in the first quarter of 2017 in connection with the Compensation Committee&#146;s review of 2016 performance are described in footnote (3)&nbsp;of the &#147;Summary
Compensation Table&#148; above. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top">Exercise or base price represents the market closing stock price on the date of award. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top">The amounts reflect the grant date fair value for awards granted during the year indicated. The grant date fair value was computed in accordance with Financial Accounting Standards Board Accounting Standards
Codification Topic 718, <I>Compensation&#151;Stock Compensation</I>. The assumptions used in the valuation of these awards are set forth in Note 6 to our financial statements, which are included in our Form 10-K. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top">Reflects restricted stock units that will vest on the second anniversary of the date of grant that were issued to Dr.&nbsp;Wigginton in connection with his promotion in 2016. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(6)</TD>
<TD ALIGN="left" VALIGN="top">Reflects stock option grants that were issued to Dr.&nbsp;Bonvini and Mr.&nbsp;Risser in connection with their promotions in 2016. These option grants will vest 12.5% six months after the date of grant with the
remainder vesting in equal installments over the following 14 quarters. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">36 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Outstanding Equity Awards at Fiscal Year End </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table sets forth certain information with respect to the value of all unexercised options previously awarded to the
Company&#146;s named executive officers as of December&nbsp;31, 2016: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="35%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="18" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Option Awards</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Stock Awards</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:20.00pt; font-size:8pt; font-family:Times New Roman"><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Grant&nbsp;Date&nbsp;(1)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of<BR>securities<BR>underlying<BR>unexercised<BR>options<BR>exercisable<BR>(#)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Underlying<BR>unexercised<BR>options<BR>unexercisable<BR>(#)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Option<BR>exercise<BR>price&nbsp;($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Option<BR>expiration<BR>date</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number&nbsp;of<BR>shares or<BR>units of<BR>stock that<BR>have not<BR>vested&nbsp;(#)&nbsp;(2)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Market&nbsp;value<BR>of shares of<BR>units of stock<BR>that have not<BR>vested ($) (2)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Scott&nbsp;Koenig,&nbsp;M.D., Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11/16/2007</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">79,898</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.94</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11/15/2017</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1/11/2009</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">79,897</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.94</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1/10/2019</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3/14/2012</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">133,163</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.94</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3/13/2022</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1/6/2013</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">49,935</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,330</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.51</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1/5/2023</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10/9/2013</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">114,393</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">38,132</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10/9/2023</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12/12/2014</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">70,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">70,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">29.68</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12/12/2024</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12/18/2015</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">37,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">112,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">31.43</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12/18/2025</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">James Karrels</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4/10/2008</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19,516</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.94</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4/9/2018</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1/11/2009</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13,314</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.94</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1/10/2019</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1/10/2010</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,326</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.94</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1/9/2020</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1/9/2011</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,320</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.94</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1/8/2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3/14/2012</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,653</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.94</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3/13/2022</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1/6/2013</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,483</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">833</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.51</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1/5/2023</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10/9/2013</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">36,593</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,198</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10/9/2023</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12/12/2014</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">29.68</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12/12/2024</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12/18/2015</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,250</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">33,750</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">31.43</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12/18/2025</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Jon Wigginton, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7/19/2013</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">53,489</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">31,959</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.70</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7/18/2023</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12/12/2014</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">29.68</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12/12/2024</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12/18/2015</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13,750</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">41,250</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">31.43</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12/18/2025</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/25/2016</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/25/2026</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">613,200</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Ezio Bonvini, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3/14/2012</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">26,632</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.94</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3/13/2022</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1/6/2013</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">24,967</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,665</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.51</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1/5/2023</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10/9/2013</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18,296</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,099</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10/9/2023</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12/12/2014</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">29.68</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12/12/2024</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12/18/2015</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13,750</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">41,250</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">31.43</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12/18/2025</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9/14/2016</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28.95</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9/14/2026</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Eric Risser</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3/24/2009</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">33,497</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.94</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3/23/2019</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1/10/2010</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,662</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.94</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1/9/2020</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1/9/2011</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,989</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.94</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1/8/2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3/14/2012</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,653</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.94</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3/13/2022</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1/6/2013</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">24,967</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,665</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.51</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1/5/2023</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10/9/2013</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18,296</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,099</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10/9/2023</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12/12/2014</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">29.68</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12/12/2024</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12/18/2015</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,250</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">33,750</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">31.43</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12/18/2025</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9/14/2016</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28.95</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9/14/2026</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top">Options vest and become exercisable with respect to (a)&nbsp;12.5 percent of the underlying shares six months after the grant date and (b)&nbsp;the remainder of the underlying shares in 14 equal quarterly installments.
</TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top">Reflects restricted stock units granted to Dr.&nbsp;Wigginton, which will vest on the second anniversary of the date of grant. The market value is based on the closing stock price of the date on grant.
</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">37 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Options Exercised and Stock Vested Table </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table sets forth certain information concerning the exercise of stock options held by the named executive officers during the
fiscal year ended December&nbsp;31, 2016. There was no vesting of restricted stock units held by the named executive officers during the fiscal year ended December&nbsp;31, 2016. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="50%"></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:20.00pt; font-size:8pt; font-family:Times New Roman"><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number&nbsp;of<BR>Shares<BR>Acquired&nbsp;on<BR>Exercise</B><br><B>(#)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Value<BR>Realized on<BR>Exercise&nbsp;(1)<BR>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number&nbsp;of<BR>Shares<BR>Acquired&nbsp;on<BR>Vesting</B><br><B>(#)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Value<BR>Realized<BR>Vesting&nbsp;(2)<BR>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Scott Koenig, M.D., Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">114,517</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,917,813</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">James Karrels</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">185,200</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Ezio Bonvini, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">33,127</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">632,727</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Eric Risser</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">37,150</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Jon Wigginton, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">45,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,129,645</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top">This amount represents the difference between the sales price and the exercise price. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top">Based on the closing price of the Company&#146;s Common Stock, as reported on the NASDAQ on the date on which the stock vested, or, if the stock vested on a weekend or holiday, the closing price of the stock on the next
day the Company&#146;s Common Stock was traded. </TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Perquisites and Other Personal Benefits </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All of the named executive officers are eligible to participate in the Company&#146;s employee benefit plans, including health, dental, and
vision insurance, a prescription drug plan, flexible spending accounts, short and long-term disability, life insurance, and a 401(k) plan. These plans are offered to all employees and do not discriminate in favor of named executive officers. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Tax and Accounting Implications </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;162(m) limits to $1 million the amount a company may deduct for compensation paid to its chief executive officer and any of its
other three named executive officers (excluding the chief financial officer). This limitation, however, does not apply to compensation meeting the requirements for qualifying performance-based compensation within the meaning of Section&nbsp;162(m).
The Compensation Committee reviews and considers the deductibility of executive compensation under Section&nbsp;162(m) in designing our executive compensation program. The Compensation Committee, however, believes that a compensation program that
attracts and retains highly qualified executives and rewards them for their achievements is necessary for our success and, therefore, is in the best interests of the Company and our stockholders. Accordingly, the Compensation Committee believes that
in establishing the cash and equity incentive compensation program for the Company&#146;s executive officers, the potential deductibility of the compensation payable under that program should only be one of a number of relevant factors taken into
consideration. Consequently, the Compensation Committee may pay or provide compensation in excess of $1 million that is not exempt from the deduction limitations under Section&nbsp;162(m). </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Anti-Hedging and Anti-Pledging Policies </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our insider trading policy prohibits all directors and officers from pledging or engaging in hedging or similar transactions in our stock,
including but not limited to prepaid variable forwards, equity swaps, collars, puts, calls and short sales. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Compensation Risk Assessment </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our compensation policies and programs are designed to encourage our employees to remain focused on both our short- and long-term goals. Our
management assesses and discusses with our Compensation Committee </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">38 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
our compensation policies and practices for our employees as they relate to our risk management and, based upon this assessment, we believe that any risks arising from such policies and practices
are not reasonably likely to have a material adverse effect on the Company in the future. The Compensation Committee believes that the mix of long-term equity incentive, short-term cash incentive bonus and base salary appropriately balances both
short-and long-term performance goals. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Overview of Employment and Change in Control Agreements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of December&nbsp;31, 2016, the Company had employment agreements in place with each of its named executive officers. The employment
agreements provide for certain payments upon a named executive officer&#146;s termination, as described below. All of the named executive officers are &#147;at-will&#148; employees. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Dr.&nbsp;Koenig </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In
October 2013, we entered into an employment agreement with Dr.&nbsp;Koenig. Dr.&nbsp;Koenig is employed <FONT STYLE="white-space:nowrap">&#147;at-will,&#148;</FONT> which means that he has no definitive term of employment. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Dr.&nbsp;Koenig&#146;s employment agreement includes non-competition and non-solicitation provisions that will prohibit him from competing
with us, soliciting our customers or employees, or hiring our employees for a period of two years following the end of his employment with us for any reason and, with respect to the non-competition provisions, for the period during which he is
receiving severance benefits. Under his employment, Dr.&nbsp;Koenig is also subject to confidentiality and invention disclosure and assignment obligations. Dr.&nbsp;Koenig is eligible to receive severance benefits in specified circumstances. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under the terms of the agreement, upon execution and delivery of an irrevocable release of claims against the Company and subject to his
continued compliance with the non-competition and non-solicitation, confidentiality and invention assignment provisions, Dr.&nbsp;Koenig will be entitled to severance benefits if we terminate his employment without Cause or if he terminates
employment with us for Good Reason, absent or in connection with a Change of Control. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table summarizes the schedule of
severance benefits Dr.&nbsp;Koenig would receive in the event of such a qualifying termination. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="26%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="23%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="22%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="25%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:27.95pt; font-size:8pt; font-family:Times New Roman">Scenario</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:64.10pt; font-size:8pt; font-family:Times New Roman">Salary Continuation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:26.60pt; font-size:8pt; font-family:Times New Roman">Continuation&nbsp;of Health<BR>Benefits</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:104.95pt; font-size:8pt; font-family:Times New Roman">Acceleration of Unvested&nbsp;Equity</P></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Absent a Change of Control</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">24 months of base salary and target bonus (55% of base salary)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">12&nbsp;months</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(or&nbsp;until&nbsp;Dr.&nbsp;Koenig obtains&nbsp;other employment&nbsp;which provides the same</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">type&nbsp;of&nbsp;benefit,&nbsp;if&nbsp;earlier)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">50% of the shares with respect&nbsp;to&nbsp;which&nbsp;the&nbsp;stock option is not vested</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Termination occurs within Two Years Following a Change of Control</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">24 months of base salary and target bonus (55% of base salary)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">12&nbsp;months</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(or&nbsp;until&nbsp;Dr.&nbsp;Koenig obtains other employment&nbsp;which provides the same</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">type&nbsp;of&nbsp;benefit,&nbsp;if&nbsp;earlier)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">100% of the shares with respect to which the stock option is not vested</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, upon the occurrence of a Change of Control (irrespective of whether Dr.&nbsp;Koenig&#146;s
employment terminates), each outstanding stock option held by Dr.&nbsp;Koenig that was granted by us to him prior to the IPO will become fully vested. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">39 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following definitions are used in Dr.&nbsp;Koenig&#146;s employment agreement: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">&#147;Cause&#148; means: (a)&nbsp;a failure to substantially perform the duties with us (if the failure to substantially perform is not cured, if curable, within thirty (30)&nbsp;days after receipt of written notice
from the Board of Directors that specifies the conduct constituting Cause under this clause (a); (b)&nbsp;willful misconduct, or gross negligence in the performance of duties to us; (c)&nbsp;the conviction or entry of a guilty plea or plea of no
contest with respect to, any crime that constitutes a felony or involves fraud, dishonesty or moral turpitude; (d)&nbsp;commission of an act of fraud, embezzlement or misappropriation against us; (e)&nbsp;a material breach of the fiduciary duty owed
to us; (f)&nbsp;engaging in any improper conduct that has or is likely to have an adverse economic or reputational impact on us; or (g)&nbsp;a material breach of the employment agreement. </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">&#147;Change of Control&#148; means: (a)&nbsp;any person (excluding our employee benefit plans) is or becomes the &#147;beneficial owner&#148; (as defined in Rules 13d-3 and 13d-5 under the Exchange Act directly or
indirectly, of securities representing more than fifty percent (50%)&nbsp;of the combined voting power of our then outstanding securities; (b)&nbsp;we consummate a merger, consolidation, share exchange, division or other reorganization or
transaction with any other corporation unless our outstanding securities immediately prior to the transaction continue to represent at least 50% of the combined voting power immediately after the transaction; or (c)&nbsp;stockholder approval of the
liquidation or winding-up of our company or the consummation of the sale or disposition of all or substantially all of our assets; or (d)&nbsp;during any period of 24 consecutive months, individuals who at the beginning of such period constituted
our Board (including for this purpose any new director whose election or nomination for election by the stockholders was approved by a vote of at least two-thirds of the directors then still in office who were directors at the beginning of such
period or whose appointment, election or nomination was previously so approved or recommended) cease for any reason to constitute at least a majority of the Board of Directors. </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">&#147;Good Reason&#148; means the occurrence of any of the following events (without the executive&#146;s consent): (i)&nbsp;material adverse change in functions, duties, or responsibilities that would cause the
executive&#146;s position to become one of materially lesser responsibility, importance, or scope or (ii)&nbsp;a material breach of the agreement by us. No resignation will be treated as &#147;good reason&#148; unless (a)&nbsp;the executive has
given written notice of such event to us within ninety (90)&nbsp;days after the initial occurrence thereof, (b)&nbsp;we have failed to cure the condition constituting &#147;good reason&#148; within 30 days following the delivery of the notice, and
(c)&nbsp;the executive terminates employment within thirty (30)&nbsp;days after expiration of such cure period. </TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Mr.&nbsp;Karrels </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In
October 2013, we entered into an employment agreement with Mr.&nbsp;Karrels. Mr.&nbsp;Karrels is employed <FONT STYLE="white-space:nowrap">&#147;at-will,&#148;</FONT> which means that he has no definitive term of employment. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Mr.&nbsp;Karrels&#146; employment agreement includes a non-competition provision that will prohibit him from competing with us for a period of
18 months following the end of his employment with us for any reason or for the period during which he is receiving severance benefits, as well as a non-solicitation provision that will prohibit him from soliciting our customers or employees, or
hiring our employees for a period of two years following the end of his employment with us for any reason. Under his employment agreement, Mr.&nbsp;Karrels is also subject to confidentiality and invention disclosure and assignment obligations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Mr.&nbsp;Karrels is eligible to receive severance benefits in specified circumstances. Under the terms of the agreement, upon execution and
delivery of an irrevocable release of claims against the Company and subject to his continued compliance with the non-competition and non-solicitation, confidentiality and invention assignment provisions, Mr.&nbsp;Karrels will be entitled to
severance benefits if we terminate his employment without Cause or if he terminates employment with us for Good Reason, absent or in connection with a Change of Control. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">40 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table summarizes the schedule of severance benefits Mr.&nbsp;Karrels would receive
in the event of such a qualifying termination. Mr.&nbsp;Karrels&#146; employment agreement contains substantially similar definitions of the terms &#147;Cause,&#148; &#147;Change of Control,&#148; and &#147;Good Reason&#148; as those defined in
Dr.&nbsp;Koenig&#146;s agreement, discussed above. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="26%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="23%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="22%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="25%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:27.95pt; font-size:8pt; font-family:Times New Roman">Scenario</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:64.10pt; font-size:8pt; font-family:Times New Roman">Salary Continuation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:26.60pt; font-size:8pt; font-family:Times New Roman">Continuation&nbsp;of Health<BR>Benefits</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:104.95pt; font-size:8pt; font-family:Times New Roman">Acceleration&nbsp;of Unvested&nbsp;Equity</P></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Absent a Change of Control</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">12 months of base salary</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">12&nbsp;months (or&nbsp;until&nbsp;Mr.&nbsp;Karrels obtains other employment&nbsp;which provides the same type&nbsp;of&nbsp;benefit,&nbsp;if&nbsp;earlier)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">50% of the shares with respect to which the stock option is not vested</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Termination occurs within Two Years Following a Change of Control</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">12 months of base salary and target bonus (35% of base salary)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">12 months</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(or&nbsp;until&nbsp;Mr.&nbsp;Karrels
obtains other employment&nbsp;which provides the same</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">type&nbsp;of&nbsp;benefit,&nbsp;if&nbsp;earlier)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">100% of the shares with respect to which the stock option is not vested</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, upon the occurrence of a Change of Control (irrespective of whether Mr.&nbsp;Karrels&#146;
employment terminates), each outstanding stock option held by Mr.&nbsp;Karrels that was granted by us to him prior to the IPO will become fully vested. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Drs. Bonvini and Wigginton and Mr.&nbsp;Risser </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the first quarter of 2016, we entered into an employment agreement with each of Dr.&nbsp;Bonvini, Dr.&nbsp;Wigginton and Mr.&nbsp;Risser.
Drs. Bonvini and Wigginton and Mr.&nbsp;Risser are each employed &#147;at-will,&#148; which means that each individual has no definitive term of employment. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each of their employment agreements includes non-competition and non-solicitation provisions that will prohibit that individual from competing
with us, soliciting our customers or employees, or hiring our employees for a period of 12 months following the end of his employment with us for any reason. Each individual is also subject to confidentiality and invention disclosure and assignment
obligations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each of these individuals is also eligible to receive severance benefits in specified circumstances. Upon his death or
termination for disability, each of Drs. Wigginton and Bonvini and Mr.&nbsp;Risser would be eligible to receive any earned but unpaid bonus obligation relating to the prior fiscal year and certain other accrued but unpaid obligations. Under the
terms of each agreement, upon execution and delivery of an irrevocable release of claims against the Company and subject to his continued compliance with the non-competition and non-solicitation, confidentiality and invention assignment provisions,
each such individual will be entitled to severance benefits if we terminate his employment without Cause or if he terminates employment with us for Good Reason, absent or in connection with a Change of Control. The following table summarizes the
schedule of severance benefits each of these individuals would receive in the event of such a qualifying termination. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The employment
agreement for each of Drs. Bonvini and Wigginton and Mr.&nbsp;Risser contains substantially similar definitions of the terms &#147;Cause,&#148; &#147;Change of Control&#148; and &#147;Good reason&#148; as those defined in Dr.&nbsp;Koenig&#146;s
agreement, discussed above, except that the definition of &#147;Good Reason&#148; in these individuals&#146; agreements includes a material change in geographic location of his employment of at least 50 miles from our Rockville, Maryland,
headquarters with no ability to telecommute. The following table summarizes the schedule of severance benefits each of these individuals would receive in the event of a qualifying termination. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">41 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The definition of &#147;Disability&#148; in the employment agreement for each of Drs. Bonvini and
Wigginton and Mr.&nbsp;Risser is as follows: (a)&nbsp;the executive being determined to be totally disabled as defined by guidelines of the then-existing Company disability insurance plan in which the executive is participating, or (b)&nbsp;a
determination by the Social Security Administration that the executive is &#147;totally disabled&#148; or (c)&nbsp;the executive&#146;s inability to engage in comparable professional activity by reason of any medically determinable physical or
mental impairment that can be expected to result in death or can be expected to last for a continuous period of not less than twelve months. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="26%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="23%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="22%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="25%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:27.95pt; font-size:8pt; font-family:Times New Roman">Scenario</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:64.10pt; font-size:8pt; font-family:Times New Roman">Salary Continuation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:26.60pt; font-size:8pt; font-family:Times New Roman">Continuation&nbsp;of Health<BR>Benefits</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:104.95pt; font-size:8pt; font-family:Times New Roman">Acceleration&nbsp;of Unvested&nbsp;Equity</P></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Absent a Change in Control</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">12 months of base salary plus a pro-rated bonus at target for the current year</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">12&nbsp;months (or&nbsp;until&nbsp;the&nbsp;executive obtains other employment&nbsp;which provides the same type&nbsp;of&nbsp;benefit,&nbsp;if&nbsp;earlier)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">None</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Termination occurs within One Year Following a Change in Control</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">12 months of base salary plus bonus at target</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">12 months</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(or&nbsp;until&nbsp;the&nbsp;executive obtains other employment which provides the same</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">type&nbsp;of&nbsp;benefit,&nbsp;if&nbsp;earlier)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">100% of the shares with respect to which any stock options and any restricted stock units are not vested</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition to the foregoing, Dr.&nbsp;Wigginton also received a grant of restricted stock units in connection
with his promotion in February 2016. The applicable restricted stock unit agreement provides that the restricted stock units will vest two years after grant if Dr.&nbsp;Wigginton is still employed with the company or if he is terminated other than
for &#147;cause&#148; as set forth in that agreement. The definition of cause in the restricted stock unit agreement is more limited than the cause definition in his employment agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">42 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>COMPENSATION COMMITTEE REPORT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>The material in this report is not &#147;soliciting material,&#148; is not deemed &#147;filed&#148; with the SEC, and is not to be incorporated by
reference into any filing by MacroGenics under the Securities Act, or the Exchange Act. </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Compensation Committee has reviewed and
discussed the Compensation Discussion and Analysis contained in this Proxy Statement with management. Based on our Committee&#146;s review of and the discussions with management with respect to the Compensation Discussion and Analysis, our
Compensation Committee recommended to the Board that the Compensation Discussion and Analysis be included in this Proxy Statement and incorporated by reference in the Company&#146;s 2016 Annual Report on Form 10-K. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:54%; text-indent:-2%; font-size:10pt; font-family:Times New Roman"><B>Compensation Committee</B> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:54%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Edward Hurwitz, Chair </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:54%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Paulo Costa </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:54%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Scott Jackson </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:54%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">David Stump, M.D. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">43 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>INFORMATION ABOUT STOCK OWNERSHIP </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc337004_12"></A>SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table presents information as to the beneficial ownership of our common stock as of March&nbsp;24, 2017 for: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">each person, or group of affiliated persons, known by us to beneficially own more than 5% of our common stock; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">each of our named executive officers; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">each of our directors; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">all executive officers and directors as a group. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The number of shares beneficially owned and
the percentage of shares beneficially owned are based on 34,977,771 shares of common stock outstanding as of March&nbsp;24, 2017, except as otherwise noted. Unless otherwise indicated in the footnotes to the table, and subject to community property
laws where applicable, to the best of our knowledge, the following persons have sole voting and investment control with respect to the shares beneficially owned by them. In accordance with SEC rules, if a person has a right to acquire beneficial
ownership of any shares of common stock, on or within 60 days of March&nbsp;24, 2017, upon exercise of outstanding options, vesting of restricted stock units or otherwise, the shares are deemed beneficially owned by that person and are deemed to be
outstanding solely for the purpose of determining the percentage of our shares that person beneficially owns. These shares are not included in the computations of percentage ownership for any other person. Except as otherwise indicated, the address
of each of the named executive officers and directors in this table is 9704 Medical Center Drive, Rockville, Maryland 20850. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="60%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:86.80pt; font-size:8pt; font-family:Times New Roman"><B>Name of beneficial owner</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares of<BR>Common<BR>Stock (1)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares of<BR>Common<BR>Stock<BR>Issuable<BR>within 60<BR>days (2)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total<BR>Number of<BR>Shares of<BR>Common<BR>Stock<BR>Beneficially<BR>Owned</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Beneficial<BR>Ownership<BR>%</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Greater than 5% Stockholders</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">FMR LLC and affiliated persons (3)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,225,358</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,225,358</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14.94</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Oppenheimer Funds, Inc. and affiliated persons (4)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,037,007</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,037,007</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8.68</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">BlackRock, Inc. and affiliated persons (5)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,483,677</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,483,677</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7.10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Johnson&nbsp;&amp; Johnson and Johnson&nbsp;&amp; Johnson Innovation-JJDC, Inc. (6)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,923,077</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,923,077</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5.50</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">BB Biotech AG (7)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,920,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,920,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5.50</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Named executive officers and Directors:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Scott Koenig, M.D., Ph.D. (8)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">924,460</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">605,307</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,529,767</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.37</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">James Karrels (9)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100,331</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">150,699</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">251,030</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Jon Wigginton, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">114,482</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">114,482</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Ezio Bonvini, M.D. (10)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100,944</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">123,671</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">224,615</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Eric Risser</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">107,310</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">111,310</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Paulo Costa</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">59,435</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">46,621</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">106,056</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Karen Ferrante, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,640</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,640</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Matthew Fust</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">37,634</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">38,134</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Kenneth Galbraith</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">46,875</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">37,634</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">84,509</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Edward Hurwitz</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18,074</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">37,634</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">55,708</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Scott Jackson</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,640</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,640</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">David Stump, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">37,634</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">37,634</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">All directors and executive officers as a group (15 persons)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,264,140</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,637,735</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,901,875</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8.30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top">Represents beneficial ownership of less than one percent of the outstanding shares of common stock. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">44 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top">Beneficial ownership is determined in accordance with the rules and regulations of the SEC and includes voting or investment power with respect to shares of our common stock. The information set forth in the table above
is not necessarily indicative of beneficial ownership for any other purpose, and the inclusion of any shares deemed beneficially owned in this table does not constitute an admission of beneficial ownership of those shares. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top">Consists of shares of common stock subject to stock options exercisable as of, or within 60 days of March&nbsp;24, 2017, and shares of common stock issuable under restricted stock unit awards that vest within 60 days of
March&nbsp;24, 2017. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top">FMR LLC and affiliated persons reported sole dispositive power with respect to 5,225,358 shares of our common stock as of December&nbsp;31, 2016, in a Schedule 13G/A filed with the SEC on February&nbsp;14, 2017. The
address of FMR LLC and its affiliated persons is 245 Summer Street, Boston, Massachusetts 02210. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top">Oppenheimer Funds, Inc. and affiliated persons reported shared dispositive power with respect to 3,037,007 shares of our common stock as of December&nbsp;31, 2016, in a Schedule 13G filed with the SEC on
January&nbsp;31, 2017. The address of Oppenheimer Funds Inc. and its affiliated persons is 2 World Financial Center, 225 Liberty Street, New York, NY 10281. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top">BlackRock, Inc. and affiliated persons reported sole dispositive power with respect to 2,483,677 shares of our common stock as of December&nbsp;31, 2016, in a Schedule 13G filed with the SEC on January&nbsp;25, 2017.
The address of BlackRock, Inc. and its affiliated persons is 55 East 52nd Street, New York, NY 10055. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(6)</TD>
<TD ALIGN="left" VALIGN="top">Johnson&nbsp;&amp; Johnson, a New Jersey corporation (&#147;J&amp;J&#148;), and its wholly owned subsidiary, JJDC, each reported shared voting and dispositive power with respect to 1,923,077 shares of our common stock
as reported in a Schedule 13G filed with the SEC on February&nbsp;5, 2015. We are not aware of any changes in J&amp;J or JJDC&#146;s ownership of our common stock since that time. The securities reported herein as being held by J&amp;J and JJDC are
held by JJDC. J&amp;J may be deemed to indirectly own the securities that are held by JJDC. The address of J&amp;J and JJDC is One Johnson&nbsp;&amp; Johnson Plaza, New Brunswick, NJ 08933. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(7)</TD>
<TD ALIGN="left" VALIGN="top">BB Biotech AG and its wholly-owned subsidiary, Biotech Target N.V. reported shared dispositive power with respect to 1,920,000 shares of our common stock as of December&nbsp;31, 2016, in a Schedule 13G filed with the
SEC on February&nbsp;14, 2017. The address of BB Biotech AG is Scwerstrasse 6, CH-8200 Schaffhausen, Switzerland. The address of Biotech Target N.V. is Snipweg 26, Curacao. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(8)</TD>
<TD ALIGN="left" VALIGN="top">Consists of (i)&nbsp;53,265 shares of common stock, (ii)&nbsp;703,413 shares of common stock owned jointly by Dr.&nbsp;Koenig and his spouse, of which Dr.&nbsp;Koenig has shared voting and dispositive power and
(iii)&nbsp;167,782 shares of common stock held by the Scott Koenig Family Trust, an irrevocable trust, of which Dr.&nbsp;Koenig&#146;s spouse and brother-in-law are co-trustees, and of which Dr.&nbsp;Koenig may be deemed to have shared voting and
dispositive power. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(9)</TD>
<TD ALIGN="left" VALIGN="top">Consists of 100,331 shares of common stock jointly owned by Mr.&nbsp;Karrels and his spouse. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(10)</TD>
<TD ALIGN="left" VALIGN="top">Consists of (i)&nbsp;93,394 shares of common stock, and (ii)&nbsp;7,550 shares of common stock held by the Bonvini Family 2015 Irrevocable Trust for the benefit of an immediate family member, of which is managed by a
third-party trustee and of which Dr.&nbsp;Bonvini may be deemed to have shared voting and dispositive power. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">45 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SECTION&nbsp;16(a) BENEFICIAL OWNERSHIP REPORTING COMPLIANCE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;16(a) of the Exchange Act requires the Company&#146;s directors and executive officers, and persons who own more than 10% of a
registered class of the Company&#146;s equity securities, to file with the SEC initial reports of ownership and reports of changes in ownership of common stock and other equity securities of the Company. Officers, directors and greater than 10%
stockholders are required by SEC regulations to furnish the Company with copies of all Section&nbsp;16(a) forms they file. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To the
Company&#146;s knowledge, based solely on a review of the copies of such reports furnished to the Company and written representations that no other reports were required, during the year ended December&nbsp;31, 2016, all of our officers, directors
and greater than 10% beneficial owners were in material compliance with applicable Section&nbsp;16(a) filing requirements, except for a late filing for Dr.&nbsp;Bonvini related to an option exercise that occurred on February&nbsp;11, 2016, which was
subsequently reported on a Form 4 filed on October&nbsp;21, 2016. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>HOUSEHOLDING OF PROXY MATERIALS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In order to reduce printing costs and postage fees, we mail only one copy of the Notice of the Annual Meeting, which includes instructions on
how to access our 2016 Annual Report and Proxy Statement on the internet, and the proxy card to any one address, unless we receive contrary instructions from any stockholder at that address (known as &#147;householding&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We will deliver upon written or oral request a separate copy of the 2016 Annual Report and Proxy Statement to any stockholder at a shared
address to which a single copy of the above mentioned materials was delivered. If you are a stockholder of record, you may contact us by writing c/o the Corporate Secretary at our corporate headquarters located at 9704 Medical Center Drive,
Rockville, Maryland 20850, or by calling us at (301)&nbsp;251-5172. If you are a beneficial but not record owner, you can request additional copies, or you can request householding, by notifying your broker, bank or other nominee. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>WHERE YOU CAN FIND MORE INFORMATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are required to file annual, quarterly and current reports, proxy statements and other information with the SEC. You may read and copy
these proxy materials and any other documents we have filed at the SEC&#146;s Public Reference Room at 100 F Street, N.E., Room 1580, Washington, D.C. 20549. Please call the SEC at <FONT STYLE="white-space:nowrap">1-800-SEC-0330</FONT> for further
information on the Public Reference Room. Our SEC filings are also available to the public at the SEC&#146;s website at www.sec.gov. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">It
is important that your shares are represented at the Annual Meeting. Whether or not you plan to attend the Annual Meeting, please vote your shares as described in this proxy statement, so your shares will be represented at the Annual Meeting. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The form of proxy and this proxy statement have been approved by the Board and are being mailed or delivered to stockholders by its authority.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:54%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">By Order of the Board of Directors </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:54%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">James Karrels </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:54%; text-indent:-2%; font-size:10pt; font-family:Times New Roman"><I>Corporate Secretary</I> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Rockville, Maryland </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">April&nbsp;4, 2017 </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">46 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">09 14 2016 FINAL Board Approved, pending shareholder approval </P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>MACROGENICS, INC. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>2016 EMPLOYEE STOCK PURCHASE PLAN </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The purpose of this 2016 Employee Stock Purchase Plan (the &#147;Plan&#148;) is to provide eligible employees of MacroGenics, Inc. (the
&#147;Company&#148;) and certain of its subsidiaries with opportunities to purchase shares of the Company&#146;s common stock, $0.01 par value per share (the &#147;Common Stock&#148;). The Plan was approved by the Company&#146;s Board of Directors
(the &#147;Board&#148;) on September&nbsp;14, 2016 (the &#147;Adoption Date&#148;), and is subject to shareholder approval as described below. An aggregate of 800,000 shares of Common Stock have been approved for this purpose. This Plan is intended
to qualify as an &#147;employee stock purchase plan&#148; as defined in Section&nbsp;423 of the Internal Revenue Code of 1986, as amended, and the regulations promulgated thereunder (the &#147;Code&#148;), and shall be interpreted consistent
therewith. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1. <U>Administration</U>. The Plan will be administered by the Board or by a Committee appointed by the Board (the
&#147;Committee&#148;). The Board or the Committee has authority to make rules and regulations for the administration of the Plan and its interpretation and decisions with regard thereto shall be final and conclusive. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2. <U>Eligibility</U>. Participation in the Plan will neither be permitted nor denied contrary to the requirements of Section&nbsp;423 of the
Code. All employees of the Company and all employees of any subsidiary of the Company (as defined in Section&nbsp;424(f) of the Code) unless the Board or the Committee specifies otherwise (each subsidiary participating in the Plan is referred to
herein as a &#147;Participating Subsidiary&#148;), are eligible to participate in any one or more of the offerings of Options (as defined below) to purchase Common Stock under the Plan, subject to Section&nbsp;11, provided that: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top">The individual is customarily employed by the Company or a Participating Subsidiary for more than 20&nbsp;hours a week; and </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top">The individual is an employee of the Company or a Participating Subsidiary not later than the last day of the enrollment period for the next applicable Plan Period (as defined below). </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">No employee may be granted an Option hereunder if such employee, immediately after the Option is granted, would own five percent (5%)&nbsp;or
more of the total combined voting power or value of the stock of the Company or any subsidiary. For purposes of the preceding sentence, the attribution rules of Section&nbsp;424(d) of the Code shall apply in determining the stock ownership of an
employee, and all stock which the employee has a contractual right to purchase shall be treated as stock owned by the employee. The Company retains the discretion to determine which eligible employees may participate in an offering pursuant to and
consistent with Treasury Regulation Sections 1.423-2(e) and (f). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3. <U>Offerings</U>. The Company will make one or more offerings
(&#147;Offerings&#148;) to eligible employees to purchase Common Stock under this Plan. Each offering shall extend for a six (6)&nbsp;month period (&#147;Plan Period&#148;) during which payroll deductions shall be made and held for the purchase of
common stock at the end of the Plan Period. The Plan Period commencing on December&nbsp;1 and ending on May&nbsp;31 is the &#147;December Plan Period&#148; and the Plan Period commencing on June&nbsp;1 and ending on November&nbsp;30 is the
&#147;June Plan Period.&#148; Notwithstanding the foregoing, however, the Board or the Committee may, at its discretion, choose a different Plan Period of twelve (12)&nbsp;months or fewer. For purposes of the Plan, &#147;Offering Commencement
Date&#148; shall mean the first business day of any Plan Period. For the avoidance of doubt, the Offering Commencement Date shall be the date of grant for purposes of Section&nbsp;423 of the Code and the regulations thereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4. <U>Participation</U>. An employee eligible on the Offering Commencement Date of any Offering may participate in such Offering by completing
a registration form during the applicable enrollment period preceding the plan period. An employee who elects to participate in an Offering is referred to herein as a &#147;Participant&#148;. The form
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">09 14 2016 FINAL Board Approved, pending shareholder approval </P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">will authorize a regular payroll deduction from the Compensation (as defined below)
received by the employee during the Plan Period. Unless an employee files a new form or withdraws from the Plan, his or her deductions and purchases will continue at the same rate for future Offerings under the Plan as long as the Plan remains in
effect. The term &#147;Compensation&#148; means the amount of money reportable on the employee&#146;s Federal Income Tax Withholding Statement, excluding overtime, shift premium, incentive or bonus awards, allowances and reimbursements for expenses
such as relocation allowances for travel expenses, income or gains on the exercise of Company stock options or stock appreciation rights, and similar items, whether or not shown on the employee&#146;s Federal Income Tax Withholding Statement, but
including, in the case of salespersons, sales commissions to the extent determined by the Board or the Committee. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5. <U>Deductions</U>.
The Company will maintain payroll deduction accounts for all Participants. With respect to any Offering made under this Plan, an eligible employee may elect to withhold any whole percentage up to a maximum of 10% of employee&#146;s Compensation. Any
payroll deductions authorized must be in whole percentages only. These deductions will continue at the same rate for future offerings under the Plan as long as the Plan remains in effect unless the employee makes a change to the deduction or
withdraws from the Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6. <U>Deduction Changes</U>. An employee may discontinue his or her payroll deduction once during any Plan
Period, by filing a new payroll deduction authorization form. However, an employee may not decrease or increase his or her payroll deduction during a Plan Period. If an employee elects to discontinue his or her payroll deductions during a Plan
Period, but does not elect to withdraw his or her funds pursuant to Section&nbsp;8 hereof, funds deducted prior to his or her election to discontinue will be applied to the purchase of Common Stock on the Exercise Date (as defined below). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7. <U>Interest</U>. Interest will not be paid on any employee accounts, except to the extent that the Board or the Committee, in its sole
discretion, elects to credit employee accounts with interest at such per annum rate as it may from time to time determine. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.
<U>Withdrawal of Funds</U>. An employee may at any time prior to the close of business on the last business day of the Plan Period and for any reason permanently draw out the balance accumulated in the employee&#146;s account and thereby withdraw
from participation in an Offering. Partial withdrawals are not permitted. The employee may not resume participation during the remainder of the Plan Period. The employee may participate in any subsequent Offering in accordance with terms and
conditions established by the Board or the Committee. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9. <U>Purchase of Shares</U>. On the Offering Commencement Date of each Plan
Period, the Company will grant to each eligible employee who is then a participant in the Plan an option (&#147;Option&#148;) to purchase on the last business day of such Plan Period (the &#147;Exercise Date&#148;) at the applicable Option Price (as
defined below) the largest number of whole shares of Common Stock resulting from the employee&#146;s accumulated payroll deductions as of the Exercise Date divided by the Option Price for such Plan Period up to a maximum of 800 shares for a Plan
Period of six months (the Board shall have discretion to adjust the maximum number of shares an employee may purchase for Plan Periods of more or less than six months); provided, however, that no employee may be granted an Option which permits his
or her rights to purchase Common Stock under this Plan and any other employee stock purchase plan (as defined in Section&nbsp;423(b) of the Code) of the Company and its subsidiaries, to accrue at a rate which exceeds $25,000 of the fair market value
of such Common Stock for each calendar year in which the Option is outstanding at any time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The purchase price for each share purchased
will be 85% of the closing price of the Common Stock on the Exercise Date (the &#147;Option Price&#148;). Such closing price shall be the closing price on the NASDAQ Global Select Market or other national securities exchange on which the Common
Stock is listed. If the Common Stock is not listed on the NASDAQ Global Select Market or another national securities exchange, the purchase price will be </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">09 14 2016 FINAL Board Approved, pending shareholder approval </P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">85% of the fair market value of the Common Stock as determined by the Board in good
faith in compliance with applicable laws, including but not limited to Section&nbsp;423(b)(6) of the Code and Treas. Reg. &#167; 1.423-2(g). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each employee who continues to be a participant in the Plan on the Exercise Date shall be deemed to have exercised his or her Option at the
Option Price on such date and shall be deemed to have purchased from the Company the number of whole shares of Common Stock reserved for the purpose of the Plan that his or her accumulated payroll deductions on such date will pay for (but not in
excess of the maximum number determined in the manner set forth above). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any balance remaining in an employee&#146;s payroll deduction
account at the end of a Plan Period will be automatically refunded to the employee, except that any balance which is less than the purchase price of one share of Common Stock will be carried forward into the employee&#146;s payroll deduction account
for the following Offering, unless the employee elects not to participate in the following Offering under the Plan, in which case the balance in the employee&#146;s account shall be refunded. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10. <U>Issuance of Shares</U>. Promptly following the end of each Offering, the number of shares of Common Stock purchased under the Plan
shall be deposited into an account established in the name of the employee at a stock brokerage or other financial services firm designated by the Company (the &#147;ESPP Broker&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11. <U>Rights on Retirement, Death or Termination of Employment</U>. In the event of a Participant&#146;s termination of employment prior to
the last business day of a Plan Period, no payroll deduction shall be taken from any pay due and owing to an employee following the effective date of such termination. The balance in the employee&#146;s account shall be paid to the employee or, in
the event of the employee&#146;s death, (a)&nbsp;to a beneficiary previously designated in a revocable notice signed by the employee (with any spousal consent required under state law), (b)&nbsp;in the absence of such a designated beneficiary, to
the executor or administrator of the employee&#146;s estate, or (c)&nbsp;if no such executor or administrator has been appointed to the knowledge of the Company, to such other person(s) as the Company may, in its discretion, designate. If, prior to
the last business day of the Plan Period, the Participating Subsidiary by which an employee is employed shall cease to be a subsidiary of the Company, or if the employee is transferred to a subsidiary of the Company that is not a Participating
Subsidiary, the employee shall be deemed to have terminated employment for the purposes of this Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">12. <U>Optionees Not
Stockholders</U>. Neither the granting of an Option to an employee nor the deductions from his or her pay shall constitute such employee a stockholder of the shares of Common Stock covered by an Option under this Plan until such shares have been
purchased by and issued to him or her. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">13. <U>Rights Not Transferable</U>. Rights under this Plan are not transferable by a Participant
other than by will or the laws of descent and distribution, and are exercisable during the employee&#146;s lifetime only by the employee. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">14. <U>Application of Funds</U>. All funds received or held by the Company under this Plan may be combined with other corporate funds and may
be used for any corporate purpose. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">15. <U>Changes in Capitalization</U>. In the event of any stock split, reverse stock split, stock
dividend, recapitalization, combination of shares, reclassification of shares, spin-off or other similar change in capitalization or event, or any distribution to holders of Common Stock other than an ordinary cash dividend, (i)&nbsp;the number and
class of securities available under this Plan, (ii)&nbsp;the share limitations set forth in Section&nbsp;9, and (iii)&nbsp;the Option Price shall be appropriately adjusted to the extent determined by the Board or the Committee. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">16. <U>Reorganization Events</U>. A &#147;Reorganization Event&#148; shall mean: (a)&nbsp;any merger or consolidation of the Company with or
into another entity as a result of which all of the Common Stock of the Company is converted into or exchanged for the right to receive cash, securities or other property or is cancelled, (b)&nbsp;any exchange of all
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">09 14 2016 FINAL Board Approved, pending shareholder approval </P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">of the Common Stock of the Company for cash, securities or other property pursuant to a
share exchange transaction or (c)&nbsp;any liquidation or dissolution of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with a Reorganization Event, the
Board or the Committee shall take any one or more of the following actions as to outstanding Options on such terms as the Board or the Committee determines: (i)&nbsp;provide that Options shall be assumed, or substantially equivalent Options shall be
substituted, by the acquiring or succeeding corporation (or an affiliate thereof), (ii)&nbsp;upon written notice to employees, provide that all outstanding Options will be terminated as of the effective date of the Reorganization Event and that all
such outstanding Options will become exercisable to the extent of accumulated payroll deductions as of a date specified by the Board or the Committee in such notice, which date shall not be less than ten (10)&nbsp;days preceding the effective date
of the Reorganization Event, (iii) upon written notice to employees, provide that all outstanding Options will be cancelled as of a date prior to the effective date of the Reorganization Event and that all accumulated payroll deductions will be
returned to Participants on such date, (iv)&nbsp;in the event of a Reorganization Event under the terms of which holders of Common Stock will receive upon consummation thereof a cash payment for each share surrendered in the Reorganization Event
(the &#147;Acquisition Price&#148;), make or provide for a cash payment to an employee equal to (A)&nbsp;the Acquisition Price times the number of shares of Common Stock subject to the employee&#146;s Option (to the extent the Option Price does not
exceed the Acquisition Price) minus (B)&nbsp;the aggregate Option Price of such Option, in exchange for the termination of such Option, (v)&nbsp;provide that, in connection with a liquidation or dissolution of the Company, Options shall convert into
the right to receive liquidation proceeds (net of the Option Price thereof) and (vi)&nbsp;any combination of the foregoing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For purposes
of clause (i)&nbsp;above, an Option shall be considered assumed if, following consummation of the Reorganization Event, the Option confers the right to purchase, for each share of Common Stock subject to the Option immediately prior to the
consummation of the Reorganization Event, the consideration (whether cash, securities or other property) received as a result of the Reorganization Event by holders of Common Stock for each share of Common Stock held immediately prior to the
consummation of the Reorganization Event (and if holders were offered a choice of consideration, the type of consideration chosen by the holders of a majority of the outstanding shares of Common Stock); provided, however, that if the consideration
received as a result of the Reorganization Event is not solely common stock of the acquiring or succeeding corporation (or an affiliate thereof), the Company may, with the consent of the acquiring or succeeding corporation, provide for the
consideration to be received upon the exercise of Options to consist solely of common stock of the acquiring or succeeding corporation (or an affiliate thereof) equivalent in value (as determined by the Board) to the per share consideration received
by holders of outstanding shares of Common Stock as a result of the Reorganization Event. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">17. <U>Amendment of the Plan</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)<I> Amendment of the Plan</I>. The Board may at any time, and from time to time, amend this Plan in any respect, except that (i)&nbsp;if
Section&nbsp;423 of the Code requires that such amendment be approved by the shareholders of the Company, such amendment shall not be effected without such approval, and (b)&nbsp;in no event may any amendment be made which would cause the Plan to
fail to comply with Section 423 of the Code. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) <I>Suspension of the Plan</I>. The Board may, at any time, suspend the Plan;<U>
provided</U> that the Company shall provide notice to the Participants prior to the effectiveness of such suspension. The Board may resume the operation of the Plan following any such suspension;<U> provided</U> that the Company shall provide notice
to the Participants prior to the date of termination of the suspension period. A Participant shall remain a Participant in the Plan during any suspension period (unless he or she withdraws pursuant to Section&nbsp;8), however no Options shall be
granted or exercised, and no payroll deductions shall be made in respect of any Participant during the suspension period. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">09 14 2016 FINAL Board Approved, pending shareholder approval </P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">18. <U>Insufficient Shares</U>. In the event that the total number of
shares of Common Stock specified in elections to be purchased under any Offering plus the number of shares purchased under previous Offerings under this Plan exceeds the maximum number of shares issuable under this Plan, the Board or the Committee
will allot the shares then available on a pro rata basis in a manner consistent with the requirements of Section&nbsp;423(b)(4) and (5)&nbsp;of the Code and the regulations thereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">19. <U>Termination of the Plan</U>. Except as otherwise provided in Section&nbsp;25(b) of the Plan, the Plan and all rights of employees under
any offering hereunder shall terminate on the earlier of: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top">the day that Participants become entitled to purchase a number of shares of Common Stock equal to or greater than the number of such shares then available for purchase hereunder; or </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top">any other date determined by the Board of Directors in its discretion. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">20. <U>Governmental
Regulations</U>. The Company&#146;s obligation to sell and deliver Common Stock under this Plan is subject to the listing requirements of the NASDAQ Global Select Market or other applicable national stock exchange and the approval of all
governmental authorities required in connection with the authorization, issuance or sale of such stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">21. <U>Issuance of Shares</U>.
Shares may be issued upon exercise of an Option from authorized but unissued Common Stock, from shares of Common Stock held in the treasury of the Company, or from any other proper source. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">22. <U>Notification upon Sale of Shares</U>. Each employee agrees, by enrolling in the Plan, to promptly give the Company notice of any
disposition of shares purchased under the Plan where such disposition occurs within two years after the date of grant of the Option pursuant to which such shares were purchased. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">23. <U>Grants to Employees in Foreign Jurisdictions</U>. The Company may, in order to comply with the laws of a foreign jurisdiction, grant
Options to employees of the Company or a Participating Subsidiary who are citizens or residents of such foreign jurisdiction (without regard to whether they are also citizens of the United States or resident aliens (within the meaning of
Section&nbsp;7701(b)(1)(A) of the Code)) with terms that are less favorable (but not more favorable) than the terms of Options granted under the Plan to employees of the Company or a Participating Subsidiary who are resident in the United States.
Notwithstanding the preceding provisions of this Plan, employees of the Company or a Participating Subsidiary who are citizens or residents of a foreign jurisdiction (without regard to whether they are also citizens of the United States or resident
aliens (within the meaning of Section 7701(b)(1)(A) of the Code)) may be excluded from eligibility under the Plan if (a)&nbsp;the grant of an Option under the Plan to a citizen or resident of the foreign jurisdiction is prohibited under the laws of
such jurisdiction or (b)&nbsp;compliance with the laws of the foreign jurisdiction would cause the Plan to violate the requirements of Section&nbsp;423 of the Code. The Company may add one or more appendices to this Plan describing the operation of
the Plan in those foreign jurisdictions in which employees are excluded from participation or granted less favorable Options. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">24.
<U>Authorization of Sub-Plans</U>. The Board may from time to time establish one or more sub- plans under the Plan with respect to one or more Participating Subsidiaries, provided that such sub-plan complies with Section&nbsp;423 of the Code. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">25. <U>General</U>. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(a)<I></I></TD>
<TD ALIGN="left" VALIGN="top"><I>Effective Date</I>. The Plan shall become effective on the date that the Plan is approved by the Company&#146;s shareholders (the &#147;Effective Date&#148;). </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(b)<I></I></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Shareholder Approval</I>. In accordance with Treas. Reg. &#167; 1.423-2(a)(2)(ii), the Company shall seek
shareholder approval of the Plan within 12 months after the Adoption Date. If shareholder approval is </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">09 14 2016 FINAL Board Approved, pending shareholder approval </P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">not received by that date, the Plan shall be terminated and any amounts withheld from Company employees shall be returned to the employees without interest. </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(c)<I></I></TD>
<TD ALIGN="left" VALIGN="top"><I>No Right to Options; No Shareholder Rights</I>. No employee shall have any right to be granted any option under the Plan. No person shall have any rights as a shareholder with respect to any common stock to be issued
under the Plan prior to the issuance thereof. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(d)<I></I></TD>
<TD ALIGN="left" VALIGN="top"><I>No Right to Employment</I>. No person shall have any claim or right to be granted an option, and the grant of an option shall not be construed as giving any person the right to be retained in the employ of the
Company or any subsidiary. Further, the Company and each subsidiary expressly reserve the right at any time to dismiss an employee free from any liability, or any claim under the Plan, except as expressly provided herein. </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(e)<I></I></TD>
<TD ALIGN="left" VALIGN="top"><I>Severability of Provisions</I>. If any provision of the Plan shall be held invalid or unenforceable, such invalidity or unenforceability shall not affect any other provision hereof, and the Plan shall be construed
and enforced as if such provision had not been included. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(f)</TD>
<TD ALIGN="left" VALIGN="top"><I>Incapacity</I>. Any benefit payable to or for the benefit of a minor, an incompetent person, or other person incapable of receipting therefore shall be deemed paid when paid to such person&#146;s guardian or to the
party providing or reasonably appearing to provide for the care of such person, and such payment shall fully discharge any liability or obligation of the Committee, the Board of Directors, the Company, and all other parties with respect thereto.
</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(g)<I></I></TD>
<TD ALIGN="left" VALIGN="top"><I>Rules of Construction</I>. Whenever used in the Plan, words in the masculine gender shall be deemed to refer to females as well as to males; words in the singular shall be deemed to refer also to the plural; and
references to a statute or statutory provision shall be construed as if they referred also to that provision (or to a successor provision of similar import) as currently in effect, as amended, or as reenacted, and to any regulations and other formal
guidance of general applicability issued thereunder. </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(h)<I></I></TD>
<TD ALIGN="left" VALIGN="top"><I>Headings and Captions</I>. The headings and captions herein are provided for reference and convenience only, shall not be considered part of the Plan, and shall not be employed in the construction of the Plan.
</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"><I>Applicable Law</I>. The validity, construction, interpretation, administration, and effect of the Plan and of its rules and regulations, and rights relating to the Plan, shall be determined solely in accordance with
the laws of the State of Delaware, without regard to its rules regarding choice of law, except to the extent such law is preempted by federal law. </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">

<TR>
<TD WIDTH="100%"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" ALIGN="center"> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:1px" ALIGN="center">


<IMG SRC="g337004g16j01.jpg" ALT="LOGO">
</P></TD></TR></TABLE> <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">ANNUAL MEETING OF Stockholders of MacroGenics, Inc. Date: May 18, 2017 Time: 9:00 am Place: Hilton Garden Inn Rockville-Gaithersburg, 14975 Shady Grove Road, Rockville, Maryland 20850.
Please make your marks like this:Use dark black pencil or pen only Proposals&#151;&#151;The Board of Directors recommends a vote FOR all the nominees listed and FOR Proposals 2, 3 and 4. 1: To elect two Class I directors listed in these proxy
materials to hold office until the 2020 Annual Meeting of Stockholders or until their successors are elected and qualified, or until their Directors Recommend earlier death, resignation or removal: For Withhold 01 Matthew Fust For 02 Scott Koenig
For For Against Abstain 2: To ratify the selection of Ernst &amp; Young For LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2017. 3: To approve, on an advisory basis, the For
compensation of our named executive officers as disclosed in these proxy materials. 4: To approve the 2016 Employee Stock For Purchase Plan. To attend the meeting and vote your shares in person, please mark this box. Authorized
Signatures&#151;&#151;This section must be completed for your instructions to be executed. Please Sign Here Please Date Above Please Sign Here Please Date Above Please sign exactly as your name(s) appears on your stock certificate. If held in joint
tenancy, all persons should sign. Trustees, administrators, etc., should include title and authority. Corporations should provide full name of corporation and title of authorized officer signing the proxy. Please separate carefully at the
perforation and return just this portion in the envelope provided. Notice of 2017 Annual Meeting of Stockholders to be held on Thursday, May 18, 2017 for Stockholders as of March 24, 2017 This proxy is solicited by the Board of Directors INTERNET
VOTE BY: TELEPHONE www.proxypush.com/MGNX Call 866-284-4925 s Cast your vote online. s Use any touch-tone telephone. s View Meeting Documents. OR s Have your Proxy Card/Voting Instruction Form ready. MAIL s Follow the simple recorded instructions.
OR s Mark, sign and date your Proxy Card/Voting Instruction Form. s Detach your Proxy Card/Voting Instruction Form. s Return your Proxy Card/Voting Instruction Form in the postage-paid envelope provided. THE SHARES REPRESENTED BY THIS PROXY WILL BE
VOTED USING THE INSTRUCTIONS PROVIDED BY THE STOCKHOLDER, IF NO DIRECTION IS GIVEN, THE PROXIES WILL HAVE AUTHORITY TO VOTE FOR ALL THE NOMINEES LISTED IN PROPOSAL 1 AND FOR PROPOSALS 2, 3 AND 4. IN THEIR DISCRETION, THE PROXIES ARE AUTHORIZED TO
VOTE UPON OTHER BUSINESS AS MAY PROPERLY COME BEFORE THE MEETING. All votes must be received by 5:00 P.M., Eastern Time, May 17, 2017 PROXY TABULATOR FOR P.O. BOX 8016 CARY, NC 27512-9903 EVENT # CLIENT # </FONT></P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">

<TR>
<TD WIDTH="100%"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" ALIGN="center"> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:1px" ALIGN="center">


<IMG SRC="g337004g57b11.jpg" ALT="LOGO">
</P></TD></TR></TABLE> <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">Annual Meeting Materials are available at: www.proxydocs.com/MGNX </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">IF YOU HAVE NOT VOTED VIA THE INTERNET OR TELEPHONE, FOLD ALONG THE PERFORATION, DETACH AND RETURN THE BOTTOM PORTION IN THE ENCLOSED ENVELOPE. </FONT></P>
<P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">REVOCABLE PROXY &#150; MacroGenics, Inc. </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">ANNUAL MEETING OF STOCKHOLDERS </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">May&nbsp;18, 2017
9.00 a.m. </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">THIS PROXY IS SOLICITED BY THE BOARD OF DIRECTORS </FONT></P>
<P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">The stockholder(s) signing this proxy card hereby appoints Paulo Costa, James Karrels and Atul Saran, or any of them, each
with the power of substitution to act as attorneys and proxies for the stockholder(s) to vote all shares of common stock of MacroGenics, Inc. (the &#147;Company&#148;) that the stockholder(s) is entitled to vote at the Annual Meeting of Stockholders
(&#147;Annual Meeting&#148;) to be held at the Hilton Garden Inn Rockville-Gaithersburg, 14975 Shady Grove Road, Rockville, Maryland 20850 at 9:00 am local time or at any postponement or adjournment thereof. Each of the individuals is authorized to
cast all votes to which the stockholder(s) is entitled as follows: THIS PROXY WILL BE VOTED AS DIRECTED, BUT IF NO INSTRUCTIONS ARE SPECIFIED, THIS PROXY WILL BE VOTED FOR EACH OF THE PROPOSITIONS AND NOMINEES LISTED ON THE REVERSE SIDE. IF ANY
OTHER BUSINESS IS PRESENTED AT SUCH MEETING, THIS PROXY WILL BE VOTED BY THE ABOVE-NAMED PROXIES AT THE DIRECTION OF A MAJORITY OF THE BOARD OF DIRECTORS. AT THE PRESENT TIME, THE BOARD OF DIRECTORS KNOWS OF NO OTHER BUSINESS TO BE PRESENTED AT THE
MEETING. </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">Should the undersigned be present and elect to vote at the Annual Meeting or at any adjournment
thereof and after notification to the Secretary of the Company at the Annual Meeting of the stockholder&#146;s decision to terminate this proxy, then the power of said attorneys and proxies shall be deemed terminated and of no further force and
effect. This proxy may also be revoked by sending written notice to the Secretary of the Company at the address set forth on the Notice of Annual Meeting of Stockholders, or by the filing of a later dated proxy prior to a vote being taken on a
particular proposal at the Annual Meeting. </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">The undersigned acknowledges receipt from the Company, prior to the
execution of this proxy, of notice of the Annual Meeting, the Proxy Statement dated April&nbsp;4, 2017 and the Company&#146;s Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the year ended December&nbsp;31, 2016. </FONT></P>
<P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">PLEASE PROVIDE YOUR INSTRUCTIONS TO VOTE BY TELEPHONE OR THE INTERNET OR COMPLETE, DATE, SIGN, AND MAIL THIS PROXY CARD
PROMPTLY IN THE ENCLOSED POSTAGE-PAID ENVELOPE. </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">Please separate carefully at the perforation and return just
this portion in the envelope provided. </FONT></P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center">


<IMG SRC="g337004g46k89.jpg" ALT="LOGO">
 </P> <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">Important
Notice Regarding the Availability of Proxy Materials for the 2017 Annual Meeting of Stockholders to be held on May&nbsp;18, 2017. </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">This communication presents only an overview of the more complete proxy materials that are available to you on the Internet. We encourage you to access and review all of the important
information contained in the proxy materials before voting. To view the proxy statement and annual report, go to www.proxydocs.com/MGNX. To submit your proxy while visiting this site, you will need the 12 digit control number in the box below.
</FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">Under new United States Securities and Exchange Commission rules, proxy materials do not have to be delivered
in paper. Proxy materials can be distributed by making them available on the Internet. We have chosen to use these procedures for our 2017 Annual Meeting and need YOUR participation. </FONT></P>
<P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">If you want to receive a paper or <FONT STYLE="white-space:nowrap">e-mail</FONT> copy of the proxy materials, you must
request one. There is no charge to you for requesting a copy. In order to receive a paper package in time for this year&#146;s annual meeting, please make this request on or before May&nbsp;8, 2017. </FONT></P>
<P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">For a Convenient Way to VIEW Proxy Materials </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">_ _ and </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">VOTE Online go to: www.proxydocs.com/MGNX
</FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">Proxy Materials Available to View or Receive: </FONT></P>
<P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">1. Proxy Statement&nbsp;&nbsp;&nbsp;&nbsp;2. Annual Report </FONT></P>
<P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">Printed materials may be requested by one of the following methods: </FONT></P>
<P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">INTERNET TELEPHONE <FONT STYLE="white-space:nowrap">*E-MAIL</FONT> www.investorelections.com/MGNX (866) <FONT
STYLE="white-space:nowrap">648-8133</FONT> paper@investorelections.com </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">* If requesting material by <FONT
STYLE="white-space:nowrap">e-mail,</FONT> please send You must use the 12 digit control number a blank <FONT STYLE="white-space:nowrap">e-mail</FONT> with the 12 digit control number located in the shaded gray box below. (located below) in the
subject line. No other requests, instructions or other inquiries should be included with your <FONT STYLE="white-space:nowrap">e-mail</FONT> requesting material. </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">ACCOUNT NO. SHARES </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">MacroGenics, Inc. Notice of
2017 Annual Meeting of Stockholders </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">Date: May&nbsp;18, 2017 Time: 9:00 am </FONT></P>
<P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">Place: Hilton Garden Inn Rockville-Gaithersburg </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">14975 Shady Grove Road, Rockville, Maryland 20850. </FONT></P>
<P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">The purpose of the Annual Meeting is to take action on the following proposals: </FONT></P>
<P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">1. To elect two Class&nbsp;I directors listed in these proxy materials to hold office until the 2020 Annual Meeting of
Stockholders or until their successors are elected and qualified or until their earlier death, resignation or removal: </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">Nominees 01 Matthew Fust 02 Scott Koenig </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">2. To
ratify the selection of Ernst&nbsp;&amp; Young LLP as the independent registered public accounting firm of the Company for its fiscal year ending December&nbsp;31, 2017. </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">3. To approve, on an advisory basis, the compensation of our named executive officers as disclosed in these proxy materials. </FONT></P>
<P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">4. To approve the 2016 Employee Stock Purchase Plan. </FONT></P>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g337004g16j01.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g337004g16j01.jpg
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M P,# P,# P,# P,# P,# P,# P,# P/_P  1" )Z RH# 1$  A$! Q$!_\0
MQ  !  (# 0$! 0$           <(!08)! ,""@$! 0$! 0 # 0$
M   ! @,$!08'"!   00# 0 !! $" @4&" $=!0(#! 8  0<("1$2$Q05(18B
M%S$C5Y<8020EU=9846$R,]-5E9;80C=WMQEQLD-S-#4F-K8GUWBX4F*T=:<X
M.0I9>9D1 0 ! @0% @0%! (" P #   !$0(A,1(#05%A! 7P$W&!(@:1H<'1
M!['A,A3Q0A4(4F(C)#06_]H # ,!  (1 Q$ /P#^_C 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# \D\A %1'R!.;$'0(J-.29L^2S#B1T;4E&EOR9"VV6D;6K6OJI6M?7>M8
M"?/@BH,TH3EQAXT;$DSR$^8\W&APH,-E<B7+E2'5(:8C1F&U+6M6])2E.][W
M]-8$-<SV=O1J9U\VLH+!E1RP_,*C(7+AIA4Q^0Q+=N-A&+VTG=GO+\5F0TT^
MWMP8+;CL_1N0[-TK5U(^GCQ$WJ^[2=[3K6U:UOZ:WOZ:WO\ Y-;W]-_3Z_\
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M>O'-)'4RS ^@C;70R79X'*NAWJ6S:*37^>@27..V7V!U(7)M51AM]5I1:;Q
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M[A)"U=H6T^]-7$;'29+6XRE/;7HU%TVY(1?^(KRN1"5D382O7[00I_3/(O7
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MSLVJ;?[WZ%Z?>;."Y376^H])OU7M]Z C.&VW^\.3Z@K)\_75C\JH2W7XFW[
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M%9)"U35NJ6X385MF4IU&]ZV*RL!A# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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M:7S>N5*E*L*Z97!72^CA+!/&]#ME2N9ZLS>HBZ&NR4EWG,^HQ80DV/C$)I^
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MFH!% (^/+G&ZP &TAA9@J'W,_AOW$.26M,N-+54BROXM!/\ S-U-5=Z'+IO
M[[./TUKKZQ+%A-5\6-M^N;5:O68.FH,,R'K#=3EA9L['[8,7$?+"F&)#KC:T
MMI^\OM]4N])^5GFG-ZOQ*VO\AZC9(W:.8'NKPJK7%U:9TT,&!V,759=8:YRX
M::L%FZ&%+FFMG@XY+SM?C1"#TM>M07-*)%DRTV+\O53D5\99'O.O51PDI7AL
MAHP3L%"A5N':314I"&1"MA=-ZB"><I%!9):;;Y"6QH\9I+K[:5;6VV-'5O\
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MAQYTF-+EQV'"Z)3-Y:]?\_\ 6M7/W&BT?M-(!!6:V4@3.Q<O.<[8N%3N0/\
MN2IW6ES"&Y(X^ -!?]<II+R"8W>TMD(D-U;:%$NC2JT)^8#RZ6"6,GNF^C!)
M>+'Y&4YI1C_%RX:]^@JYWGI)+D?'K5Q2O32#:S(*]] %/08^S#@23%U]C\QF
M-'=:=6:T3T2$6^4'RR)YAY9ZHN=?I8KU[UL+Q;E=;C4F8U=AURGW]/++"]?*
MZ1E0'*I7>>]$=9#G2"W'6(\Z3&:8W)5)C_E)HFLQR3-["]D\8\/\JC==[9)L
MBP9*W5NDA 5*!_W+;SQVR3DQ]:%!?VX"%CP(U$@F3E.O-,0AL-YU:M[2A"R6
MVS=-(5WL?RQ^5JE=.K5&P0NRP1_+G.V!XU^:Y4<)T;JE^\Y[@,]HY7QV8)>G
MGKMT:D3Y_P"JN%H=&9G28\E$)^3J+(VV:T74JQ[ORS^?60P':N8^F5](,=7O
M?%27!6>0ZD=II_0N<T^G7ZR"K76X]D<"1HO]G]$ 3HDN(3F1IJ#,5#*UNK4V
MD:)Z.FXZ9_(#X,_4:9"U.AQIGZ9%C<4A$_990]^M.C;4K<>8Q]_V.M[WO[%Z
MWKZ_TPP]F P& P& P& P& P& P& P& P& P& P&!6SLOK#CG"NG>?^.7HF;U
MT/TQ?7N?<M!!:\2*MRB<0":L1$H=+H;:#  8^ #<2MQ^1I]UYQ"&67?\>T%B
MV9BL90^W2_2]4H="HW3*K5[5W6E=#LM/JM</\3*\QL(J00Z!: E+I<E)6S]&
MIPF>)L%GL$:(W*A2);3.U*<?VTTG;F%BV9FF23:QU/G=O@6*<!NM2(?V4\_"
MOL:!:ZR6=H):%'7)*A;D^$+DQX(H'2RXF4AU_P"UI32_\6TIVK#-):!']0\(
MD%Y4'73*:R%:JO/+9!ODFTUIGGAZ)T^T=%IU4%UZW*,?QI8]).\N*M.16]_<
MG[$?;M:MK2V6DO<5]*<($7:J\YD=4I,F[7'HD[DXFN#+ ,*DV.ACJA8[Q*JI
MJ,/DR'0!9-?JLQ:6IFF5J>0EG6MNK0G8I.;]4WTEPR^R;3!KG3Z>_/IO0RW*
M[ /FG!XN?#O0:V#:+)!(A$)$:3*?DW$S#&15-I4B7-ELLM;6XZVE0I+<*YUC
MEUQ.O5BI=(H=HLC *!:'@%>MP T::K11,9P;8'!@Z?)FI"SVYK"F96T?A<2^
MWM*MZ<1M1*2KM7O<')3[H>0]7NEUFL6JP#A-)O\ :ZQ #4.Z@R:+^XS?0EB4
M>>9B4YAKG$]U[9)$ FU$>B2]P_TY3,A1K3*;(_?N%2VPST;L_*7V;%7C5N .
MM=!J:VS-6K?[O]Q6,8O1;[9H,#_&2OW93?W,Q?U7OR*3^)S[24D-=PYT*KW.
MK9 .1[;6.IW>K4*FV"ER1UD"DB]OE288J8DG"G;A.!D2(;B7GVEN[;VGZ?;O
M>MZT*-<MWICDM0Z5#Y$_8H!CH+P258"5<"G*FN;6!T>V<LJ#/]V-E+$*77I1
M:=U\2\/9D:2X0CZ=U'TX]MAE\1$TKP;2-[OQ TX*9#]CY:5<.Q+&0")&] JD
M[9B!3T..6R:+W&+.Z(1:PVRXH@XS]Z(:6U[=VC2%?04EHX_UYYC*%+8,A]UY
M>XW2*?2+Y9#JKK7FZI!JW1#EGK53):M3A!("1HD=J,R+]C<A2VWOQ(7K2GFM
M*&F>3=97>>&#I;PV9V3E4*=&+UT _ D] J4>5'.V^%LG5 KT9PLAUHM9AO\
MSF!'WK3TR/\ ZUI*T;^[!26*-^@>=UOI)7F)Z<L*4 UT!:SAXW/K@*JB@-B$
M=1-Q9[Q0V>'29+<&!R(JN;J-'?5#;VT\[I,?\SS(I-*L&+];>:C!6Y"H?;.<
M?2A#>>%[*9DVT)$K,0?U9!)=!DQ[/)FM IZ+'_$O:8_"^OZJ3I._Z[UK!IEE
MX?HSE17H'1^9@+'!LEIY/1X]ZO;0(M7IL"OQ9!6RA] "Q#9II@+:&)=5E;>B
MS_U$,M_:I;B=??\ 8*32K::=V#F5\*.URL7NG%;C!!C+ <HXZVU<Q;ZV.*PQ
MLZ,Z>"@C!1V"C\!B+O;NMKCJU(:4AQ:'6E+$Q,)*PA@,!@,!@,!@,!@,!@,!
M@,!@,!@<U_?I"N1C')V#L3G%A_"!ZB<=J?0./IZ0E0,+NCJ-VR";1UKCLH*.
MKR);3! 4W.);-M$&_P#H]W<33C1NU?;G9X!:*'3;!5B(,M72]9"S0Q&LQ5P*
M_)@.CV-L+#CG''7A@]*=?:W%<5MV,G7XE_XT;PQ.;9Y\UD;!FD9.GE1X$23-
M?U&CORY&V8K*WW=,1(S;LF2]M#>_M;;2I:U?32=;WO6L#DSSOV+1?3M%\[=6
M\6\WIE*G=J*>G;6"MOI/BYJD$:ROEN_X[I;LRNCIU8L(PMU*W_Q[,LR@@M&Q
MB'I;S4QYE$;#<VTKJ;T][3\]\PL!,3(XCH1=J"BOBI$WGS7&)5?@PNN%;*9L
M<L7>]7"OCZK63MSI<I>M'U )-C(R!JV8ST@A'U@TS,5JWBE],Y+,YO;;1T7S
MI4*-4!/>.H>4'DQP'/#8'_+YCKY>I1[#8TQ5)BB^?7"W,LOE!SB5Z;(R?S.,
M.(W^?9)B:YXT0-Q7J?COF%LN9.J<(Z"))^E>JMGSURN@"G&91;IOH'_(1RZ<
MO8>F6:=9*^! B.JUZ:0%[8;!:U&(MQ5R)$;;3JBS%T_)9*A]SXKUJ1,G5CS\
M:+)\^<NA]#JQ>72><:<K*9[EJ"@J%S)I9]TN*MI&#S^7I#<-F(.8CIC-N2D*
M<0VDDQ,<5:^X]2\B=9Y3;>/C.9]#"TB_463SD_T+A8GGG.3%=X]T@_R]H[&#
M6]PE#+"*9?.A]49KQ=@9&>DZEL&)+C3:(J9BHL1=$UXL'Y[M/D?MG8O)23W
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M XW7 T(.@P=G;TG<TP33#T]*=^FOR/K4K_EPYSC-6VX# 8# 8# 8# 8# 8#
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M?G/PV][L:8:'-2=.MM#ZL_7K!"/._6? 2IX$&"\"K8![N_-(AGII6;+M<H+
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ML(5&L$\^G25ZB-+TRC8BV*=?^6AT?Y)[@8CPRY3B$D\/Z!T<&GG8BED+*3/
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M(DQOWTZC"Y\=U+STA+L1(TX5=&,,F P& P& P& P& P& P& P& P& P& P&
MP&!2?V?YDM7I4=RH?7K!$'0*5<R9H\&(&Y%>C3XY:MD0,&Q0R42HW&8FPTB;
M,U.@-QFQ<Q:]J_7+#7M(D:-6S$*G@?CWZU-LED,W^7Q2;%+W:RWY@>(:F:"Z
MN)+BO<^80[=&K,?G0 >'*O'NB""NU/NF"<?]5U3I.=*88?<+JBE,6N&OC4[
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M^(_L]D<N4DCZ&K1MPY;^@F6QYX9T.3!M >Z]!Y+<23-UDHN>R4>?=!//%B[
MT-6U"?8CP?QM[2AU&R:XY.S'$.?RN3<6Y#RN<2CF9O-.7T#G\PO$C.0XA653
M:H)KD@E%B.NO.Q8\YT;MU#:EK4A*M)VK>]?7*Q,UFJ4,(8# PA*LULRZI\Q7
MPA5];"(RWB0F!.=7&:;(,MQU.2H[JU,-M%I:4HWO[=)E.ZUKZ.+^H0'Z%:C<
MFXETOI_-/. 3M][YW49ENJ_(ZX%KHVR= FU6O."6*M6)L@8^RQ8I=0_8%C-;
M0K_ XF*G7XE[1LL8S2M'!+X2/>4/V5V'UGS<-QKIG1:"]Z@]2=LF]DZQ66(
M#A/,[L:HD+@?FYF&9:FO1[J1BM'I$L!&6VP BC%?<ES]E.T1UW+=,1/1_2D_
MSKGTEJ2Q)HE-D,3%$US&7ZP$=:EK-.R7C*I+;D%2'U%GICRY6U:WM]3J]K^[
M:E?6N-9;7&C1H4:/#AQV(D2(PU&BQ8S3;$:-&8;2TQ'CL-)0TRPRTC24(3K2
M4IUK6M?3 H![+ZIT6GV"C0>?WT[4Q+$"V)N4&N,2Q9R:9?15I5/DQCL[RKZ;
M#RQ$,?LIJ3':CC'?SO,*VZ]]BF4FK8YKU5B0_,K5>ER7GI$F4#$R)$B0K2Y#
M[[\".ZZ\^M(D"E;SKBMJ5O4&%K:M[_U#/_FTF6<P& P& P& P/A)C1YL:1#F
M,,RHDMAV-*BR&D/1Y,=]M33[#[+B5-NLO-+VE25:VE2=[UO7TP.:O*_BB\R<
MDM%:.!3_ '6QUOF 'HU;\^<JO77CMKY5YF%]4"$JQ;T</J<]C2@<A=4,2A(]
MTI(,.!Q4AR) W'CK4WLW-\SR2ORGP)PKC5B\GVBF/7=LOXY\ZV7R_P M?('1
MLG1GE]IB\WC3V^@;9!17;(=C+Y:,>C26E0T-/JD*_$K3V]))-TS7K*[6&3 8
M&E]'Z!5^3\]O74KQ-?&TOF].LM\MI&,/G%9,"LU$--/G9D<6+CRR1%Z,,'NK
M2Q':<>=4G24)4K>M;$16:.6O3O7-#[[S7D/HSA?.>2]KY!8_)W5_7+$[L],L
MHJV'^><4OO$+BS3:C&)0&I%-LDZRL1"D>02@S(S)D# =TUM*42$&XBDTG.KV
MR^Y^(CO;@W/*/YF ]%MLF\GN5WBQ!:-SYQ=7 Q.?]XLEE);BZGO'RS;5@Y28
M!313D:*2E_=M]EF5%U#W)A2ZE9EG2GI#S%=PA[H?.>*G#/0^=B^I=6(D8E2#
M-1*+<J7,M9B*WU:XT<X8;8%7Z]<P?_UX^04B.28.MS5L+^W2J4F,)2K3.A^9
M;N _SYLW%(]/NM@Z9S_FW1S-BH &)::MTC]*IF::6LAMB7/_ %1#3I( ["*H
ME.N-*='I?TV['^R.3ZLE<N%VGPER*O3JZ&YS?38VU20EA7;^C<YJ#SABP6D9
MYGF+H$-L/#!18!BI@'^>SB$5(V-'4H5I_<B80@2]MEG5*R86U>6^]="ZL9%<
M%A6F^TBDD)EPZ!;><5V/"FI'F[KSV%4G[+*?D%29(FOGL].VD,NMI%Q8^WUH
MUN(WLF,<53_.7ISD/0I7..G=;X+RPI92LFLV#F/9./<R+( UL_T.B]%[_P!G
MADS'0&8DT=/Y C^8*GS8V?.8EN63:&6VR$N3$<C4Q,81*6)/;O#5]L^B)_S8
M4(=.[)/A!X@H[Q*OR[YT8K%K//>P!X"934R:PZ1>YE$$W)"9<R.ZV) /N/\
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MPFDL0QXT=&;AP8,1A&M(9C1(K*&VT:UK24)UK6$9# 8# 8# 8# 8# 8# 8#
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ME3L%IIQS;3BE,H,73$S6%CL(8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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MZ+8!5"ETJMKAM6*X1I29^V'ZL =(QTS2"5;B15/MZ=<3M:?J*2\TWK?*1O\
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M2*K02!MRX QV-IEI*XTC25$BZE?BJ?:/C?[O^K89%+*U:+.)]=]*[%MS!]7
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M.WO<M*'D*W2L5JMCUKF?9^V=!\K]"K#EJX [1)'8Y5Y?D_Y36JX5=BSU)NO
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MS4U$!3PYJ%0@DDB!J,6]6C4Z2P\Y7W^GWRK5O28R7']3+$R[M/X67E))$51
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MU99#45;K,<G'C+?BJ:D,*>9=2YA)BB?<(8# 8# 8# 8# 8# 8# 8# 8# 8%
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ME$-+VC6F6DH)-TRU/GO@;BW)]P(G-[%U^I5IBM!Z<8ID+I9>?6[=6 1VZGH
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MRF%I9_ ]:E(K^*MU?]J^C;%=!746Y >4[KD?\(7X8+IUQ:CT^R=+)<SJO);
M:?>/.(*R+ATRXAYS2W(L=^!69$QK2E:2[)3%TQ2B1XGKWN]5LMRI1,I2@XZ%
M+N$:,;52K18VZ,*B^G7>>W#M/0%'K]&-B:M6JJ0FEX+:&9%7EL1$QDD1[D9V
M%LFF&YU#U;ZB-B:]:"\"ECXW0.E<VX+5ZY_E[984@+<+]Q_D/2X/3"DZ99G9
M<VKR_P"X+"Y^AMAC4-A,-E<AQ]#JETI:T?IWJOL?'>F>J0=?N<(Q#CWHG+ B
M3%'*V29RB:U5_-@^F,SBQ6[5VO1:1U>;;#S4-;GZ\:)/'N_JIFS-OQEEBV)H
MTXC[D]!F"[LAG?/8)(<PY8HLW0&T0J90*X>".?6$?L,J\CPZ;BV';_/J'=1P
M<=#F*;GIFJ!26B+(TPM;W/N5KM7D_FG1:'T:92+++N?!8O39T&IK$$Q[5X&U
MHN:J1JL3CA:;0W; /N(]U"%$)CT5F8QI#[^G$.J)$8XY(?X7Z;].1.F\ X=;
M4UFQ!)$2LCK->#-=- #]U@E>&\WZ!*A"HTJPGB4FU<^G7#_I&6E$EF5&^UR<
MJ&YM2U"8C-V$PP8# YHS;)[ [+ZE]/\ ->4^A>;\6H'!G>," XHUYWUU<V<F
M]"YK&NY@H0L,CK5)1'0S,E?A9CMP]Z0VCZ[6K>_IHW],6Q,Q699.HV/UGRKU
MMP_CW8N]\\[71>R\J]!6EQ@!P'7)#=</\A(\7;$2&"['5+TT2@DXW2)2'V%Q
MFMI4RVI+G^G6Q.F8K$4=&5J^U"U:_P!*4J5KZ_\ BUO>&')OS(CY!O1?GOC?
M>'O97(*>YUWGE9Z JJQ?'+1B-7=V8<R3T%8+2/04-\FV.U(_%J0MEI3VD_?M
M"-[^W1TNTVS2F759/QQT#M%IF>GJ#W&\5;I%FX/Z(URT1=JISY7,8IRMSN&<
M1ZI&60JG]VW5J.2@E>ES(VWFYVTO,,MJVA"ONUAFZ(BDQQAL'MCI?2.4\'<L
M')#8&LWX_P!;\[\P#66S5A=T#UYGL7?^:<I,FWZJ@Y6OYR0+"7&2]'85.C(5
M(0C[E_;K>MI+8B9QR1%:>6?()7JS8C[?N?DLA8,$7,(CK\4Q$H?6,'R)J65*
MUZ*^J4N[8^W>]?UUK>%K9R_-9KRWT6Q=@\R>=.M6_0]-LZCPGD71;.D1%<A"
M4V*[<_KUE-:&0G9$MV(/T2)N_A:4ZZIMO[4[6K>OKLS,4F83MA# 8# 8'-_Y
M,:5VSHO.//M)X<JT(+V+UERN!=G0%@ZU5 S7./[>O[UA<Z'8^)'ZMT(/S_4Y
MJ%^V]%(Q&_V=Q].+^W?TV:LI%:\E9N:=T^1HSWL9R>;3Y53YF.].!Z+8;:8\
M_7R:'J_(JTCUVN8!K]VL=BBZOHV]T3D/-BC-W<DRVAQ2\[C/:??VB$@U,6TK
MQI^SMSAS,"BGLWN70N+S>9[K-JK5,K%F8N;)LV3UQB4;=L0U57W618X?VCOO
M"1*Q$B#/)/39$1X@ZPXQ'T[J.TYM:S5L574KTF3,  Y<QS\TR4(&R93NT0&]
MNR7X3+K[GXQ9 N,1][JM[^D:7*8U]?\ 5NN(^BU&67P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
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MW(S#UJ3"9GK8'15/-R):7I;PURWT-X2#0>3W/E!7JML.0;59.6%(9IP)6X!
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M<A//28;A2- CLSUQ)$F/$D/QERT+VVMQII:D?3:D)WO>M&6<P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P&!SF]K\ OG0+)7>@\JYB#O-H&T6S5P[*.73I<1YX0L[5
MI0^I@:=6O1?GVINS2Z'Y\UR?-FKVK8UN(M;*7T.)-VS3"5Z^?CYPBATD23$C
MP)(94:V/( Q*]."@TZ$&A1I8D8YIZ1I8\<^TIEG?Y%_5M&M_=O\ T[,2V[ 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# I%Z0^0?SCY3OK//.OR^E1BC/-
M%]FM!BF\?Z1T2J<[Y*Q:%T^=T;I%BI%<.P*74A9MI:94N9M#<=E"GE_1I.U:
M-1;-T5A@X'R5>6YO7YO'7R?2PTZ'V8UYYUT8[Q[I OATOM8( _9YG.8O:9%=
MUSO=@>!QG'XZ7)[;4G[-H;6IS:4[&F:5:?!^6CQ81K-MN,>U]-:K-7YF4[<.
M,DN#=G!PNE<-KIT(!MO:.-/':.-3USF=,=L4286)@/WD0A3R)ZT_IK0^H:+L
MFTJ^3WQFWO4^1TV7%I<DQZ  !.J2*E9D\EM9;S#3T7OLL:H]%0,76;*BO5M@
MB[%>B/N,%U@RC<!<EP?)2@:+O75D>O?(APWB-+X9?KI3O1LFN^B8-0>YJY4?
M-_7KG.?-] T,_LBC60;6ZN0F5+HEJ=+--0@1!#!)YY+C>FOO;7I(BV9K2F#8
M!/OWS(7Z5VSCR+><']-\[\.KWH;KU--4FV!S-1YQ8JVU;$+D,D!+")5G!A9D
M198.RIPB+60B-R&FUR&];)IGY(VH_P IWDJ\BF22"/6:<]-1YZ(!@G2N&]4Y
MX?LE5]3=&@\GXA?JN+M57&NV.@V^_3T0%%8>WHT%:5*E;91K2MEFR8FB: 'M
M?S[9NOQ.%B+,8?Z/-ZYU?AT<6Y4[%'A*Z)Q7F=0ZYT 6HP\/0,1"&4>\CI#,
MS;FHTMUU3+*UNMK3H:9I7@_73O:? .2=YJGF.U6(])[K>N27_M--YU5Z9:;6
M<LU.YS$)SC$4.D"+FL3+:6C B.PX9*_Y$QL;*U%:<VPO6B1;,Q7@K]6OEC\H
M6BJ3[;$'>B8#2.F/\7K-<+^7^Z0;STKKXR5<8=IYGRRD;I#EEO\ ;Z"[02V[
M'&'1G=5]N&MR>IA'T5LUHGHRYGY3?)T$-SHU7I'9^E)Z76.N6X8$Y9Y\['?+
MA60_!+4#H_9]=%I 2G/6_GI7FUPL<4:5@%H46;'EN?C_ !;W]/J31*7.F^X>
M \RY+PWM:R5VZ)1_2ABHA.&?Y.\VO'4[-TB9>J&>Z96%U^GU (1LSL:?1ZS-
M(*6Y%;_"TSO3FD*_PX(MF9IR1E=OD]\H\U<&L= (=>J4Q%%K?3>C0BGG[M+D
MCSY0+@3)AZO:O2W\?2)S/!!9J<%E[:W95P'$QHKLIQ"(C:W]#1,Y,PKY'_,S
M7:)O$)4KJ4,M [6!\XR.@O\ %^FJXDCN5JK]>LU6YFKLD>M/T!FRV09;1FH2
M')J&GY$]AE+GY74)4-,TJOCADP& P& P& P& P& P& P& P& P& P& P& P&
M P*+?)::Z'4O#?HV^\HZ!>N:=&YSS@_?:?9N>_PRSNCM:A/38 Y^(=KMH@D@
M\Y_Z)E1OU?R/-Z^U*T;_ *X:L_RBN2L7&_=/3F WN:LV*LLFHWBGG=R)UJS'
M$7*PWDQ-YU<.[4*(-[<V KS7\O>+X$XV.NS2:Z.C:=!6J*EJ-O7XI+Y9MRZJ
M4B/D\]J6XA1^A1QM&"5B;KC$HOQT)1YIJ9;]MW3Y%Z#>(%5N3<VRKC,]5L'G
MBF,0W([Y9 R41A,Q)$K4M;D\UHMR]<&[4?Y>_41\7R8\0\]\U*0;74.AG+&.
MJ!"XE9YDB%B]J=J$6DD@\NT5^*MV?R^/")1ER"J_V7W4,O)<^C3<)LBM*M@I
MWL_U58O)'+.OIZ/67;!T7W9VOG-K/!J@Z4K2.2;I'=S--J_/'2,?4P3 '6:N
MA(8DE,_9DO/MM-.NO?G4ETFF*TZ/%Y0^3_U3<+]X]X1T;DE/,2K\UJI]-ZJ]
M,.@2%LE#:W%F+LE0"3]0U+L@>(Y'(6**Q#GQ-?N;7]PMC;&W:LV129A)ET^2
M[TM5.]7VC0.*4"RT&H]@+\_&Q($/HK5^L0@=U$-RN*J'/:_? ?SA0A8X\]I2
M(CC/X8ZV=(4IY+S)-,?DK_7_ )>/7M_JG$H8K@G-*Y8NTUWM"O[K@%21\;!+
MU86+37X]*#MF2C9^V4:::5)/"6'3FW$#742/XK2GMQ959LMQ9OE'R<^H(-AY
M0 *4FN=5AWHORQ5\L3\6U0"!!RY<?\,-2-<N'AAS8.L17[OZ$*SW(<M,]M+D
M)YMM:/R;3'I-D8^N:<J!\G?6KA\>_7_6CU-Y=OH5#ZC2N<@0@6)>9E'?E7('
MQ FN.>8G$8!8>1K9CJTH5.>F$!(R/(';>DR8C.G-I)-D1?IX*VV?Y>O3YKFG
M62<'DW.>=;F4'G<NAW":GH,E/-9]Z'<O8L9V\+D040BZ Q'IVFA&V&H:$S(S
M.I2%I<6WHL615:WI_O7T9PRO^-@PWD3'8I_=?(YKL!(M-CV"-:9UUXGQ??6.
MK@YS("#L8/+VT0Y!8#MZBI4LM*=1IEQ*4,Z,Q;$UZ2IQ/^7;UP'!]:Z;%IO'
M+J #5[C *B#1H^Q >7SY13K?JZIW3NT*['RXXG-H-FB\JKP5F,^2VS!)SXJF
M7)#SZ8LXUHMR7?\ 4'R(=ZX7T2MTNM<*KUD;M/CNS^L(NYS]M<D"HW,JM<==
M7K)!X?#;7)55[W9.<M-J1%:D+&F"*E-:=;9V@S%L3%:\:*SGOF$[^+%DVA?&
M>7V$[$XIT7I5=G1%]#9K70E46#Z@C";I5E)1+GIY=?S'#@DJ \G<R0T.L.DZ
M=DN?@<<-:(]?),7R.>W_ $MP":$XC3HE'!7#H/E6]WI?0:G!NECL%;['6P]@
ME[;J8IX'.'1:-&E5Y2VIQ*-+0ZAW]>:X+DN#$E26VQ./"J'+;\O_ *,K:H(N
M)PSFY:R[\S=IZ42@?;T4? 9Z?R^P]@" $QY,E"B,OG]RWR=7W,Q(DZ4.W-1^
M>=I_\$22(LB>+Z]"^6[U)SLUZ "G^&<?&_Y']IH7+9<YPET(I+EP")WH5=L1
MJ+50K<NQE%V[5+C&:PPZV*)2PQ!6X, [)1"9)ET1@_H90K[DI5]/I]R=*^GT
M5KZ?76M_3Z*2E6OI_P"/6M_^+#D_6 P&!4?T]W?JW*K/Y\YWQ?G-"Z'?N^]
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M879B)4Y<RING(HA]EF;(%;;&RY+:WHS33*T-I,2WW 8# 8# 8# 8# 8# 8#
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M_P!-@/Y\%_ZZ$_\ M&'_ .FP'\^"_P#70G_VC#_]-@/Y\%_ZZ$_^T8?_ *;
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MR;_97S3_ -P:E_U1BD<H-5W.3_*/DW^ROFG_ +@U+_JC%(Y0:KN<G^4?)O\
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M -UG8O\ \H+O_P#\MZX9WL_QAB[-D<TR8# 8# 8# 8# 8# 8# 8# L5XI_\
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MLV1S3)@,!@,!@,!@,!@,!@,!@,"Q7BG_ ./;W'_Y%7#O_OO[OG+<SCX.EO\
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MM[S==-V,KA$4A:O(& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P.9'R,5PM8F>70X-([9;8LMJWBE$N7[OI,#42\V73G
M@IFRU+G5,N9@^0D/0G(C*IB((Z.*D$E?GW*W%:6;MET#YQ#6.YY0A[L0W <@
M4NKPW(-F6/<LD)<4'!87$L"Q.M"EFXRD?9+W&UJ/M]*_Q_X/IAB<VZ8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8'/7VA[KA^2NN^+^7.5VNG=^I.V1.>
M6 @=MS%9D4RER#=+HCEL P78SZK488Z)U2M1MP-*:_YA(ER?O^D;>L-6VZHF
M>4*S]5^9.B"0L0AQ+C'0.EN/ [63GR;#L?38@@A70O+;.-"[A;E%"!:59@O2
MT-,+9_&B/.92VY]4.*<;+HYI9*?+SY4%!%V!T/VN6.;YA"Z2O^.YJJ;+_>F0
MF"VN6,P&36YDOJS )_\ >4/90Y#6PG:6I;CVT-*&B<L*OF7^5;CW/X9R=U*E
M=/&CQDWTC*6;KM2A2Q($)YUZ0.YI81=S9*6B$; 6C^Z;,#$J?7$T!<+%V&D3
M](_(MH:)G)G^4?)9SOOGH;B/&>14RX3J]TSF5NZ%:KM;P[]6;J$\;6JO:*U1
MXL-;LS^8M,H6>6^1TC>H4>/MAR/)E:=W]@FVD5G-!-(^6:1$$W4]Z"YK7N3,
MT7L-MIIZH5ZP6.^]"&TX+Q#N?:@LJ<#55ZW"?(6BO<=;F@CXR23IEH@$O^C2
M*GXTAMH:.2;Q7RN><"E@A5G^T^X#R\RD="N;K,^@C4MC9'-)/H&-8*42?B6J
M6TQ<GO\ ABM[D5I.UP'&H+:ERV_SMZV-$HT%?,YYTG;,V291>K0N5L\VJU\K
M%\8$A"DJPD2 GUB<N=4?KD$XYL=*IL+R,>;;FM3)D$K)>;U'<_!^.0^-$_/_
M (_=),WY9/, WH87F4X%W%BR6*[=DHX)+?*B4YDY+X?<B_.;6<KT4=/F&[16
MB/0@$T*.DC(<Q;LZ,O\ ,VPUK\N#1-*X++<A]@\0Z_Q/EW?(MA70*+V.Q0ZA
M0$].=#58L=M14R1! JY!;9,%!9$Q89HMW]%F'+DJD)U]$_X]+0DS-LQ-.*B/
M</D<[7Y][5WVLW#CW/K5R?B5V\RA_P!V@62VD.L'JQZ1,6G]0A'JY@"*K"[!
M3ZS1R,A^*DGIF7(6PA#R$_D5HU%L3$<T[\X^2+D%[[;7^(,#+C/-](N)83S,
MV$IQ5NLKKPSB_(>Q[DVTN;D#MLG5B.L15N11C,Y<2.I#LI##27'M$FV8BK7N
MF_+1Y:Y(1Z6+N8SL4.9R[MS/ C++'/=./&+KJKV^ZD)-:B/&H\\B%'5.CSB#
M>W6H\XK#7%=%1I[<Z$J06++IR:?U+Y6Z76I#C5$Y-T@M74;]-0U]1N%?EURA
MKF>:/U!YXM6H[2I1N^58S:TD ^GX.F94*9 5MZ/IMUI2Q%C8SGRZ^5@#LA$P
M1V9YICH;M&1*A\^8?CR@[4JWP==4B?6P-OO<Q>FT TTB5]FB2E#G-_H_:MC;
MHT2D7T+\D7"?-72;#S"^5CKQ8Q5*L/N%A+TRFC3E=&AY],Z;T9S\LV191LYV
M4.H?'K$4D-MQE_1D?^-O;DEZ.PZ2+9F*PU=_Y4_-*#\*M0PO8BQ.?UP!Q9C0
MR@-NPTV^R77LU"%K>GOG8\1D?).\).:82I>ILU.XR(D>0^]ME T2T-OY21D"
MD^*^H6_BUMK%']5#>DS+6Q$G0K58^/:J%RHM$!&"S([<."8J9$U=F7)\MA6Y
M,.,MI3<9Y6UI071C,<EM/*'L_B_LP/T ]Q=VU/C.<W)=++R;-7E!&B4E4%HC
M!, 7D2YS$X01B._5*7%LSHSB%-2XT=W7V89FV;<UL<(8# 8# 8# 8# 8# 8#
M 8# 8'*_T;Q#J-O].QN@N>9J]W7FL2!5P4@=(7P"&P<J7]L7'=A;(S[_ +'=
M&:O >]3!3@[<<BP$T)0^VMI;SRU:C<3%*5=/ ;#<8*'C-"M FHXL>PV$2J,M
M(9MJ(RV@5I<)QZ&O0Y*=,_5E:FM_9_AWM/TWE893 8# 8# 8# 8# 8# 8# 8
M# IK[ ]JT[QTSQM@_P H[CVFU=XZ)/YAS>@<!J-?N5U,6472+-T(AM0RQ6^F
MQ&X$2L5&<^MQ,A:M?B_\CZ?7>C5MNKI"N'_S4*U__P"+OY3_ /<!RK_\?V2J
MZ(_^4-UYO\B%DZ)T"FT.3\=OR.<[CV^PCP#U\Z-Q/FX2@U!N>[^-1^XF!O:C
M1 97X'_E2'F8<EQ"?ZZ;5_HRDVQ$9PZ288,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,"@/=?D+I/ ^G'>6F?-?NCHA$#%"RGK;Q3R'UOJ_."*38F*7:9
M"WJJB)0,K)@-2],S&VE[5%E(6TOZ+1O6&HMF8K6$1?\ S6[FO_<T^3[_ /Y^
M]]_Z@R?*5T3SA:WR/[%Y;[.J%^M_+P/4JIKF'4#7'KU5>Q\Z.\LO=<O=? UF
MRDA12H61#1>%IL5;H2]*=0C:MKWK[?Z?7=9NMFW-:["& P& P& P& P& P&
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M$BZ81F>^*/S/9"70"Q6P=J>F]*O]]Z'95ZZ*G;*B/1JVS5[&,AQ'0;L5H<Y
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M:=*WM*M:-WY1\/W=3<,& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
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M]HE/HA?;.+,Q[=.+^AK#D8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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M60"+&=%1Y)RG_P HS'J8HV_'Y0Z["O R+^Q.*&DJ?8(,.,PD1$.-JE:%;6(
M\E]MTR#>3Q7I>[F;$<1[Y#H(\3;6WX\WIUOD #7-]IKU@IC$!\R#."2:M$B4
MV3!CQ"D:$S!2PPYA?IEFF^4>ZY*H^W>YPQ<><7=B16D3*P3ETJLK6 =&SRSR
MN41&NAV 6'6<@S$:V-:GDG1\Q"V6H[B-DK;R:=8N*_(2:88GQ>T4\19I9*!;
M?M%'I4.HUVR:J\/1<).$_P"7RR=VIT<Q_P Q#1E21VF=1-3YR92I"XZ"UM2
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M4(WBS0!KD:(_$8=$501)FN;D.,IVVUO2=J7]$[+$3.,<$F80P& P& P& P&
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H& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g337004g46k89.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g337004g46k89.jpg
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M P,# P,# P,# P,# P,# P,# P,#_\  $0@#*@)R P$1  (1 0,1 ?_$ ,X
M 0 " @(# 0$            '" 4&! D" PH!"P$! 0$! 0$! 0
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MPYP4%:T%P=CU!_\ T7P +M]IV2)?'[_:+X]AT/TW[??K>P^[^Y[O3>M^F_\
MT9%<1"N+6@-]NMEGICQI5B<6];,3*0!"/98MZ_(((RS C +^ 98PBU_#@<W
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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M P& P& P& P& P& P& P& P& P& P&!'ENE(#ZHL\EU3J%C8=7DU*<4B17I
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M/,LGFP)2<UO\[A5<MX8?"9;/G'4EG\B1Q:/_ %K3"V=\<FYD [+B_KG(\HM
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MJ1[G3N%YQ)D<STW/MNK([33S0EB%R=* **-3-EG\9 O9-''%;6G(#2=>X&S
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M%KQJM2N[#<V&>,[=5#^^SPYX,=6-U;3%LO$Y$C2D'^H30*NE[28QFN\GR_\
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MIG<5<7D+7*X\H4D ,*$,QID;(D6$[]VO:<0#?Y?3TPLMES.Z3,(8# 8# 8#
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M.R;F>GGEF54&OC0&YLA$:9G5#6E%+')8W(V5L1C3'EG.*W:K8CQ#'*X[=/\
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MF$CI&[T_0$3A+0Z--<MDE?X>NGB0D"\4A7/3R8UIR4A+@0627[1SM9TWQ/\
M/6D[HF;YU>#,2^UKT'5+^6W2N(" ]Q;HOHMWZDD^G IR@#@28JC-IO:C;4$(
M0I#6D>T#H0Y)QF!&.=;S%O&MSO%>09%Q:0ML9=6$DEZNQ#'\R3-K--H]8 K!
M;+48Y7 1Q*/1R%5T.%SQD0KV5K8V1 Q-XD@"PH=E#. :3E>7+U078_C7Y"K.
MN+MMNZK9NHY*LIOLO715YS271Y5*9'%.EJMKR$W+8$J^P5ZD8T;I!:PI5H21
MTEF:$3:UID8M;0J1#WZEF]O28[QJUO\ BHKNW72@EU>/1"JKS.P8IV5<;[,Y
M(YGRF0,$>H6O*F15+7[*PQ-N:W"O[<:ZPCHI*G>%Q.BBTAAI05 S2R4Y9O9G
MWQA:[M?QW4CWD7%B+ED=H-"*+1"S(,!M@L@CJ)K=6"U4\;(D1BUMED1F*%ND
MJ 452B;'QK+;WMO )006K^F5*"33.NUU[-;I[CGFDF[5]O0*6V8\SNENG^A+
M'?D;NI C8D5P=!T_ XA8C*<F60IG$\QE#"0-BEL$WJ3"2%AYNA*C]A&04+M<
M8^#*//C:H-^OE;>#B^VH<UNUTM'2;[0NY8V#H-_Z&88$FK9JN%VBAL;-DYTC
M(C"%/HQ"!Z+8%*Q,4K.;S%(?DV.=QCX*^#\(/&Q=/5K3[<Y6ZW)ZJF=L2Z,3
ML^00>5SLQ/<K0S1:71)V-G]=RZ)+XXB@\386-F,^T =6-NCS=]$M)/($>87]
MS;.7&@_-GCSZ\I7ICGBF[<ELABG0#S3W3DH<:_D V*8U>,QCC%74W,:ED#C#
M"!1--K]5$8$6S2UZL*E$MV8+11Y8,+G:66SM]OZL1U7XX/'U$XX;8MP3:9TZ
MTJY]SI'X"[M!L0?2HC*XC5(N2ZM@5=0B35?8S2^[FL+D@&TY L:'DX2[1*Q)
M](:F :7";;7I/MZM/OGQS^+JO9'(IK<-E/L"5PZ.\=362Q<-@-)!;/":"D15
M0UV]+H:VQ=<^ABEWN 4,7F2D)6R9$!L3D:&F$08+=)OO>WQ7\ZGX0JWJZ0M,
MOD<YN*KI:DK"PJ-?Y)2\O:HHZ3FC[64,:N?51+MOD9E:4^-/BV.I3RU2$I"]
M-YP1#1+DXC![$9FUU9"D*)YYYQD]J477*F0M[E?(E=W.,(6@<5;,PQ>-5[4?
M.?V^(O:9B3-C0Q-$>A;&G)0K%ZIU&>:<HT(PKW;*%MN+?1 D$\2O.4$B;##2
MIG=<F:HVAXM9FPV42B(*5NH[P78TOL:A8\J,:H$SD*FXL^8G-;P,96U3DU)B
M _*4IT:I-+=[_/YI2XV\=//W#3A+5U+&2TXJ2,K5$VM!*APL\F%0AD=WE[;(
M?'W",PF*O[V@3KGH6A+I&L?7HTI.G+,6C 2'6$VVNW= 3MXQN,ZQC<;CLGL^
MQ(JW29+5M'151);#AK6ID#VQ]EO';$$CC.:NB28ESF+_ '*Y'H@IR@#,5L8-
M)2BM'AVJV:YWV^V,.6\>&[EQ^^H0.LSOQ;$&EPE;A4E>J)^Q&POG_P#2#=L.
MOVQ$=0H3(6)S2))M-X.C(4:?%;X8B:!G(F\:(HS\A)Y+\$A0OA;D:#]U2^_H
MO*%:?H&0;=;W?J@&\5ZK1HW6?L.JC=+A*;CH@.W4:"1)XTH1%E#?Q1L#GI4:
MG1%JAFCPG*W7'HPJ7@_ESH)QZ$GC585[NM/]-/-O-%TT,@F[_"Z1EEEN,6)Y
MVLZ<+(B=&F&;J9.!N@99*81SH<PDN2,MW;TFE6REFR\MIB>L1G3W!O'%H2Z>
MR9@OJ\[]M>H+CD4&MBU)A+F9SDX9K'>:+!YH)J1Z=&ZM8Q"UK95E:7B[# 2T
M) *29&K&>YJE*K2@H1;MM.\Z?ZY8N7>(&.H+$YKEE&7C;-4%5(MJYJF4K0R9
MA'9(871/(5I\MU9^CE8KKYWBB>3JTT_*4R';PWK6YP)"=\1!(M@!@F_2YGVR
MR;MX/.+US)'VAK66Q'5,0:*F:8<^IWZ$2ASCGZ*839L"VY%HK&KR;1E^=K#:
M+;>5$A.=V]Q^9R&0L1!0GD%CT3]S9J=I^.KQ]KW>1PEXMF>,S^1/>-&XB&QE
MR@4X6U/:\-JY[Y]H*3"A+K5,_1M"BT*N<5;6Y:E"!=&5I)8EP4Z0\K:L)9MM
M_-8^_. ?QQ2''5"4I8+M4D9Y;Z J*SRI:C5)"Y_J+UM&)TRK#(RO#&G2,_CQ
MV<I46J$)<U#9S_\ ""SDVR3/AV2;8MM]8UAK\0?*[5$I3%"GRYU!LPK^'1%Y
MERB>H?QN.90?I6;==,UZ)I GC2<2:Y1WY.U;V<L"5]H%HDA,%N"E",DP<[]O
MNPQJ_P 0%!NSS"9>[W%TXYV' KA?ND&>QC[%BR:4+.E)(XP4ITO5[3-E?-\4
M<I=JNJ^1PA,W;; 1E)#U"Q&2U@.5FJL'/X1L_-7+T5XMM+O#K*Y)?6\)3=,7
MFWR9K$"5K]0BL:T"H);HZT'R&:-\<*:)/:=M3)YDCVC2EA;]/T@T00:J$ )Y
M@MY8UGI&FW#XW>/XI6]HOED32Y&2%2F(=+P67N;>Z)7A8B:>T^H81T)8)C8V
MLM?/3B-:CM1B;T;./2526A:#32U(#]^JD!9M;>GVQ'&7^&#EQQ772ZGSJ_M.
M]VL4QC[N\_C*&'/D92S#H*(].?6,3ZJKI0]/KM&;5A2(QJ52=1(34S2'[8+9
MB(L@DDG[E^#6;>\4O#4&9^F[VL^:61#X/*4,[N6V'CZR )FZ!J3IO%KVMZQ6
M=W;:K43P1DD?Z^$L6HEJ]U;$"9:N):D2$!X0@$WVZ1F;[\=?&?3=BO*>86/=
M":2]3N,WOX3+%G-N,BDD8S>>*NYDE9B5/(*SDT292$U>ELBEL4JQ%2=N=E:A
M6T+"-;4  )MM)T]&-O7Q*\6JZ>F!%LVM:D%JQJF4KNR>2EXG-;M;4RZ<:GJR
MK9"YJ7Z6UVY-T#):(?3;:H22)KVUR5D5FK#D3LF"?L &";[9Z=UC+>Y]YG[?
MD*2)@LV;E2?D-58E1RA)7S\D N:2^B.<4\6E,+FBJ:1:4DOFI!3=F('),L2C
M^L(4&D'A5:'HTL1);K^*)IOX=>8)XC-1.<PO!$0I25 W+2$$KAREO<6RF>>7
M[F6.(W-A?Z^?(XY&+JZD2@\U6>C,7M[YHMP:CVX\L.\+SJSG.'$U7<N/D[=Z
MVD]DJ$=AUQ0M;O\ 'I*_L[@TE)^=ZL;::A,I:E3?'&F1MTL<X$RHD[J8!?M$
MH/2@/)3)S=C$,EVM[JO4UX;^7:0E4+F49F%X/+[!9Q3,\:U4GE,*5#<72AD-
MSMD )DRAGKIC6R<SZ*]7K3JY+C3WUZ- F.6KSCRQF&EN]O=-7+?C?YWY!L^=
M6C4/XK*6S(B7H6^-O@H6H88*USR>'63+&J+N+1"62<NB1SE9VAEBD+R^GHDI
M1:5*80F $K"7:[3%0@7X9^5='7PJ5RN\W);?T!LFO7YU732,BD$4;[&N9NO\
M$AB<I305-*%DY@%IM*9?&GI_6OJ]K)3$)=F&IDR8HDO[FW3X,MOQ)<J1^P*A
MMHN3VPR_J],5%D0UF/E<2/B;47S;&9+'8D\J5+S"%TD: .[/*%Y\D2MSHW-+
MVX&:<5242X 5.ASN,>Z-V'Q <6V/656JX/:MP2*O4]2\[16#R:-6!7\GC$WK
M6EZPM>OZ[=%9*VOGV$3(J2PN\714-Q$C-$2N"B<6D;>J3A.$6[[2]NKV-_BN
MX[:K'9*@_2KT<JT5%*5M-;22V6)#ZVE8>7JSB'-E/V'(UI=:%Z')(4A8FI5M
M&G>T@7-W3E+%B%4G3E@*'/;&>GVZLC3'C@X2ISK*#IH%,)F?>=*4Q14T65H]
M*8>[%O<=KZO5W,%47+*GE16H)62^*F*NC49Z5F?VMF6.;6%8>U[.T$P0N^UU
MZ]LM\ZAXSY:<[M;;SLBZ[=INU[UM7GJ)U2]PJ2Q]"-FZ'J*-6TCJM^KQ.[5[
M+R$\P=JVE\L9W)*\?7QMR:5!H3T7U 2CM$FUQB3HVBX.!VHOQTVQP[S\-$-Q
MF\7F:5AF=R2Z0F. ;/L6=K+#D-XRR6QEA<7Q=/VNPGI5+$NT:).2:])R""_H
MDWM&0)M^KE5?Z5\>7$%\UQ7$NJ"V[1E%1-41I.F++:Z_DNF"HNIC^*YJOW"7
M2SF]ZB2MZD(F2Q$*\Q4XQQT;$[]H1A*I0O3>FL+=MI>O?\UK.<O'92_,5QNU
MSP.87$]NRB+VS"(Q$9O,6E\@M=0VZ+H)O^;QR$-*.+M+HG1GV: U60<X+G%8
M40H$G$<,DM.$DS=[9A#4P\/'+\Y!8S2^R^]S8)-D'29<4J\J>,>H#24AZW Y
M@OJ;5"WFPTYW;I++_OSGL@+TN?&YI^Z*]($B8)PM:+SOV^"RKE07/E)P;K^0
M3F9K(O7_ %$_+)=><AG,N9F-@CQC]44 Y[.)8GPY$U$1EL4Q>%MP2_J35!FG
M-08,)GH8 H!,VV8[Q5&K?&CR$\HW..M<]NJQ-U+:7-[',=S!P9V\Q;*N/:/.
MJROXL\?2UG$4#XQK:LL DIY4M@/C<3_8,I44>!1K9>=^WQ6,XT\>]&<-L4OC
MU0+IBYHY:T1.+_/,-P82]BAL$;W-MB,4;%D,@L+-=$K0F=S]C<'G[J^+S1:,
M6+E ]:%A-MKMUKKEGE2^+'B605SS]:5]7%#YBCC'#2"$,#DS3&5N,C;>%[;G
MMY4D%$Y0RF'9F>GATD;RZ"DR9,9]0<T)@B"4AT#:@<:SMMUDZ=?FLBP^&+DM
MGF-<SM._VVY+J]=U:Q C?G&MGQ$_1(V\I/T6P5T\GN]6JGU!%8E9,V=S$2EH
M6-4@/;G Q"O<EB8)19=3]S;[?P;#._'UR9"Z[INN9C,K=;8^UM_67.T!5)W(
MAT=79=Y%71U/LA*[J&>!.)*=>E6K#M,2\XE(WM00A^M$HU^78FUSF?#Y-91^
M%'CA!NX$Z119Z=DNBL[&KB1,1#M R0LQUMP-IKVPYW&I.5709\1+W]H:?G"2
MM>%S @6JU1J-L(TH&#&#]S9V0555ZVL4KVD5VC9EF =S(P),*QE\65ZCA4:A
M$;A@TD;3Q2)1)&W(Y"?'1/+@6(LW0WEQ5F$_"G&4F),VY2OA# 8# 8# 8# 8
M'S*C\*=VAM(YR(E=:;JPWN<U5N/&NS[];_5J.<T.Z,>J1^$+!\.I6HZ)5FD:
M;_D^W[9=Z,VH]_\ %9'7]R8^./FN#P-P+T_SAUO>UUW-:FII'IT7<*;3X@LU
MQ>AVX;8-UBL:OGV85BNJYC!$7JI(-_\ >\B.')WW:4@PQ(AT2W" 474VVEUQ
M%.*G\0O9+ BF[#:%P$RY),KJYL=[*=R+\FX"+\AE?=;:N*U+"D3$TUA$7^&3
MU\IE2HCA:<R0OIZXL\QN,6E-Q",0"W?7TGVPD^M_&+U9![#H5?(E5=6? JH<
MI$QUV@DO1O0455\L1YN[5L^YXY-*W0PML3JK8?I+SC(X_$3&IV=&I.AVPDMJ
MA0N9#%!!LP7?6_?_ *(T2^)_NA-';-1H[ K=JF@X*N2/\_\ T\W2]K>XK8;.
ML*NZ%@=G74RND,^WT4Y1N$U^X1H'VC<C,3[D1Z<D7VA,4E'3GK]O3HE%G\9_
M8+W-K/M6>2"M4LU=H-Y"9?3T:07I>KC7]>=#].VXQRVD%CX*--]9NTE8ZX@I
M[NVG.(2"#VX\[1K<E /98R2<]>T[='7;T'POU9S#2*5BF;5(K0CK_(NL'FIZ
M(K&7]/S)AKV=V5S#3<6K":H9ESU0Q8&:SX#;$-D9L<95K,SL+FHE"A06[IE^
ME*HPW-M;>GP=CO)WCJ[!A/8E0=-699"\<2;(-6S@Y@4VLX$S!E8T?)$-J!YY
MKD]:#K5Y12..M%LM:R1[5@F)#>):/3AI'MST88:]6=MM<63[=4;VIPWTG?\
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M%Q9W6J7BZ>6UHH^=;-F1Y6904+I6Z(1T7!#8S'=HV0&K$ELGC1AB,)OQNZ5
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M3%NTB) 7HNVTO;W_ (?!7N->*;KED9AM [I8 K:YZ3H:*\[R<$PER]V@O#]
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MUDLZ1>I[+>CG.=UC')CR[)K"B$)@:3B&NK+@]7QA<RL,U0LS38-OC<8WM U
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MBGD>L'M&M+FY&LOG5'9;RY(Z([64.-#1>.NLOJBP+Z;::C$EIN#6BZQ]OT6
M#G(D+@4SGJUC< ]2A$G1J4ZA8+8S.DULLOP2!Q%=/6]WP/J]GE$P?'YMC#/%
MT/-?3-D\S/\ S0\R">RRL%[A.VMXI6=(VHQQC])V/]&02XB0$)7$!YJ,8U1B
M(Y4:3::RS#K+KGO/RXW*S2(M%% 56]E\\61TS&QR&C22RC55(PK=-.7/;B!\
M(V4*9V_TW$W.3-00: X_A)R3;3:VFT W<;NND_BRS1Y$?)Z[1BV[C4UZ]-D.
MH5AKSII361=&;_%]S4CT);D#F$/H2-$JTPWP=LTCS2DE""0!;@[<]23:32HL
M!@@@V.&G;U2K7/D$[9@W.W9\MZB.31ZU*.IZ<UK3:A-2KFEA=A],5=3-X=%2
MVVCUK:@4MC;4:J#BAS.D/7+$C&>]-JQ&4H$N4Z*V3CK;./9K54=I^1:V)!7<
M+B5C%*X+9%^T9&3>DI?QU(*\'&F68<O79:]YP!#6TJ<V<E7'JXL*$QAL:9FI
M&-!]5(](C3G,PKU-%UUG?V: F\AODZ%!YT\MS2_2.WD\!CTD4TZX<BR>&,=9
M];G]!Q2)1+AYBF3V>0FM:MK:K-R>A.D^2KCPQ5*SER$;H4C5 087CI^']/?_
M $2; ^Z^_'"R^:*D0/B>Q7_HFA(WU"E<I13+54JF-CHB*6JDZVYTDD?<R$:N
M*.<AO!17,<8UJOYU2)O?E2@M4HV4!1LG'7K?3/\ LJW7O57>'Z17N^'&:VJM
M.G=!\002_P"W5?%-GQQ)RJ!TLGI*0= M5<\].:=5JY)#4$H7L\>4/*)$[?2M
MCF4M5@<BD?RB+9KC'QOJM]27<?D F%JT''KE'(:LCCZAAQD0*:>,IE+2^MV9
MUOZV(5*9?8RK<E:RN-5K/1$8BTI&W/#@C.:SY"-4:0N("!K 2ZZXZ?S^V6]<
M.>0'K"0MW1*;I^/2&32YK=(7'*/^VT).Z\@3Q<4Y-M(ANJ$IQ=8C&IG'6Y$?
M%&D+HID#6I;HT4N*/5R=8!82$@FVL]$-Q;NON1QHNNI+);3G3.CE5F5RU=)W
M(#QVV$W27D0U]I*93&<US!JF4JWMWOAA8;M:V>(F2@F/K$S 2N$)0H=1GEJD
M9>.N;\NKBL_8WE8GSK3Z=S6-E&J'W?"</G#*9S09(Q"'T[(^C8M9]J*-O<A&
M?"UM=Q2OXI)SX^H.4%QI<]!1.Y@BM_"8..G\U1;X7]A]]<]1>P9JFLZ$6^Q3
M+D'FEN-B;1.ZN2J;%3V78-HW%<)<.3G$JF>*.>TE=)EJP0C&Q,)"O3Z-^#8@
M:+..M^'5K4-=[_M*P;@Z$NJ)=11[F3IN\>+;YZQK*.)+@33F-<\K8WV-$6>
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MU:VV^0^9[XD-=2RY*7A-CR2J!%?@1YE3>8Y+6A,2Z,SZ4V*S3#]?B%D _1U
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M,=3/%B)8BPO-2[NA?S'#^HW:$QYD,M%HG[HA+KZ2FFIU)Y:1OVI2&(AK]*-
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MNO\ =/O2[2O_ /9NI?\ NR@?_P JM6"]TFX0P& P& P& P& P& P& P& P&
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ME%KE(V)<%$/VJMI_09>6?NZO.'>/@MFGL3@L9MNIWAPK21\?7#:K6^0&0/\
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M"SM7WU)&H;);3G##.F!9:CF8)EYK5O5=WE7S5'4<':F9D9I&ELF(/D/<D#4
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M[%6>GI[K4\/Q^:-O/T;E4]E%AOSW;2M5;R)BLJ7.\V?JSBLZ3(7"%U>%^?\
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MNN(N[AD]-?P>GY-^OY/_ %_P_P#U<!@,!Z>GY-?DU@,!Z>O\/_KP'I_^S_\
M+_ZN!^;UK>O3>M;UO7IO6_X-Z_Y/3_DP(<JSG^IJ65OCA7,84M"^1(F9I<E[
MG*)?+EP&".'.ZF.Q9I63)^D"F/0^/*']<8@9V\25K1C5G")(!LP6]EMM[ID]
M/[O]W6$,!@,!Z:_)^3^#^#_T?^K >G_Z?RX# 8# >G]W^[O 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# KS-.6Z6L:Z(_>T_AS3-9G$X:AAD7(E#4RO;+'2&^8 G"5]9TK@UGK$
M,A ^D$C^<"C1?HF)%\?R% 'HN;C#GMO+W.+._KY4U4;5C=)71TT].#\CA+ G
M=5;H&9LUC%JSEQ2$*@0RK CZ)\!KW>P#NG"K#K1_J9L9ONY+US7S[(SY@I?:
M8K5V46 <J534]=#V10=)5BY9%'%6N=C!I-C4KSW."LJH1^]_-]4U)3O=\I!8
MPC-1Q*N&N6IE)*]?GNFX$<W5LQO["QPLN'Q0,(5I'MFAT;2F.S"-D, J.C,;
MA*9N;- &44G0GJ"! &4;L.ARK>G7ECFQ]?Y)*GFB*G=)',$D@02A[7P2.JG)
M^0RV.CB4K1N:HU (U2EE$;']$Y%BW[5Q 0A/T9[ ^@S614\X4"L=(N]K*;K9
M6\0J0K9;$W55$&10X,$G<7!O=U[\VK#D8U"=U5O+2D6C.T+WB6I"%'K\Q)8P
MC-9@FD*>3:9-)JRA";\-EH2F#Z>.-A&V8IMFC?8Z ENV4G!M(4DGS4F> !!Z
M!TXD /\ 3Y Z%@S4I80P& P& P& P& P& P& P& P& P& P& P& P& P& P&
M P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
M P& P.M_R#=[&\/BIE0F@6["2S(GH">6 W)%!I3XRTWSE04VMZ<R"-DA&4D4
M/(W]O86H&U0])B2G49N]#& !8S>NO)LD6[:35_SUR7:/8C &E9QTSM,UNC*U
MH'$^(5=*U=6SZ[#V69O3LK^I96Y@@-?+RE+B?KXSG!/Z!+*"<  "<<V\>LB/
MF#RX\F/KA#"!IKH8&*8[+:!SR35!)VBOHA8JBH7&^D=-SB6F!,;(_;1U1MHG
MDUHV(W: )I:5:8F7"^ET7ALL#4/;-+W<"1;@Y,X,'$N=Z3Z9DA#K%3FU0SP+
MH".2Z75TRK"Q*S=ESY5'86J5+&C_ *5&6:1\@O4W6M$NMG?W5YK/R_<9VXZ-
M#/"'JQ7-<[-$.D7PZKIY$-NC<JY]>^E7*0KB4HU2@357U>LFTLB&G H&WR%6
ME:0!.7'@*PM\>T[M'*\VG&2F&NTM0ME^NREB66R4\PUCIA]?YBUM%)UK!;>L
M*6N")E5+VE%$V2OK(:%IBPU:#1)JKZ,\)*X.TV#]O;X+*\Z]NL_2%H]10^*5
M;.6RON<2ZE+;;6="R"&NTW2S*F:+D6-$?8%($;JSKHU$)6QFB+5[^0[3H#Y
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MFY2;:'=KPJ=?SO7U;1"9QQRAMS$-AL%A'.$ZB<7B5AL$]C3Z6XM.ZTLIA:T
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M*(QJ$M+;M*VKEB>+1Q'#:Y0M[,@3!*;B4C:("4/H69Z$VY=.2Y>&3 8# 8#
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M=G]*QFN(4LOJ-MAC^X+1NU75-6C9'F5*>O7&A:A&:4+QA'H.B<ZB6=>%& 6
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M_-UO6OR8+;>Z4\(8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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MLWY1'/;;.).TB^F&3 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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M6$L33:-'I8&<0-64<3,U!3F(J+FDF(#PB"NV1L(B3-;_ "@%Z%Q6D_K5<O\
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M].>7+QKQ:)6S<<-@FZNO/GN5O2&/"LR')T3FU$N#(X.SBSMBT:V-N>D*I/\
M6)5B50W-ZM)I2(!I&RZ;:W7AMV8:GVSS;^0GLOGRVNC(#)/&)QUSJ\?BR55!
M";K/<IKTB^I5S8YE1*8DQ)U2'O<4<ES0G(/TY)F]$D:1K"R JU"O8BQ>&NMD
MZ[5%K12'DT\1O;O==G\F<7(>]>:N[K"_3&RI(Q:4;K>:5/9*MSE3V8T2A+(
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MOG3E:LCJ_DFO3J];6K&E!)5Z1 8$;KLOV .-UZ T+U_+Z:)M/'MM=N7=VO\
M6-&=#^2KPWVS6%\T*UTKU;:-2R&0I*.32QFEB6(V]7LN6R>L6-%,RUFF4\R3
M&Q1MT)3L\!)(7,8#!A"$>]5C6S3?,ZQT_P!+^)KKQ;X$^Q*0MNJW4ONR];L7
M="M,/=91"%LH<I;7$DK(NNDITG;Y&KB!*]VCU='[($-Q 65IP]#! W[M:GHZ
M7?7]R6?VQVT^!7BZX.-.(W!+TG'5,;Z8OB[+1O*ZT#FY,CV^IWN0O(6)B3O#
MS'7%W9EZI1&X\G<!?3J30%G.)FM[T+W!U6/)M-MNG;#%?VACE?H+L;QN2RE.
M9:Y<+2M5?:]42)!$VMZC3 L-:(Z]J%;NO XRQ[C[.7I 0/0]AVI"8+_V BW^
M3!X[-=LWLO1RGQCSU3%:4<\).8*(KZYXM5=?MDBE,>J2M6F<-\L20YI0R;Y9
MA'V,#B>X#="SPJ%!:LS1X_<+WCT+UV9VVMMZ]'6LP<?=)(_[1?..T5-7.)7,
M+KQ6BK!OMC;Y$Q-JF>%!B>AQX+ !^%+P'AVWG?QPF\*;^+_Z3\NO6>K69^UC
MURK!->>_(OXO_)=V#V-Q_P E)^\>>^[RV223"!1ZS8]7%C5E9C:<K7"^J'(D
MZO:MD^_.SD>6:E2+"343@$LT28Y-K9YJ77?6:[7%B"ZKY(\MW-E ^1;KR-\[
MI7WR.>4*RTR!FJN 3:O!1_E2MCAS!R<9K*))*)8ACCM)D9$I-2-2!$J<1D*2
M4)ZD0_1846ZK=O';-<_HB1/%OX[N_?#QV-$:[C$/<ND.+.I:BK51TA.&!X@C
M<?1'1K4UJT3H_IVA\D#))7Z)L3T:>FV8A(6&K(^XE'# )8@^,PF^VN^OMM'7
MQY(.+)^Y>;YVX0K5<%/S[Y79US7U%>,9:S=*%*%II-]G;S;#FK3D& ^V@4*8
M\_NON-![5!SD4$(O4O>\-Z;3]OE>^K[SV]O0M*!"U-B0A VMB-,WMZ%*4$E*
MB0HR0)DB1,2#6@%$)R"P@ '6M:"'6M:RO,^+V5>*#MF55UYY1%T:[MM@W3VU
M4/4W$)XI77WRV2Z5->=FS=([,IY<M$3'35$6DGM %X&VF>JT(=ZUO0]!COSU
MSKUZ2=6)-\4W>7Z!?#XN>*/>I%=L8\D]I]H]OI@2NNRE, 56?=4.DB]]=UAL
MP"@?1:B,:)&(MI.<30?%\>@[WH.MEYZYVZ],8C@V%XX>SWKN/R(NEY>-)D[]
MF?1$YESAQOUC<]VQ5/0W.E=N@)81%M.$%?G-Y6HE$09G1K F;$C5IP)6LX2$
MP@$'?6;)RUXS%QCNQK]XFO(1(? 1S]R8W\_JT_3="]MNUU/M3OL^K9*X2:"'
M.=EK4[K')0EEZV'+#S"YZDV-.<X)U&_@4Z"#8@%A-+SU_<MS^FQN?9OCSZIM
MOKNN?)W:7BI8.MHO?-$1^(=+<!/5XQ4JPZ*M6%)RXA'I-%I\WJ6R/RY,KBT;
M;%!1R,E5\/U2U*H(+WLE7JIKMK->$N.O=D7#Q<=1RSQ>^15NA?C-YPY N/I
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M0>K4*%'L,W%GDTES)UKZVLKB_/37_)K_ .I@?N P& P& P& P& P& P& P&
MP& P& P& P& P&!6OL#EJMNT^:[<YDMA)\\.M>)K&$QP*)+.<8P^%B+7Q>9L
MGR"!HM]B$C2)7%)OW!ULY/H(O4 A:V76W6YG=_((Z.Y^LGE2][5YSMYLVU6)
M3\Q<X?(0 +, B<](Q /:)*S#,UK:B/RQC4)G-O-UZZ,1JR]_P^NM1[999F=D
M*85_3I_LP7_T0E-?]Z'0/_FY*,1Y/+_?7T&Y7,P& P& P& P& P& P&!TP>7
M7PXQ+RS!H4,HOF5TE^@DVQC46XS"F.8?B3=AEPTL_2W[R[M?V_35J'@V7\?O
M^7YQ>[T]NO4Z:>2Z=GQW^9#P+0[Q:<]5O=D1Z-G=X.L_NMEJ,,3>ZY88T @+
MS#YG)B7!O/8GIU6KW(:N*EI2DWQ^ANU/Y-^[0=;CMX_)=[BST?8-X)/&\7XZ
MN)HXTS1G)1]%WH)MM6_%(R]?7L[PM;]!B=8B.]-"^CK-@4_2& UZ@V[J%YP=
M["=KTKCY-N6WP=U.'-U7-'E$C8_*D_\ BTE],RJ&3']%&[9K>WU<G9U\1L]I
M!'FV1G-S0P%H$SPVK4Z4#R6,1AIH-&L2C7\ @;T;X7AS]'LL?RAQ2&>3FJ?&
M3&ZE?YU-IM5"VX;"M-)+61EB%-11$W2YW&.4-:Y$>X+SQML93C#\9I(/<[)0
M^OY^]X)I^CGZ* 2O^T2$SVR+'B7 'CRZJ\@D#J!U.9K!NBIDAK) "UR41_S?
MA(PF)S%QD:=04G&8CV>6W&N!0?F3EF)Q%G#-3Q=/U62IC@_GBKN^N29!T1R7
MRAT?TC;==VA$JON3CZ)L8$M\56JE"20':ECTWH$4D1N$)2JHZ<G"X)]; )1H
M9)VDZ@HT@,RG[=FV-K)/=4*-_P!I4M*96A.*0B/AW[6E%S5DC*<+&JAA<6YT
ML."H3Q-X2%DMB22&FO+"F.$[I=!&I*+"+:DOT_YX?5EK]KIGE,+(=/>=^2\X
MV/RI2:3QU])6E>O47-44Z$1TG%'AL(M""+7Y5+"'JKWN''1M4^.,KAR>'JCU
MXRB"P@+"+>RP^P6\,Z^/.;F8E3-QWY6^D.G>A(72M@^)CM/EV)RI%*E3C=MO
MLZA+7\4,CL9=']"D>CS(DU! =(UK>!O2_P >#U4J :_+_!L;:23,VE=OEC6)
M!ZB@,RM&RY.U0NOJ^C3Q+YG+'P_Z9IC\;8$)SD[.JXW01C^%(C3B%[0!&89O
M6@@"(>]!W7.3/2=WS9#_ +21()LURZWN<O%7VQ?G(T'<79,_=+L[<6PM VV/
MBW]^?&R,!B\@3GH6H@ CCPJ7=(<C+U_A@4@M#"".O[6.ELFSO'XA[=H'R"T#
M'>C.=)"M>84\K5S&[-+XA"TRV$RYI F&\PZ8LP%"LMN?6TM82;_%''IE*902
MH3G&D&EF"K&VMUN*MQ[@^[0/<'W[#L6@>NO=L.MZUL6@_P .PZWO^'#+K-6^
M2J,H_*:T^+T5320R4NU &WV"X-21HU&"6\O3EO<;'&-H]O(U^_MN_P"/T=\7
MY^OS?R8;X?HY^F4K<6=17;TR3>)ES\=VAR*.K;<>:\A!5F.VW45R1)M"/:.T
M8MO<8C7TD>=MAUHLKT5>GK_THL)M).URNY[@^[V>X/O]ON]GKKW>WU]/=[?X
M?;Z[]/7#(,8"P[$,00!UZ>HABT$.O7?IKUWO>M?EWO \L#\$(( [$,6@A#K>
MQ"%O00AUK^'>][]-:UK _<#QV,&A!!L0=#'[O8'8M:$/VZ]1>T.]^HO;K?Y?
M3^# \L"CN_(-S_KO77CC])W^L5NHOTV:W^%?_P 7_P""OSO_ .K?N/K]X_-_
M_AOIO_WL-<;QY^B\ A@![?>((?<+0 ^X6@^X>_X A]=Z]1;]/R:_APR\L!@,
M!@,!@,!@,#Q]P?=[/<'W^WW>WUU[O;O>]:%[?X?;O>O3UP/W>]:UO>]ZUK6O
M7>]_DUK6OX=[W_<UK \1&%A!\@A@"7Z:W[Q"#H'H+TT'?NWOV^@M[UZ?\N!Y
MX# 8# ZR^L?)7%^5>R^&N/'.J9%-G?MZ0R*/L4]:)*SMC-7XX\K9DABMY:%B
M0]<^%*]O(1!"F,+V'1>_7^'6&IK=M;M[.S(0P ]/>,(/<+0 ^X6@^X8O^:'7
MKO7J+?\ <U_#AEY8'B$8!^[VB"+VBV 7M%K?M'K^$(O3>_06O7\NOX<!L8 B
M"$0PA$/>] #L6M"'O6O7>@ZWOU%O6OR_DP/+ \1# #6MC$$&M[T'6Q"T'6Q"
MWZ!#K>]Z_+O?\&L#RP/$(P"V+01!%L&_:/01:WL(O36_:+6M_F[]-_P;P/W>
M]!UL0MZ"$.M[WO>]:UK6M>N][WO\FM:U@?FQ@UH.]C#K0]ZT#>Q:]![%KU#H
M._7\[>]:_)Z8%-/(-V;$_'[R%<G64OCBB:HJL9VLYJ@J)Y(C[E.9/(7]JC$:
MBC<[J$#J6@5.SP\%!V;]*H^(H(Q_&+0=ZPUKKRVXQU-'_P!H5B,7[VJK@6T.
M3YY YQ/7OG6)RF=_I)C;O$ZYE_1%;PJ<-#(ZI3(\TNB\,=>YN0R*#O:FV>H)
M,-  (/S,C?[?Z>4O1)WE9\[5;>+:Y:YI9^Y_G%X/\XK@NRW5?$)E'8PBAC0X
M2Y?#V!.[@>&]>8:H?5[.M$5O6R]:"1Z?EV/65-/'=YG*POD4\NU">.YFJEDD
ML/L&Z^@[Y*3#IKFRHD!#Q8<N"J/3(2W!8(>Q%,K(:[JP(4YNB52M>L]Q2-*H
MV4?\1-=+M]T4_I_S^(R>@JMYV[SX2Z/\=T@O9R2,=.3.XSDSY7LI?7)>F;&U
MJ=7\4>AZAA&L<UZ9((X"=:0C5*2@K1I0#T9AJ^/IG6Y3#V;YQ:1X<[_IGAZX
MJRDZ9HMA@KM^<>@"I0Q)8;7R>R9/+(@TG2..*4OW@UK;7F-%[7*RC] 3I56S
MO;L)(];)KX[MKRBR/9'DDC/'W4W!_+[Q5,CG;IW18[O7;#,6>2-#0UUVH:7>
M$-(G5[;%Z10L?$QXIJ P):898M!3BUO?J+7I,IKI=I=O9&=4^6R)2?R1VWXS
M[EI23\_6K"(V\S.LIO*9@QOD(O6)-1&GXEZAQJ1N;%+8%Q@VCG<!:G8ME!;G
M!.9L)Z(>A4NEX\YV9?QV>5%A\DMG=+M=,T7,6CGWGR8JH"S]+OTG9S(M<,I*
M<#"TR2#15.W@=PI#F C[L:<<HW]*C5H?D#HQ6$)8VTXR9[UVQ88?''_:K_&U
MJP*VCOD8JE@^29U @;X)T8D;4X?J'^HU*[942L%2626$:A;6C\X"2+#A;&/;
M,XZ&/82F_7I*[^';%XWLI;PK_9=ZV[$X_P">.H77L6QH&Y7A6C'/UL.:ZIB+
MVVQU0\:.V)L1.JV2(U:X@C1>O0PPL A?W=:PNWENNUF'U\^-;A1E\<7)T0Y6
MC]D/-KMD2DL\DA4T?V!OC+DN,G4K<I2<D-:&M:X(R2VTURV2 03=[,"#0MZU
MO?IE<=MN5ROKADP& P& P& P& P& P& P*G=-\B5WU9)^8G2SRRW2.\TWZV]
M$M<44)0*6^3SB+PB:1F$%NVC1?'MNC;]+2WG1>P#"<J;B "U\>QZV:FV)<>L
M6QPR8'RW^?:,G\R=6^+;RLQ\HQ(GH;H>/T1>;BG'\7R5'9"]4I3F+Q UH6D*
M)K52A'L0][!\CN6'\F]Z]8[>/K+I[Q53DJ,S'LM\_M$?E"A0EK\YV# >@^1>
M17I*3L\]PA%<5<N3&N$5-#\ANCGQH8HF%*)/^7:G9P0[]=[]2[8UXZ7\78[_
M &79[JIQ\1E1-==G-/XD8+!MY+;Z-#L@+FGL!=.W5R0*'PD'HH"H6UVI8MIA
MFZ_/0A)"'?M!K6JSYL\^JH?C$6QR3?VD/R[R>C1I5-,EUDW-D[<6$03HRMM[
M\050E>#2E*/8D!KHIG#++QB'K>Q&'@6BUO?N'ZO5=_\ ]6N>[/\ CA__ .ES
MS'_]TD.__70N3U3;_P#5J@GS!P_I">_VA'Q_Q/D:UXO2'0SMR4^ZKRT)G&DL
MPC47-1N?1J^0C<XXN:'Y(Y!=(NF6HR]#2&Z+-4!'^;L.A:K6F)X[GMEW1<*<
M\>9"K[P/DW=G>-)]'4<*#2!L(KNOZ;8X(_ESE6O8C8_(Q/C=7\94";VQO2KB
MC"/J=A,$I!O8!>W6PNKGM=+/TRRM1_M&B&:.'ATZ^+A05(SD[963A)@)/?LX
M4';[@@2R6C&$'YXD2=I)&:K_ /9TD+-V+\S0L5?%_?%EO$S)J;7>+CBIYK%=
M'4M:L_,==I'<\D]"F:V>11^*IDMJ%OQHA@3(G%OG"1U$Z[/V$05.CAF[]=BW
MA-\\[GOE\9O.KP-%XI?[2).J57/,<H5QZ6@1]$.T:7N3$D3)/TWZ/5;BSDV'
MI#$9>Z_>(T 7TXPBTD,)!O?M]-9'>_WZY[X_HV_MOCPWD_Q:>/[ROP+I/J%S
M[:DKGRHL<[#D-PR%>QI(].*V7R-FA<>BWO B88W"$C @;TR<H8BUR0!X5P5.
MU MA)KMG>Z63CU=O!:XYS_M6E:.2G0-*'#QJIUQ^B];"7HY6AD1YNBP[V+80
M>\S?IKUWZ:QZL?\ \/\ _<Z::[E,H;?#1_:!WA!*)0A=6SR#M13<Z(9(]H75
MN3CN^OB34[<Z)5Q2]N(-3F"+$$DP =@%L.]>F]ZPW9/W-9Z8_HWWO+CU1Q/P
M=XV/*56?2G3KSVC8$SY1_&=B2RW'YV9E[1850K)PEBK3%A#+;F*)Q-/&TK0F
M;BMB2K&O9I:T"@1NQZ&NW*W2R<4K>023SOM_S0=1\[771W;G5W/G)];0QNK?
MF7CNP6.O3F=VDL7K]Z<+AFP'V410EU1N#I+U0"U) SEGR:0$"%I(4,!I-9Q\
M<LQ+?=W#_P!GF8^WZOK[J"A>J*\Z&AE/UU9[.\<B'=+N3(^66AJR6[E0%T!=
MWIF?GXE0=#_L+><80 S21,J<SPIM!(V LNL>7C;+,9]58?,DWR;LWR_^/+Q=
MV);$]JKDRR*QDUQ6"UP:3'PY9:<L1BL\Y(P'.A'J4O5$I*S(0-Y:@M0!&8ZJ
M3BB]J!%##%\?Z=+OZJL4%7;KX_O/]8-"5Q<-R7;5%#>.^TIU5E>V;9#]-W*)
M-P8:DG;34RTT:DHIR+:G@X\UK-/(^M(;70@KWBT  Q%OZO'FS%M1#Q/P-'?*
M/XZND?*CU1U3T2J[#4.O0<NAL\C=Q/46B5$'U T*7V-LR&*-^RD;8Q@-2!4&
M)23$Q:1F.3@1Z3& V>8[M;;<-N$DXOH\\!74]Q=A>+V@K<OAT<I+92-5.J\=
MYL\:UMVGB*O9>ZQIEE3L?HLO2]Y4M*0E.N5;U[U:U,<</>S#!;RN7EDUWLG9
MT?/W$5$R'^U0+($XIY_N.N5*%]E*@)K0GB1QW=A<J#,@GE.Z=\+<B(+]]3A%
MN-A-TR;(]2/IOAWL&3U=.5_9^3'\8<C,/GCZ3\E%T]T7-T 0KH7HM\HBAZ@K
MBTG6!,M%Q=K6R9.RO"&/IB%"/;F26SE% $83HM8X)5QZP*DPP/Q.YMM^W)-9
M.L6 \09=X>2OQ@=M<)W!TY:[>&D^CEU!5IUI&'E4JM =>1%^B<U9R$,H4N*=
M>[F)1L9B8L\]8,\+.ZDI]F# 4#6ZSOC3>;2>CZ?N<ZA%05!TY1YDWD=F"J>M
MHA7H[!F)VU4JFVXJQHV84FD9XCU6SWAZ^D^=0+9AGN-'O\[?\.'*W-R^$I_5
M6?3!GE/\,+)8DR:9QT%Y,^1(;SRM=),^'OK54'14]W)79X9W!2Z[<DK/'*[B
M##]4!.: K0%!FM[UH0O6/1TN/)[2M^Y9L*==KVOX&^!G:5RA8[\<3/JF8=8(
MQ2)\ I6I^5[<<XI!V:<#(< *7-&\M4"2(MEK!&:-"[^F_70\&WZ9MM[X1Z]J
M[4J4OR@>%MGL:8M4\OWRB<H0N@G%SDSX<_-E.]!34Z6.KVTN"ATVXIF2/5]!
MF :H!!P"=!5#T+>M#%ZB8Z;^TJ1N4K%G/<-P>!CA1VE<H6.7&SOU#-NKT0I
M]@4*]<O6VZ0N#LLY$0O"H=4KN@KMO2;+6['HT+SO6_70_P HLXS;;W1FYJ;7
MJU!Y+O"FSV3,6F?7GY4N6X/13FYR9].?VVF;WE2J8N;ZUN"ASVY)V*/P&O&
MU4 DX!6@K1Z%O6AB]1TN/)[2I2Y(LF=]SW7X$N)G272I2X<7@Z5L#JM(&0/A
M2HY7S%;3G!8*S3@Q.O"I=2G,BLVM/L"W8]&!>=^OKH>][)9-9MM[]OQ=\_\
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M#0'(^--SBO,8"G'81F:/7HF@\D@X[UU\YA0C/0/N]NB[7E<K(80P& P& P&
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MY@O)<5VW)W;QG1Q<)(I.]2"AEOCZ]/;U3BU>9*C':&R><@HGJ5N9VZB-=7P
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MZ<D!R="?MMTM.V4 PO#$N;UCN=PYF P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&!",QY_K^<W
ME2O0KYI\W85!QZVHS =HW429BTV72CAZ&:?>VG1 PNBC9$'0_2#V8#Z;?R;U
MH7O_ "%STQ[HPDO%M9SFJZ0J>PIA<5B-U!W;7U_Q"73JQ7"36(\6!6,U7SN(
MCFTO<4IJV3LJ)S7[3"2F!!H3>241H6@EZWA>5ES$@69S75UN6K2UP3= Y.4G
MHAOMQJAC>!>$N,K6Z[8>D@T\12EC&G-)?DRN/HPED &( 21B$+T%Z^F$ELF/
M=2)H\-_(K-$9A!B'GH);&I36;70K4A>[TF+\.M>;$<T9)P\<VU6J>#%JJ$T[
M-%T=1(7M(0,3BX,R<MO$MTE+ 6$U^YMG/1'-D^(B!NSEP?6E<F-K7S-R-T[-
M>E3V*;RB4R2;,+:LVMD$1YRJ5 6V%LA%"F3U8E5JF]X7G?:T#(B1I"SB] ^F
M+-^]O>Q?+I7CZNNG7&OI*_S.ZJKL"KMR<B$V;05L2BI)VV,TV3-B681I6YL!
MXD#Y'9"6R(QFIEZ53HD]*6<GV2<'Y-F9M9[*OR+PZ<6OD700=O9[+B$-0<[1
M/FC\,Q.RGM(V.$*@-S&=!P:2/6W,+NM>[$B]PJU;V6ZJSCMK5*Y0%<4J*-V7
MHO/;YLLW^)/DU(L:UJ\=N24XF:]'364_BFSG=\#90^M:WB]7] Q>P]*T^Q/<
M.L"/PY :-$3M+] K)T)$-,7Z%:F#G60K'Q5\R58@KM$U.]T2,VJ[JK&\84XS
M:T'*2+VI\IR&R^!US% ?.B)1?@9@CLX< F)@DA6.*@8#UJI2<6$>J7>W^#6%
MOASXN=(-&J]=V:QG1@AU2RRH(L-5/UY;JPM4JZ%8^H2Y6VNB)(D5)YY%[@CB
M-:TN&M^U.G*VF,*.*&,(I@Y[)+C7C3YUC1-;"^XVO('BLX[TC'4$FE%AK7I_
MD0>JV6-1^UW24*#41:-0X#:8DA):2T1"% T@)]J=,$._;E2[VMXYKX5I3E"6
MN4NJ)?8B,UYHZ@J$>6)_F)S[&72,<U0XNOZMD:EJ4(B]ESE##RM(5:\DPHM8
M7ZB&3HS>QX+M;W]T@]8<Q5_V/0<\YPM1VG+/7=DD-*&6&5W)S(C)'!J:GQM?
MA,OWDM(NWIF>#VL"=P3"*$4M1&&IS-;+,&'9-;=;F=VK4GR.U4>97GVR^.FY
MVAK9MGC.T,=DVV:_QIV;)R"(E)T4FC;:R,3&\$5\GB!947UL@O[(4N6@)]0J
M-ZT6[9](K@+P\\,B?Q6$.N5P[P%T^5UQ^L<-<VBZ #:Q-D%664B#9FV7;N&O
M0+20M6H_Z?;OL?\ @GL]-^_"\]L8],,JY^)_D]UK=HJM25988HR4EUU0"$!,
MY-+< U_VS.4%A76 Q;]MWLQZW(&XO[.J]NMMJ?U+T$SU]<F#GMG/K^3-6-XP
MN;;)D<JFB]TN&+SF36#05I(YO ;.=H?*H9..<*Q?J<@#S"'=J3@.9!K*ZE+D
MVNQ8M'E+RUI@MA /V"!4YU$*?PG<2MR:.M[(7=;"TL$8@<54M3;<LI&GE2"K
MKSD?1==J)BJ<MN#L_JXK:,L7K :&I"0N =H*XI5LHD9;"_N;+1J^#J'6\K77
MQV>&:[IZ_'2]WB?:#*!AE8EG14^E=D6+MDD&D7N:BA229+-H Z*']&G^,O7N
M]GKLG*YY>L:7>_C.Y>Z-EC]-[*;9J?)'RF:JI0#@QRY0RG,352-J*;FJJ9QX
MQ.D$<VV)#IXK,/)</>,H],,2900<0,8!";[3LJU._#9 )I954%!MVY&>C8;S
MAT12\]2LUN3=BNVT7CH*RZVF<I'*K!9AI$J^!2!@B;BV.30 E,224I3!;RTF
MDQ>RS7[EQ\<K(-'BRY)CMOQRUXXS6#'VB*S^&7 T44SV7*D7.9=U5W#6J P>
MXSJA+6?8CK"C478D)1"G8M)AJ41"PT@Q:6%1A.>V,-EAWCHY^@#!QPP1%?9S
M*#AF22^14@Z)9R?]V-+L!N?FB;1R='C0"32V-29KD1Y"A.8249HO0/C,+WK>
MQ$Y6Y^*^>&3 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8%?.L;I7\X<QW_?S4P(I4YTS44^LMOC3DXG,[<^K(=&W!
M]3-2]U3)%ZAN1KC46BS#P$'#* +8M %O7ILLF;(I-#?([N#6#/H;U<X<\L,6
MA?/[?T2X6[SY94LM6(1*-*;%8:R%&;+954(;9!&7]W>Y*G4,II&EA+HE3.&_
M83]",1AKA[=\II!Y!*/:W)X(E+P_DFNT[9(+5T"C]/7Z\79)'QPH>+WPLC3W
M4OZ+BI:WS$J&/1SL6B3IE&BV<)8U R505"8DG&L2P^2GGQ]F5A("ARH%6PRA
M^?[X8[I3PV<N,3L-KZ(E,JB$)B$-;T42,=GB<KWYC2($#.E"I=W5U5J&\A'I
M6W*R@CA<?'*0#>^.9B8]''X<GFPETFF4K@*> )J;N!=;S/*( V(GVP$<JIU!
M!E5FQ1)!(ZYI')U6.#4G1I6]<C4;-V6M2"/'&L'5_=%://&]$=?6\I35W'+O
M::Y$T-T?1RBP-*)3:KHG98+%HXFC<>6R*0KI0[KTR9"$M#H9YZ@ -!UL6O47
M6\N,>4.\CG(LW6."-NL*1,VVF/6F_NBR;5/;<!:F\ZBRC3[LB2AWF4'9&S=B
MU(F)&;((Z T3TVE@&(Q-K19FP"ZV-5D'DDI9([54PQ:+6W)7ZP^@ZZH1_C#K
M45KP.95N*T87+YO#[ D\-E\#;Y'J&O;7$C1)%6TY292#2D03]"0*RRQQOR;^
MD\@?*"I+8+J98[BV1JN()8%H.<T?*]LED@LGKBJ'$EHLV<U?,W2))8W;D7@C
MFJ))<ED94NI1'U!)GKLH\DP8X[,&V]\4V>MEB]2YOBN/)_T1)()&6"IKV7W3
M*':UVZPW9C2"JI16:60J29 S5VN=&H;>6KV)F2GKU>DJ;XC#!QK6$OD=I93.
M511*Q0OJ593E43J&2MFCD[=K"F-CV;=%Q4N&GFNGTD4,G9LU:9#4J@DYNTCV
MYIE8%9:E,0!&:9H<;CXK&K^J**9^?W7J%^FAT<I./MSFY2252*+3!D7QDMCD
M)\3?D<CA[BP)YJR.[!)DAR%:B4-Q:M*I)&$PL/MWA,7./5%D-\A'+<YGK;63
M7*IPTS)?.#JQ4MLTI6YX ECME;C"B<M%?S)ZFL"8F2&S*6P5*)[96YS4)5+N
MUB+4)0&@.)]Y>-G7T?L7\A/+,M>(ZQ-\QEC:NF3S7;5"A2NI;7A:.:(;:>'*
M.5M,8DOEL,9DD@KV929LVV(WY,,QK$O5(R1G!$N1_..-?E[=IPBM>5KPZ@@8
M4TXCM(R.41-\VZ!>XVRJ7JO;,)K*QPI7,UG/4N+=%GM.X%?5HB%*94>A& D8
M]?G8)K;9/=D_U\.;OP\]/?W^>Z=6.PFFJU%:G4M<J6ZUL[D,94SB,L;-2*R"
M)[6>-26"HE#XA4IV@Q(<SI5"OY=$I5(BAQK?UW55!-?/BGJASL)&W4.@:!O3
MK.EK1(TX65(G?OPLY)WR.F,^I6S/#')@F-[B@4H2ES<M)-(4DE&%&!"3C<X]
M6BM'=?.#S,HQ!"9#-T#Y*7.(1TL]_IVWHY'HS-+!:TSW JYL.5OL(;XW6MFS
M)G7I5#?'7Y4WO)X%R/7T^AK483R\=N[3P^2KCD1ZXD5EO9)!+1*Y&R.RNK;7
M11R>16#3&,5_+I;64H5PHB.63%&&9S%N;SG%E5+4HC5(!EC&5O1FQQV2I.^O
MZ)KISE[ _2&1KY5#)_&*L70N'UY/YW-GJP9A72>VF.+PR(PV-/C_ #5>.N#Q
M/"D36G5$H$)!YJD9(2#M@)QM:JC[VY>=%\)0LDZ?9 7.&N$O!+M'ZSL][8(8
MCLB7O->P,%LOK;#U+73R^43Z..+*0DDYK4J+<T"@@XLH1)GM+QJ+H'Y,J)D=
M7-=CS*/VU %KQ-+_ (VD@&J>MR;SH,9YVL=SK^=6@LC,/@#A(&^N&GX$1[D[
MGHRV]J6KM-IIXEI0B]CA<XCEW'Y&:3@KW"X?7SD99DIEET<NU08N:8].CJR0
M"Z4F5?IVE.9<#5%'*M"YP75<X!*V]B-<RURYOVG'[0%J2AB$UM9JXN]*XH#H
MU_IBUT;RSQ)DYUC%_*9W'8?8D_&RL[A8TWA$N=9LWP2'R)-!:[A".-(EBZ0N
MAZ9 1I<+1H@!+V+8FMLS/=,<>ZRH:5NL18H]-ONCW.+?LNBXZTIF1_$O4V-4
M+3)G^P&Y21MLT)O9F5BBBA:!V/\ C:U:50C,3J#0KDFSB8KA3+L'G^!6L334
MEF#FFF07>!1U[5(83.7F$PJ36JL+;ZNB]AV.SQQ= :_DEBKCBBF9"\.2-2M&
MI3^P'^%)?F'&WJT:'^0SD:< D:QFM%2B88U7]A6D?+Y5 ;'A,)>X'4;^1%;8
M?X=,)?$F2/38FLY*L(0/A32H6'MZI0468#6QZPO'9,E+=$5A?A4I# %DI3/$
M(7-:&71&P*]GM4SN._?VT+S&W!U@UEQN*2M*RR=I%M0W+MI/I%@"S0EF",).
M 62RQ3*\/*914'HVX;-J$N16U+8#!Q3."18R!6M&V&VV8R?Q^K!3:NY497ZT
MBQ:OCTWE*$EW?(T6[I4I*@D>A;"K1C/-32VXO1/]S=6DTC(>7X8^0"62>0=*
M/4MC"9PC$=EHV*&/$1IV4VDI5R(LR-GN32VKU$;^CT6X!0J$B89ZP_02D*K0
M229S\$0T)Y..<[:HN-6Q*7QU@+X;1]/W)+(JN@5HA <GMHQFC3:GJ)2Y0AN6
MWBV'6FZZBZ!1&$[D->[C3IRP;-5)P&%NEEPL"3U=6;W0ELWY#")=)&JFV>?J
M)C"%D(FD3LMGE%>1T4D=X&^UY)HXWS>/2D] :F-)3J6X(S4JU.J+T8F.*,&9
MXW.$$T?Y%J@G,+HT5G+SX5:-JPZF'N5,+'!K;=:_JR6W\E2*JJKR>V0ZP)I8
M8/*)J-Q3IV=,_C:5+L-0F-()^%<A$>6ZV?<T>C_)A%YFP+9-;T8*KM!NL^=I
M1&VR)AE=DRZ9SZ_;"Z-@[;6L/A<<BZB4RA\)!1(%*8I D4*#2U:DPTLHA(,[
M9;I[)H<O(WQZS0]_G;Q:XVF.19F@SW(SG.%SQN<F,J?W.^\]-36ZL"V-$/S?
M)66XHRM9'UJ.3 <8^>1LQQ)3$B"9LG';.'IE/?E PJ:3E)*+#C[1!*V;5K;+
MW(R.V:LE*:?([LB%#_:FEL;(.N9Y$Q"L::(F+YD*Q0L$\F;)"0(HHXTL<;69
MUW]S(.-L,@)DLY5+Y#/)A6:6O4-,W"ON%!,Z[;R'FPFN04VB@Q]FQPB#,*Q.
MXNBM:UD(TB!8E/$;[%:79PX[-R<.Q^<6ZA(+TZ;8P%5(V<I@R&OIDU1B9/)D
MP7V8](XY &YCC35'EDL6.$M?G!.D1$:0Z--//+#[=;%KU)QN<>J.89Y&N19N
MX+6Y#8KY'MM;-:3L[N-A5?:E:,+.KHT@]9=42=9'/89'6)#8%2MZ8Q3(6 :C
M3LV)BQFFD: 68(!>-:K*_)+236UP=?$XY:\M<)5?M&T<\Q1PJ*VX%-X:COQ6
MYEPFT':$S"OV^6**_=$3,J-0+RT6DCF:F.3$G_4DG%%CA?DQE!^2^A[,@KB_
MV6\ZJ.01YFZ"E<C"^1Z?)*]_"G.EGOM?V(XQ*T7R(,\-GKA$$J1N5/2%F5+5
M3<8Y *$ 6PB]"W2SMU2H#OGFG<8<9$;(9XB<VR<Q:M3:S<:7N)NN]3-YPP*Y
M;"V)KHY;!2+6=C97$&U6[H3DS0:F-;$*M3\FBT:O9).-1%3?D\H*Q(XF>9(N
M=V12ZV+:<?0AC,%M"9-,<KV*]&6'SW75C6N[M4(&GIYNL5]@)P ZDGVT"9<4
MK)$+8$2@T!;I5_8E-8[.$SVKC:E<J(CTKDL*=1+V-]81DR*(NI[*^IDQ+^VM
MASDA3N*8825R8)R!8#6C4YQI0@CV8QAM> P& P& P& P& P& P& P& P& P&
M P& P& P& P& P& P& P& P&! _4=*?K)<WWIS_^(0Q+]-%53BL_Q.-JT^@8
M-3./+F+;L-EVO:].H$.EOR;3[4D:-T'V^\/KZX67%RC"T^+JKEG/TWHJKHQ7
ME'D3M97JY[>X)6D;:$Z]3 9I&)82>ZLD>#'"W8]63'A)0#..V(@*C8M>[0=@
M$7E<YK7R^,A ZM_69W80!!U=;O;X8=N+_G!^Z\B1#EC[%I]^^;]!$;B^WKZG
MZ3\[2CZ3X]>WZ@0Y=,?#^N50U_B??%$ !6VKBC#DQ(JGYB9&U2\0&0E&#M;D
M_HJT;U@KR[(V"Q&8]76\Q06PO9GMK3K4CH5\!2I&XE&?F!+S]?MU;_7_ (^+
M0J%;";3JBQ:4AU[,4HN94_E@J27.-1.D+NY@J2.N[#]O6VB99;O*8D"C8VL1
M/SF_JCUHDRA&820B-3%H1RSTN<)BAO#JF+\J\A\UJ[. [*N6YWSY-U4W_"!:
M,,]/HN6()2:FU'2WT94:%*C47LT,"E4!"(?J$!N@Z#A+M^JWW1_.O'=)9%$]
M-$1Z!=:]E2"Q.]K'CLY8(D,I\CKQVGNSS6P;4>3*4RE$LJX^Q _X80<4I<-)
M-B($WG# :27E[SV^2(:W\85E5_/B[-06533*[CN3E^X38A%JWL0,8)5T6P7#
M7\N:#Y!,+:ETXDCA.(/;9JE.\."P:E(\(R_E*4)=_'HMW]&OP3P]ZB-=S^I=
MV'7!,9'SE<?.%53-OK*5+[01L=ME-+8&3V$ZRBTGN/G.,;C3*2A4(HNACB1_
M/$)4JV4$"=(0.?7/Q6)Z%X+F]IV--K)A=MLS4"<RRA7F2UE+&*; @,SCE-5_
M<,(,B4[7US8D&E[TSK7:TDDA2IBE:=%IQ8$Y*TA80=OX23;$Q5>XOXDY/%*P
M608=H4W.!%1UDB*2,S6A51]8/<<C_3G0'12)(XL:2Q-R6'.11EZ!1-SDP.B1
MS8E;&F6)U!H#3DHB\YE;4GB>4./##KR%,+I=)&]OAZX\VPG=))96GCK<JM;5
MD-,(8$LWFLBFSI#H.SEDQUH$]2%Q<_MR4H9ZDP6O9HSR_5R>^:</*Y7(YU(D
M=K*(\KF'94"ZV1J4,33*5\<40;GZ%4<FBR$]8\&HU*\2F'Z>"7$Y.(HDPT)
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M4>S%!WSGFFX.?M\/DR$8\7S@RQRH&UYOE1*9% 854K9.)6Y0,LM99=A0OMF
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M!R^$8--QR)8\JXZD\CG<:J0-Y>CE[$FNFE#WE$3OV^AJMK*I 2U,7OWA_.&
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M61F "87W]WZ, PZ$ 8+5J(0!!WKUT((@T3O0@[U_!O6,'+X1Y_J)2;]OSO\
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MCW('W38!X?%B@!(U(BRS% _9H.M^F4V]+\'8[ADP& P& P& P& P& P& P&
MP&!63M?_ %->MO\ 9DOK_P JY7A=?[I][>.=O]7ZB_\ N<K'_P"2F3!>Z8\(
M8# 8# 8$&]!676->US)$ED6M!*IW+XU*(_&W.;3M@@8ESNJ9%2<LIB7OCJTB
M/<DQBHL8=)Q[-+%L.]>F_3>%F<NN'FCE.$]#4<5.4=W] P-:^*Y"PI5U06HF
MC^HU]F4B9R-L2L]B?5*9^9C$WM.-4&J#PKRS-F_GZ$#1O:XOH^;'S4<D,7C
MFD-M?F>SK&#;LKK"Q+F3W%+&FFB+:C5EU[T!S&TH)$RV+6]2UQ*U8'UFLUV2
MO2-R5+TCLG4"+4%C+$((HZ>.\^E[?[OK^\;75Q_;W#'-?4#BC2-TBM&ND:J:
MMR#T"A16!&UZ^'SXA"3K>Q)F[<PCZT:8H7J("89>M[W_  [KCMKQVL7@PR8#
M 8# 8# H$[?_ $I4!_V K=_WB:1R>K7_ (?BO[E9,!@,!@4 Y_\ ]??R&_\
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M@_\ M]3?_=\YLPUMZ?<OUADP& P& P& P& P& P& P& P&!63M?_ %->MO\
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MVU^[^J]^&# 8# H1V]_VZ\>W^WO#O]W3IG#6OK]R^^&3 8# 8# 8% ?*O_\
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MT?1UF63 8# 8# 8# H+P]_VV\@_^WU-_]WSFS#6WI]R_6&3 8# 8# 8# 8#
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MWE>9LV P& P& P&!0)V_^E*@/^P%;O\ O$TCD]6O_#\5_<K)@,!@,"@'/_\
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M!5-I)?S!%LG9A6P#$<]IBXBS>$40Y)_U@/))_M<0;_<PY5PWMVU^[^J]^&#
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M3VU1=JSFSW=='87'9BTU7S[8=*R9!.>8&.$JF]XO-UU.STK!)4#ZE:&YB&6
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M/1U5.O1K,H<T#A4J.4)#904[L: +J^QXH&O\!62EA:Q?4KFHD\QQ1$:V8<2
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MN=ARNYX'9T,E<M5MEHN\2=I1%8;9"]S @;+.0LVGA'(5\#TF)VI,+*/-4:&
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MS?Q<VQ9&\7:A9HK-K DILY98-(7R7):]W-F]P9&1=.C$,<;VDE']_"8Z(25
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M)^4H9].&LEEZ[2+A]P]LR+E7L1^5(TT\E3%5WBJZZZT-K@NQ&Z.U3+7NE9Q
M1(4K]&=5^^/VI<J3K3$J5[)=0D(49QQ8FY2,P)A9-=<Z_C&^\5^0VZ.@>C#N
M>KXYQBE).LNY!K/MFHW2%7"=:I;A4]A2;4-%'+ +4P2$@CM@-3V(!@R4 G)
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ML RY*Z[07RJGIQ-4=;5M+G.O8E5Z^(2B<SHF#3R5M+=!5#TJ-)(:48SURA6
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M7$ULWE*!*D2S:(A<K*,/V6#?TN"R3U;G'>@.EW"^[;@JOGXU97T/7GH8NI(
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M%K7KOG9BX;G6-OR*8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8%$W/_ %E+Z_\
MP.H'_P"Y[7S>O9;VGX_T;;E9,!@,!@,!@,!@,!@,!@,!@,!@,!@<CFG_ +==
M.?\ >= __(2J,Q>[5[1;?(C@N;6V/;<M:'EN0NS2Y)C4;BV.:0A>WKT9X-EG
MI%J)46:F5)CB][",L81!%K?IO6]8[=AP%,6C*P]$J5QUB5*FUL6LK<I4M#>>
M>@9G,HDAR:41QJ<1B5L<"4Q8#R ;"4:$L.A!WH.O2YHX+= X.SL*N+-,,BC7
M&'#9^U\<;HZT(F%;M5K6E6U;0F1E-ZG:G0=:,]Y8O?K7Y?7&;G/J8CS3P>%I
M(V9#4L0BZ:(&E&$&Q5/'VDF-F$FF?*:28QEI M@RC3?SA!V5Z"%^7?Y<9N<^
MIB=GC^!81^&OP9^#HK^#_C^+\)_AYH_#7Q?+\_Q_8OH_M?Q_-KW^GQ>GN_+_
M  XS<Y]3$[>CDH8C$VL+&!LC$>;@1@E8GC8$+*VI QY.X@"6X$,84Z8O322N
M+#H)P4_QA-#K6A:WK&:/61#(>F0M[8FBD:3MK2\?B%J;R&)K*0MC_P#5*%OW
MQO2%I0IT3Q]:K-.^I+"$[Y31C]WN%O>V:,JM:6IS-;E#DV-[@>SK=.;2<M1)
ME9K6Y:3J$>G!N,/+,&B6Z2*S2OE*V$SXS1A]?:+>MP8-7 H*X-;JR+X7$UK*
M^NA[V]M"N.,ZEK>'I4( U+NZH#D8TC@Z*!E!V8H. ,T>PZWL6_367-[IB.8D
MB<60'LZI#&H^B4QUO5-,?4)&9N3GL34NVFVM;&<TE, QL;UFT9.S22-@+,^(
M'NUOVA]&:K8,@8# 8# 8# 8# 8# 8# 8# 8# 8'YO6MZWK>M;UO6];UO7KK>
MM_DWK>M_DWK>L",T5+4^VHY$WMU65ZWH9<$()2C0PZ/HTTB+ ?I4 IZ)3MY8
M'(H"G7R: ;H0=&?G:UZ_ER\MO>IB,ZYU]!7MU"^/$/C3H\A$P#"Z.#*WJU^A
M15>J=(T+ZH].,[>V!S6G*$?Y?\&/,$,OVBWO>,WL8C]5U_!E[T9)%L0C:N0&
MKV)T->E#,WG.ACE%RUI,;<#%HR!*!K6$IR4!2&[%[TX3AZ!L.A;]6;C'H8C"
M2"FJEE@%I4GK2#2 MQ?!2=>6\Q=F<0+)&-N(9QOJD"I&:$YW&U)2TPE O4W9
M)80;%[0ZUI-MIVIB7NXQ]'4PK9&.-*ZGKE7'XRH5JHXR*H9'E+6Q*%ZG:Q<:
MTH3V\Q.WB6JQ;,.^((?E'^47KO+RVSG-R<9VPE LLLDLLDDL!1)0 %E%%@"6
M6666'00%E@#K00  '6M:UK6M:UK,J\\!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@4(L J9Q._K2D!=3VA,(_,8?4);(^05FCSTW"5Q?5B)WQ L^OE3*M1K$8G
ME,+01$[ 8 [6PBWZ"UK4LBXS)U</\<2G_0!T-_F5$_YP,<H<?C#\<2G_ $ =
M#?YE1/\ G QRAQ^,/QQ*?] '0W^943_G QRAQ^,/QQ*?] '0W^943_G QRAQ
M^,/QQ*?] '0W^943_G QRAQ^,/QQ*?\ 0!T-_F5$_P"<#'*''XP_'$I_T =#
M?YE1/^<#'*''XP_'$I_T =#?YE1/^<#'*''XP_'$I_T =#?YE1/^<#'*''XP
M_'$I_P! '0W^943_ )P,<H<?C#\<2G_0!T-_F5$_YP,<H<?C#\<2G_0!T-_F
M5$_YP,<H<?C#\<2G_0!T-_F5$_YP,<H<?C#\<2G_ $ =#?YE1/\ G QRAQ^,
M/QQ*?] '0W^943_G QRAQ^,/QQ*?] '0W^943_G QRAQ^,/QQ*?] '0W^943
M_G QRAQ^,/QQ*?\ 0!T-_F5$_P"<#'*''XP_'$I_T =#?YE1/^<#'*''XQ*?
M,+9* NUZRF00F609%,;$C*^.H)HD:F]Z7MS+45=QA:X[0-3R^ 3)-O;.J)+^
M0T)AGP[%[=!V'>Y>M+VD6PR(8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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M=DQ ?C)'O0C=;WZ!UO>BR6W$[O7=5Y5/SK6#_<]U31N@-81<; 6_R]T3N2I
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M!!& 8=""(.]""((M>H1!%KUT((M;]=;U_#@>6!XC& L S#!:" L(AC%O^ (
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MB_FT#1AB8T(?798]:)BSND3 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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MCCX[2AA9WIO<7F%.2!GEC:D/":KC[HZ,37)FY Z%!_.3*5D?>DBPL._RB(4
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M^ORC3)E2@D<;Z=DXJ^Q*73TW$+P3*9<\Q:<SM)5<<96&%2!XG"FT%4M<X"9
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MJFP^CHQ(K?@C- 'B01^N8)?JB$0B0Q&>LY+!(J]G8&7G.+MUVSEX<@W+^L%
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M.YNPY+;S'%+4B6T2-<SO1\J9=U5)8U&(:Q:KV(RF#3M'::I2<QR1\DDW?%K
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MZAR=6)6X(;'2UJ!<-"V.1@SM&;$0,LH],+=9Q,_!5%VZ4[N8GB\8ZOBS-Z0
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M:%[ ?EWZ:P/%O=&QW(&I:G%"YIBU"A(8H;U:=:0!6D-$0J2C-3&&%A4)C@;
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ML"=W)R:0UO;T.[8KMLCSB%L<U))#XH]H_IY6K/<4)*=I-4/$=;TL"?3%CJC
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M<6SDEDK"T!R=. Y2G4+!'*32<ZVW^KYIA+.)38[$^SB-31[G[M:,<?V8-?\
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M]@48=H-Z1D^@F]C?+ X/I^QY#*Y$]/UB(C9JOE3E(V]I>6 AN7*I6EC"4X0
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M[]2$'H Y7+T4%KUMEC5'#6YV;R'PI+,*QLBIE^E*TQF/2G#11JT7 Q-Z)PZ
ML*3C'HP !EF#E9<^K&,7%U<,VN@]GRRPW@SI.'/,*L Q4OBC7HMOD),G+=W=
MO2Q>(,#>X2Y0*6JM =W@EU<"4Q:9& T*).4G".5Z?!HDQ\<M&SEZ4O#W(+,
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MIL6C C..2C4)"C=%YUV%-#8G96EL9D>S-I&EO1-B79P@C.VG0)BDI&S1  6
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M++-8@3@MTLZ,5]#+#YLB+A<$WCQ,1&;'&-B8K57R%G*2+CB'N.^Y28( ]$Z
M.'\7Z5Y,IS"BTYEC4\66M5&V<XO$13S@AYF[4Z,+6Y.L6K:.1J/P9.]#5F::
MMD*'!S2 ;2% CBC''Y" A-+PC>D_D.GHG"9$E5A5\IC5-QETL*X;(K^W7.40
M997C$X5DJD;W4"\J D?C<^)Q"?+U+KI2- 6F<8ZI1!$8(X(RB<>CE7/VY9<$
MBW,-KMK) &%DMF%7M83I 9U."HX3)HO$XL@G%;-K')S(DZN K(DL2&68F:"2
M22Q+EQA9AA@$NMC$UES$;;\L!ZE@G[XV5M#=D1E=!'AJ,=;&/:1A@$O%?&ER
MI_8%<:!,]S&-[HDT"QI;FQ8NUMUT,A.J+0C$JAPZX3!57?A4AMZ'UK*4$998
MK+U-H[23I_G"7;QI6PV'>2!B;C(^V11LU'6DF,527\*E^+:2U6E6BBU2I<E-
M+4TNO3+ =$=9=$UETZ]U_"&^KGV&16,M$V+BCX]KXV_/K#^@SHZ>R4U]>"XU
M*%*1(&1U.A);!H$X-;/V(*@WX_D!H22S-;A2OD%56V_7/K]#KP@C5:UW9%A-
M"5O> .5AKRZP?=1]5'7V''($(D3U8 _5='=HSEB<]$#T., 8,K0R77"/4ODH
M?BC(\%;#J6D(%":$O;I^C>[EDN,E#=8LHB<9;8=4@#($V!FMK5]^+"ULI:1"
M3EHD6T1@#O\ WB'20O!J2KR;6]'X@VSB8474C(POJRJF-N4_IX>0)&E[N>JX
M5<<952IU7U.B0MD6BT5DYZ=Y7%?,/:L@)A!6R!"$&+PF<9<1]\KLJ8SY&D)H
M=CD*B$L<L ZJ&JRS4K%/7QA!<^FZ7U'('")!3RFF%RBG_:>[_%]<5IT%LM(=
MIO-VHIP2%*?)$_5I)MQFSZ\KY@'&76U8_/'9MLA]>D&WJ#DNJR.ZC#.V0!?.
M=LSZWI"!J7%:S%($IPSR/F^0DO2@G#/9#RWR<V6I=80]AAL6#%T+C<T>FT+@
M\D*?YS+Y;5#O4KBA*@:A8QKTJYF>8C8V@*6\12=R"I%H85!(0:"9%XQ+"7R-
MSU0\*6E%5E62MNANFYYL*=0>XW%_@KK&7:24(RDEU*\:@!()?(F@J]-!<2U8
MF],F7,9R?Y=[5 $1>B<8Y76_<-G0(V^ZXJIHA#),8HV2B(0]Z>),)=8+/*4%
M'(KJ*MY?6)T5<6_=*IT*_;&F=S5"DL<F++)-3C*&(&AKK.EO9O/1'=C[S_.)
M1"BZ^9Y;^!88S."Q&OF1[38DU>'Z 6',TTBA$01Q544^UM%Q5Z81(G<)A(D7
MR*S0)O1OV4I)-<]6]4WV2?>5^6M6L#CT'>JPJ1F*<G6U&>PAOALA5N+6UJ&I
MMC3*V1T]G6E$N1B\E<JVZZ 1]* ( &F#,T2+KB9O=5*0^4Z70F",LGFU/P!H
M?7F#5Y=2:-(;5=UQ:BI)U $<W.1I7MQK]C;?Q_'C5&T:DHT12,WY"C4NU/J:
M63&N$].S8Y9Y)+0A9<[F#ES]&'JM(.H6+?2*6@\.UD/\=4W1=U$1;;1&!5R0
MS'/SO**<^YGD:<1%)VQR"468>H)W\E3A+TSU:;(O)19CW&H^@8XE7<"D"Z<U
MXSK98JL,ES:)@U2*^*=KU<@I)N<8B<.<2!"RV H ^(EX&Q2V>A1A.QZ4D' '
M&?@EFZ?(X]U1:EV09'38)"TTTF6A&6=*S6B=S1R8X77%A'I8C%3F,X#R982*
M?AC,/)2GJ#W68Z2)3=$)UFSTXFF9E'4=\JC\_FN'QT_%-(0M,>3)W<-EGELK
M"_R0FF%*>635Q611,-MI=F_322G<GQ*0K4(CF14,Q,$LX'PEX.5-?)9)=P.1
MML-3463<+7*Y:QD&H[-6SBO]Q>"UW7EANEI(STT<CST[0%\!+%*!*K$2E3EB
M+"9\Y@@#!A.'WX>*_P F$MB30C8SZJ*DTM.5L[Z)U5RW8F1NJ2;S]%3T4L^2
M.##!D1:9K170N5-"L@E'H6FUI-4Z,$:/0<'!,,V[[>(I2=+VL*N(LV+K*@=H
MV([-4PL@MD81(ZA*;3'&#P"3-\?>BI=8MH <?FAZ PE)M<C(/-.T6,@9.$X]
M<*C,?=?35?32S)=:ZAIE\$;I7+T$-K]D&SQ@QG2@G?=;2UE3QP4URH=VUEBS
M1SNT =%)2TTYN3(E2\T2KU/3C-<9V]?]DNO_ )091&7N5,>ZGK^<C@<)ESN\
M/%>6X<YQ>8/;#!+;G")VKF0.<-0$/=>$#JW30\+-%F+6QV6J2P$*@-9QBB'"
M+'5CV4]/EFWG65FQ6"Q-VI."/4S<#HC.GB<I7 B&)F4,R4C5(8826UMR5R?
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M-]O]''Z![3OAHI&E; KMIKV'2.?#O:.2UG>7@YV"&=5(>Z,K<UP-^7L.D:I
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M0.AQ ]-LW/0V ;)$"=QD+JR3A,W(T*J-L3.)DAZ<MODB! G+=U3<K<3P$G)
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M!LPL(M!'L.O=K?IK ];<RLS02!.TM+8UIRB )2R&Y E1$EI2]C$6F 4F**
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M>/L![]&>T/OT'8-#]NO?H MZWL.A>GKH.]AUO>OX/76!Y8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8'_
!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>g337004g57b11.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g337004g57b11.jpg
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M P,# P,# P,# P,# P,# P,# P,# P/_P  1" )Z RH# 1$  A$! Q$!_\0
MM@ !  (# 0$! 0$           <(!08)! ," 0H! 0$! 0 # 0$!
M   ! @,$!@<(!0D0  $$ P$  00"  ('!P( #P4#! 8'  $"" D1$A,4%18A
M%S$B(]27&!E!49$D59766&$R,R5Q@28G0E)31#8W=[<1 0 " 0($! 0$!@(
M! <!   !$0(A$C%!46'P(@,$<8'!!9&AX1.QT?$R0@84!U)B%36"HB1UM18(
M5O_:  P# 0 "$0,1 #\ _P!_& P& P& P& P& P& P& P& P& P& P& P& P
M& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P
M& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P
M& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P
M& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P
M& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P
M& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P
M& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P
M& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P
M& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P
M& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P
M& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P
M& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P
M& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P
M& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P
M& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P
M& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P
M& P& P& P& P& P& P*'_)CZ3E'D[Q1=%Q5\4 A[00:Q&!5,_DR+)R":6C;,
MZC5804@5:$54![L:'/RU%\Y37[Y1VV:J;4WKC76\-8Q>5<G*R)_-U.JT\<4!
M8%@4D\].W:1JCVS,;T)U=-*]K>)A^/CWL$=";TD[7DRNY'.?YX.22,!V O3C
M]O2B:27TX5Y5X-_M^:8X1I^:U7?S!"-^G=40AYIL!2 [LQW36KO5G4%1'J68
MIXT0]L  *5?\K+2O; G7/YV3E_WOANS(\)ZUM?E3?XS.S2[UKZTPT<^9@-/*
MCE5F0/S?(G;F,4AX>O1^SG5PU=6$*C\4]L 9=(1Y.P;-E3Q,'#(W4K.(]\&G
MW"!!P]<.VZ0]FX4[^W1?VZFIGK^3V>1?DGEGLGTUY0ZAHKJ$4-?W@[T)>Y:O
M3C4.9DPRTZC].P"D.%V\U8<)=O8^B@Z+Z;Z3313?(+(.%$DE-?CY)EAMB;XQ
M/T<^K]^5OV=5_KGY"Z-"2J&KA!Y\1Y^\1,7%="'#N,^BR3'R*\12D#_G?*TV
M;+Q[T>2-_JO/KSI"/J<Z^G'W9&XPB<8G\4ET!\\N@D#\%0>^H>VL:W/0M.><
M9]:T^!RJ%5TLBMZ5NN34I#7]94ZLW6+V7W'R4>[*RAL,49\ @F^7.NG'6]I<
MB?3UFN$,G</SV=FX5[WC?G:HF*-I^:Z/]46/5\CD%A0Z6-'CORS:(RI)V4MR
MLAJHXW6::CXGU(8Z+>/E74J LU-H]M5^^$\J1Z?"^$IPZ^4^RJ\F%K@Y%4,Q
MMN?.K\\)^=:_I ,6JN%CXG97JGRD/N1<>TM)R34:R2-IR9%?3U^231[9]+?:
MUY6;I\[[)LOX5/\ %@4_G? $(S1TQ ^3+&+QRQJ<HBV[0==65 1SRF$_0GJT
MAX_A0+]![QPI8NVUG B"SQR.Z1VB-305TCUM;OE ?M\=?%6V3Y//?-]^0O9O
MAR)0F4QL)YXE :76+ZF'EX@--D7E7QZZO/-4FC8N0N?H_C/,.%W,N66[0WK2
MG#/>N_\ #6##&,L9GFJ#Y+^9'U3S4'K"Z+_A4/M<?$KZK!K70I>5UMYHA].T
MI=%%KW]#.K'L*5_MJG7ZT>)B! U)F.+&S)PBW03;ZX4462C4^G%Q$=$Q/?G
MDH*0V%=YFEW''DQM\<_CSUM7H9])(@#L/NPO4UUO:F$!9E(')-<5'HNF;?\
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M#S1K.9C4'2F^D:LMEV\BD"E<.FC91JN+/.>QK+\#C?:VDN4N\,SC66U3^O\
MYU*QD,.U,II33F.A ]\7#Y]G4L@EOP:VZQC\OK/R@7]: 'T?L<$S$"YR$L&+
M@'H-LX9H)I-SC;OC72[;:;CLU/IS^3<89\PW$D]!^:J"F'FN052Y]312,$X(
M1.W%5T@L,27E7GAW?Z!,S2T?7>R9A6 [A@YC?]B(.&'3R1-%DF[!5LGTYT-F
MDS?!7OSU\I5_2).MIL]$E;RAY3XEA/L1W!%!-25!-99:[OTRXJ]V?-RU_(VE
M=5Y%A<-YVX*:[(=#1[)JN[U^53G278G"/_FIITS^<6SI&/\ .5PTA2S&21!M
M+_D4BGH6G!%DP,\.G"?C6EPEE[E-4WXX$-A3Z((C'ZA1B[0&H*F_KPU_#SQU
MI;(U^W&L3V_-)\A^9EU5DI]66'+ [*5T\U*?&F \S1 Z8B=2-8Z3]KTH5L8L
M0M^V3/) ;&HH,VTV]?D7*#W0Y)OTDBDI]^LJ?MW4<]?R=!J_]_,[6^/(=[XK
MRF)3(4BD+,R1K3SB9P*-$N",:FQ* R9%]9,J+A*_&PP"4#/"+B0N'"37^ ;=
M/N$NM[Y;]&)QK+;+G[ /F)M?T%:GB5K1M#C"4*MNV_=5.W5'!5BPN9J'9=Y7
MJKN8@.*3LM1Q%@<@C4D<+-W[,NNT:MR#97\&^$/\%MFMD1=]OS=YH*=-2B$P
M^322(%:^D4ABX X>@1U\'*&X29+"FC\I$C!*.OBD?(%(X]7[9N%V+EPS551Z
MZ15[3WSULYMJP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
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M9_1=MR>[+QN*U:2:^H]<3.QSL8=*38EZU/P^0V(Y-!P\5%BHZ'C:\)9MHR&
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MC>N-&)XMJP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
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M88S4\IIH55>Y/><+F%T5(O,*@G7H:V?D6LBJ@4@L 7;![S_4<%JCXX8#ZID
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M,3P+:W*OY6.WZ;]--51JGQT,9J;1-+_'O<P9W7$H;?@B,>9_0LE0FMR5TQA
MDX?32<AH]&[! 5U:*4P'C8)#;)!0[A$DF\!F7+'M=[V/<M-JI?JC=SF-8?RW
M/#;"UX19T6:6+$G"EJ^L(+ZX9-YM7FYU"^^80&JL3Q!C<6'3R)O)9&BG%?I*
MJ/423'M/I]S].-Z3U^0L95/RIA$?'%K1ER*EU?WG152JH47,J.-;A7G(NSA0
MB*2:?NY\UEE=A"OH%^TBTJ&.""_Y52C@Z-=.>M..FO/&ND.XFZ.%<T[3ZA8
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M7LRHG#O U*U+5=4P6LY["J^OJJ93#IR&NIE%H]_*RV:BFLK&<K3Z"J2)NM*
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MS<>^+<J\16_X--XPQ<MFW6_XZ0-&CGI+G^4>J(FHRCGRKZ+>>/:L?BK#:RR
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M69)H)<\H:_<(]\5+BN].[^',P& P& P& P& P& P& P& P& P& P& P& P&
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MT HV6W''XY.K)CD@IEJ]^QF8Y7_IQ5R]Y%N5QN^G98B)BVG5]ZY]$6_;@"'
MY^:3 !JTJ(E*2-8>0I4?:N9X>N[T/6%A,+'93N5,Y%1KX%JG&[-\)=\/.A1'
M@EOAT[0114Z+.,1_5+%,>B_0KV04-+IU-(-,8/Z,]*^E*&;UN+@'];D=>L:J
M*>BGD/EL>E3:3OU)2/:!*+3:G$WS'6U.BO+I%9O^']=<DQ&O6(A'/_-5Z3=2
M+V+)>)-(F<7H(]ZD&0X&EYH4>56Z9T[7!<O%/Y^\.Y=PHY)]'FZ:KQ)-NA^9
MPGMCSI/[OR9%VQIWIA@?OZ^=$HJ(F+6NPTEINNZEEOL"-#PI)T@W&G;:BD&F
MUE0E^N7X<A:Z+57-VU@!>U^7?2(]DX8.%>W2#G25-L?CP>5SZ_\ 4,]M&)!8
ML?/1B"V+";@MR#J5AYE7NT_W6XR]-UI3A*2[7F ](4PEL!'<R+3O26M..BW*
M7.N.6WU4&W&NZQY/U=:XND;CE:2<*ZF03VMUY3@TA.B"*$&BHF27E#*:CT]G
MS%B:9NRC2-:E73QTB@]'Z(NDTVNEFNE?S)Q-L7'P07;OJ;TU4]R1WS*6LH3)
MC+J>UTY(7%4WG$_8,Q3A-ATMZGFR4&*4G'9#*^D9T(EOGQN[Z(-.ND.XN634
M4:(J)=NEJ1$3%^.3RUKZ8]G3RY ];SM:6ULZ"5W1\CD B&>5EIKM\K8MG7:#
M3.68]>3Y]NE7$FKVOPA)</VJ]5 +/WG"BRO3?[>"SCC6C?\ YD_9GJGP%Y*5
M]2>9:OK"VV<"F 1G<D<L5G,G+@/ ),I_!L)A'?Z<?"+]]AI<[8(/DE>5M;:O
M=K<_9I#O[B88XY95*\?E&5WM._.--SCTU%8?!+VF4%#2JQH-!$CB,:A9J0(_
MRR42;<R,B5,=D8Z-=H-'_:J_7/9!%;:>N4]\<Z,Y5$S$<%@\(8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8$&N?,OG
MI[$)A7[VEZW>P>P #*+3>)NXF(= )3'1IN124:'-C%VRC5^Q'R*6DWR''?._
MPNWRJO'T[ZWUA;EDSB\)+V[ PW</92><0H4?DK22]-FG:E5!9$-<1W;OE\OS
MM9H_G?2';!!JA]%7+5NY5Z^B2&_NM:;N2/ :\V4#(86*KLY4, )P4"#E\:"Q
M5Y'1Z@03'Y\,>AYJ)'LMI:2:,9.*(KH/>.-<Z625ZUU_IR+<_-Y8OYAH&&0:
M>5I'*LC#& V@/?B;!B2J#HD$EPLH(7 D1YIF4=/>'3-\'<J-U4_\..TN]ZWK
M?UP7/%^*\\O>?JH=,7U>U5%HT]%F_P"R"W;9!RZ<C#NXV;A_14:N1=/%&#SN
M+21^PZ[1WQ]S5VIQOZZZW@F9GBPY#QQY2*BXN$(>=Z@=!843E1:*B%()'_XL
M*ZG,I>3B9HM!_++EI_&2J8OUBA!EWQTR=O\ O\RJ72FM=:&[+J^ZOD7S,O,I
MG/W-)5^\E5C)'49\_? T7K69IR<4W"2+F3A7?2P,W_-B&B3=UMPV4VLEQSKK
MZ_3!NFJ?-#Q_Y=:P9S6[>AZS1ACN2M9HY#IQAAQVK,6+/8QA+-E-)_S',F8"
M>MLD'^G&G2##>VW"G*&]IX-TW;'DO%7E$J2C)AQ0U>-R4-  XM&70D/_  70
MB.QDP7D( ,WX"+#TNV H[('[Q'A3GO7+EZNI_P#A+*;Z&Z6TP7S#Y[K.;%+(
M@=00:,3LPZD[QY*1H5#DNFYFIA60S%4:X5_+_#;E9Q;IV2TSTAI\XW]ZVN^M
M:WH7,Q7)@7'COS [FLGL1Q2D(4F4T<2-W+C/Z"W/4F=3 "YB\I<G&/#GD837
MD,?>*M'?2R/>UTN]Z[^N_P#'!NFJ;Z0H>ERI*1F"56P5\5F%6(4?*R+J-BUG
MLDIYMV74;5H;<=M]JDX6W[/OMICUM]M^-O%OISK\G?U%RT:;^/\ S'8W,,YF
M5*08QJNX>C7T&WH;V-[BT%;_ */ZT0#]B5V/;2.MOXUOM-ISO\">T>-\\ZWK
M6",IC@_*?CSR]Q)9C+MT;7JYVPVIQE/%W@1)\QF+:2M&K&0IR4*]Z7"&=FVK
M)+EUTNW[Z6_'K?>][_QP;I;1!O.%#5HW MH%4D$BG$8E;^= U0\?9-GK*:%(
MJ3@S^5[(?CZ?NI"YA9ER(V[6447T-5VVUUI'6N-"YEC)UY9\]67/VMISBJ(K
M(+%9LX^/1F+E!TW.=,8H1?EXTS<O&+IKT];@B15TLUX6_)RCTX4^WZ:[ZUL7
M,:).3KZ#<11Y!>HF =0PBJ66(18@+:D@+]0\7=GS&WHL@FY:.^2!E^LY4Y4Y
MZYVJIO?T_P!&$N>+<,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@?-;E7I)7E!3E);I/OE%7M/\W"2N^=Z34[2UVG
MM7GCOZ;WS]W/W:U]/KK_ $X%<NKS( 11"*RD"@I>C!TR!!X(+55;L;$)%_VN
M(]*H>Z=[76X@A--DNY(N%-J]Q]-H\3=;[Z;:[6W&$SK']O\  T2;6T%[A(5U
MLJ_Y/3.2O^Y%/)1M+I'H_)72**"O;9'OKOMD"$,VZ3$8T^[>F@]LDGO?7>N^
M^\S-_ 2)_I_PW_CK?^G608%!]^H:Z!K=;^CIBH4$]=?Z>D&RR+<DT^N]_P"M
M^DJZ0[Y_[?QKZY_T<87E;/80P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
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M9J$6ZBFN?[OVOW_^SQ]^^U8^CG]Y]S]E]3#/'UL?<^VCV^?IYS&>4^MZV?\
MQL?3S].)B/3Q]'=Z7J1,XY^G/K83+UG[U]M_TR?]8^]Y>OZ?^O\ L_\ 8?2]
M3T\_;Y>S]W/NO3]7TXGT\8]O[?T_^7GZN'JY1.7JY^XV^OZ641GZ?JX^AG&-
M],<^R/S^8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# AVD?_[7D_\ _M^[O_\ K4Q^N?//^L__
M &3WU?\ ^A^\_P#Y7W;W7_?/_=O:?_9?M?\ ^/\ ;)BSZ&]*:W+IA%X%'2DM
MF9T;&XV%;=.B1@LYX:M&R7/^'//W=[^]9RNIO7"**>NUEU>N>$^>N^N>=V(F
M9J.(@6F!$CG<XD_HF:!B,9W(@;6$5)#C3?IF<C-6,W^S#@W(V'?T[&2FR#GX
MWSAGWK\K%@T8MU?HNFMSK64Q$;(^?Q_06>S 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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M76R#Q\\W60;N ALFYF"3(4707=)\=ME^TUN>U.=;YUOK6MBL>[T!9M\A<D1
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MGX&_]C]#_P#R'!Y>Y^#Y1?\ U/P-_P"Q^A__ )#@\O<_!\HO_J?@;_V/T/\
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MG\4,=/XW)'+@65<;! &;LFW66'M=L>T>]USFN2>_KK_OU_XZPA]=?]^O_'6
M^NO^_7_CK ?77_?K_P =8#ZZ_P"_7_CK ?77_?K_ ,=8#ZZ_[]?^.L!]=?\
M?K_QU@/KK_OU_P".L!]=?]^O_'6 ^NO^_7_CK ?77_?K_P =8#ZZ_P"_7_CK
M ?77_?K_ ,=8#ZZ_[]?^.L!]=?\ ?K_QU@/KK_OU_P".!_<!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,#@MZ*@M,WU[6_H5?4S6K6W CYH-MHTUC_F&0SJ1QO\
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M_P#QM'?^W_#7_P#2?]N\&_+K)_TS?C[_ /HZ\^?\-H]_NF#?EUD_Z9OQ]_\
MT=>?/^&T>_W3!ORZR?\ 3-^/O_Z.O/G_  VCW^Z8-^767ZW\9_Q^=;^O7COS
M]UOZ:U]=UO'M[^FM:UK7UVT_T:UKZ:_^V#?EUE^?^F;\??\ ]'7GS_AM'O\
M=,&_+K)_TS?C[_\ HZ\^?\-H]_NF#?EUD_Z9OQ]__1UY\_X;1[_=,&_+K)_T
MS?C[_P#HZ\^?\-H]_NF#?EUD_P"F;\??_P!'7GS_ (;1[_=,&_+K)_TS?C[_
M /HZ\^?\-H]_NF#?EUD_Z9OQ]_\ T=>?/^&T>_W3!ORZR?\ 3-^/O_Z.O/G_
M  VCW^Z8-^763_IF_'W_ /1UY\_X;1[_ '3!ORZR?],WX^__ *.O/G_#:/?[
MI@WY=9/^F;\??_T=>?/^&T>_W3!ORZR?],WX^_\ Z.O/G_#:/?[I@WY=9/\
MIF_'W_\ 1UY\_P"&T>_W3!ORZR?],WX^_P#Z.O/G_#:/?[I@WY=9/^F;\??_
M -'7GS_AM'O]TP;\NLG_ $S?C[_^CKSY_P -H]_NF#?EUD_Z9OQ]_P#T=>?/
M^&T>_P!TP;\NLG_3-^/O_P"CKSY_PVCW^Z8-^766?BOQ[^'H-)X]-(?Y4HZ-
MRR)F1\AC4A#U^"9%@9P2Y3>#"HQXBUY6:OF+I+E1)3G>NN.^=;U@W93S7%PR
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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M,MNA@9ZFAIN\TX(\,FJ;M/74.,5,QNKZOQ8%53JS_9-TV9!?+?J$+?UG>Q?
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MD.?Q&H+#L\>/81CD<KLMHK_1^N5WRCQ!LS1UUK[%.U.-\&8BXF4%^'/8LO\
M4R\S;S.#CX0L/@M2VG%D4!LV KOHE;NYSRR9MD)T'$]SX* 5A.^6\V ?EBTD
MVZZ_0WS^JK]Q<L8C@TV__<%I498UF"M5M!)K%(+%I2<ZCT?E1IS/8V*'0% ]
M"K)M<XR$D817<.L*Q%N8RR#.]Z/](=Z,-^7;9)VW:EC&)AL(GUS<PZ:0&M)A
M64!(&]^MW?EVV9O%):69Q84H\H%OZ A\FA,9,#'1XDX.@S3(>\9N7G/(UT@Y
M[_,OQM'6R;8XQTM+E"6=>DXMR\(C.NJA-5]4[P'$D);78J8A2"]G$6:<H.0U
MPVD<AD3,DWA\)-!5'SU#M#G^3)=M>>/O:N-<"8BNZW>&3 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8'+&N+GM(Q[QE5:EKJ4<P0/)I<T%1#^GR/F(RYF[CLO=<1@-,'=1"XRA.Z_
M>PM%+]!G*GJG7(&1N5?SJ.>VHHW,1M=3L,.?=5P;X\K4W*]5K$JS/I0^*UH(
MDJ[D&=&CUZ[K4M8ZU7$FSR4-A["95H++&)-P/,,^WP1]UIRG^RORW^U,U.Z%
M<W*'QIH#*NLV+SX/&*\KF\8?9),.G';)D4AF]BUE3I9W4,K*<R9B7GS6&5_5
MA/HXW/MVFQ+F.,FBG;_0EKSK9KS\.;J7(Q]82,E6DEDRD6(D!!MT7JLH_)L_
MIV=DL/.Q9RXC'6W?#<PY,0N2OVVN$]+Z4:N>^N>?]'6C&J'X]YP\T4Z4 N(B
M(#U@_92$;)![<?+7PG9!"*QB<"@D3Y;E"Z_>JWBH>6&'+&.-/PA!RFU%T6R?
MV][V6YE[D/*GG(O(YM8B,,X,.;C3,$9\GN;3<I ;%3F$.:0LJ0/P'N4N*XD'
M)B%MF[/2R@U3_P LDGM/>M\<=:)<MKB_G.DX8"B4;CE?BF0N#SQQ:$<_.Z+$
MR3:Q78TP&<S4@<+$'QP_)%Q!YTUZ=D'+I7;=32?U^U-/7 N4@Q&#Q*!M#+&(
M F0%K(97*)P;29<J:_DY;-#3N0R@Z[[54545>F##Y593?U^WG[M<\:YXYYYT
M2[;7@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,#\]ZZZXZYYZWQUUSUKGO6M=;XZWK>M=:YZUOG>^
M=_X_3?\ A@<6:"#GF7ODPW.RZO+#FL7E5FA)G*4XSYXCJBD7(PQ4O%_X'4/D
M_%F=7*F05UQ($]QQFAI@J1TH[^U+[7AN?[>SM1AAR[JKP#*(%Q:S8I.P3\?9
ME6AO-*(D<\LI8/"O/8Q>SG2R, '3"8RS^FR/?=AI(CA+=10*(;#N4^>E^>^.
M4(W.5M2X\!WWP11LO5Q5/NZ6]?)4,FXW7$D_RVZIE*LEZZT6[CO]N_E_\R^B
MJ_\ /?=IW_':XU_$?3\.]O\ *;HX<FV>E/ $PMB+T'!Z\LJ, (U1M8!:_$JS
M*+."<BX)1$_5IV/2AM(@+L6:WT0;UDFR>L>'+5KKMSP]WIQVV3;]#'*(UEOM
MQ^).;]LY.S[01JDV39-Z)""63Z%+2!$9&J:];N+W(M&BYY=SVW<6#6Z#,$3Y
M3YY15>Z6Z[Y49]:;X2,JBH3_ .:ZADM$P3BL'I*)D(>"(2E_#>8\*?AW(Q&6
M698DS4 JL57*PIH C<?D(@:,0:<)\HZ9KZ^WE+:''!)F]>:Q.$,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@<=Z[%0UE\BA(N+D?!UV0G]DC%04JC_H./?UTXI!9P2_DZQ6(W
M!(J-/]H/1\I8.UDXB"74_8)N$%5.U>UGQN?[7819+A=)5!36]IK)]I*:Y[[3
MZWPISOCO6NT^N5.-[YW_ *>=ZWK_ +-X8?Y?I?Y3LFJ6OLPQYXB]Y!;!!?)M
MXF@%"/Y9._44\B+>A%SWBB;3/O\ AGT[).9!33:<.)$XDI%CUM3EEHFT[>)H
M)JI<1VB8F8OA4_5&<_B?OHC9WHAE-"GI 1(",U^1-%:9^783<1>.,&1#S7\?
M2-?%*:A,KFP5R8&=/FDB2%LFI]J0<D$SN@3C@EOZ:+&VN7+ZK@T,I>:WQ<_)
M+&1D#N&/E@T&]%,O/LA%OO5/3BQEB?G-F\8F?/-?^HVVO4U:CF5A+N6+8*^>
M%.-R-%VL(=J-EDN4ZS-;X59,^&_:,> >9H^L%2>16\?4-7&U/.#7TI[,EE35
MR B?BV_4)U+KDNS0L7;D(U9=BN [I<,S9\1]F>%C4^NUEW2W>%W8W/P[=46Q
M&.7^TJ,H-]3Q[Y&21T-YLLJ,>'A-%D?59G^@^L([Z1]0!C,==R&%O>9,0,!1
MC6OTJ\DEJ][$D8$VY775UKM_QU#2_+7'7APT\:)]\[UMZ!L#VV3AWJ,+ZRX\
MRV;!;&KQH0$&K#!5T+^0PWY]K@#["G(UR(18R"*4A)$$SR%9%EW',5;39"0.
M@O*?3T2K@F8C&\:OZ<ETO"-4^CP'DSU]87H"=6I8/H(VA<- 1-V<932//O\
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MNUKA3CK>^=;^W?6M<[WO>M=?X?7_ +\#ZX# 8#ZZ_P"__1_I_P#M@,!]=?\
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M0XFNYVT[CG3-)(QV(VU%T_)VQ/>J!PRB-1O'<>_M\D9W"[0J.%N7-:UCQ?\
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M_P!FYTXUKOOZ)_Z^QM\U<OUI,/L6S;EKPC6T-I40T[!O(U.I9+^(A64>N^Q
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M_GX;OUVA9QJZ=.L,& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P.*@A Q//?\F<5;
M/*+K>6PVQ96'/MI+&J1,6Z>!B8TD_D 9M7C(\QLY$3*?Y%-?B3I.&Q%0?WM9
M77X%56_9TX8Z\':O#FI*>"_'P7A2O]A=>75X'2>S$$</GDEKU #52\S/C3!:
M+N2^BB2$-?G);&F;S3;M9NOT6&H+\:TY:I]IFO-?.Y>JK6OAHD*MA.KQ-)LH
MY2LN#@K3=BF  /&HA((>5&^D0CLD0ZY;"$6 .33;F4H/N5/U4RCE=SI3\_*V
M]"=W-D68?PL0,#)<R[\V/S%\2!L^CQ=$Q 7:MHR:.RY@?VI%MZ?*)2(JWGHQ
ML\>\,.5.US**:KG7;KGGK!YN[UNW?C'RS&IQ!5NZ1JP2XA$HL2:5QPK%V98]
M HW%R.SY1S!^E%#,AC@N(1YRV30Y:K-DA[/INCQI%+:?(\TZZH9JR0?&1V-D
M;VO'?FV/C&)<)6IX@\<1>-(DS-H4]%3PB-?OGEV6Y"_D]028<U^SCM=7MBAM
MEU_@RZ21$[^=I0XWX'JNPREF;,^7X%9D?=*0$O+W4GK@!)X\34$C1+V*O'SH
MFW=!##P( 9(O&W7XG+ALP0TOKOANE]@\TQ6M-R=<^1")&15<](4,],L;- S^
M60-R;A+@TQMN7R-D\C$DD$?4>]D6DSE$F=-N6*CA+ER]66212^_7?'&R>;CJ
MCT#3?Q]EIBVB\;B'F4Q/NH<\BS*."U((5ENX7%Q"U7%6#0,@Z<E_XX0!"[CS
MU3A/[N&C#EBOW^-MPDF6\HUUIM]PH^,+;>E8_=Q/S_,2U.HJE#P^:R2%+&JT
M82'H<+>]'OW"21.*!Y'TZ9MW2+K:#5_^1NFMPI]R6L)&Z.%H2L?KXV8F-"6@
M8CWG&2.+2_BHM#MQ+_+DP:L(9,'T?H%^C!A;0FW3D(/AD79B#7\;KM/3!IPD
MOKO;9%/DL;N&J5Y177A=M;3]M, OG-E=DKT1D3T2?>P=C8)E-XR;ESA?D&]>
M(FE6Y5I$$G[]5-'7#S8OETOM3IMI3@7E7.F2!3+QW'YIS84;M6DA4BDL*G\K
MY<B+,AC=E((BX.]R6R+ VS:F^6IAF@7A:RI$QO2B;70YQKI7C2;C!YJIKKU+
MQ$!G5JR(H&H@(6;HQ6<VW9) C6H\4Q,BY\'/@-2HJN<3(!)"WGH<47[[<-VZ
M+DEIFOTLL[UQKD>:F]3\1Y']!F8?![&ZHNVI"^C!*30B)'BL.E)DQ!I<)3Y+
M%08/MXY?&X3)Q#=)1QTFDL.>IMTE>OO_  )]<$C=&L6K*6=^'O2$#LVEF$A@
MM:,"EFW=Y,=/5G56B)%.CLF*13_F1@];MI&ZD#E^K8;IPD*)K;8I%5'?VNF_
M&N_TG?9KS1K\UB+/L;R(\I7I*PY/4DFHQ2=5_3*G'!(%)X<PGIJ91>(0:*]*
M"5WS4.=#RLN,VGUKI%<3USPYZZ1Y1_)R9B,KTXM8HR[?%*-7K6U6$HI:L(8R
MBU>Q^6]+GX##%X"'9\%DJ\AE@MFQG].(/6"A=\FQ8.U4^]++K<IZZ[Z[PLQE
M=<VXNX;X_J>)BSI,;1=?0:1EX40!&2SR(QV*F2X22'+&KY0*1(.FHIZH+DLC
M(%Q7#?OKE)1TJLCSKG>]X+RGJB2 <?'03;$X]#FGG<9P9L:W//ZD?=<Q8 [D
M4['<HUO:59@A)91F[-I_QZB SH>QX4:_HKH)H<:163UT)W-D?VIX[A]N"C(Z
M60!.9(E[8$S _$93&E(_!C@NN8X5GCZZ'(\VFWC9%O!J2',4E2?'Y$>!G*/T
MXUQOKD5E79@!17P!<)2[9:5'T.I)A>[ A]X;FSB"#Y&R!0N8+5[()/,6+LHH
MX"1TP3AC7;4T[Y:JNVC9AWTIS^-#E,>:--6%0:?'* --77<5\^ 15;BX1;D5
ML<BG &%>.W=WR:=)@'\1FCLER&/R8]+*<?$5M:[[Z[)H(ON>NW>^E>"^:4O4
MW;GDM2.QB25_(JJK]T=\\U;-N8L_.0Z*S:,^?PD94D-=]RJ-Z+;? (="P<S6
MVEVK_P"08:>*?:K]O?W=&9B>?5H$?>?'^R4D)46)\_QB.QDO&8+Q8CGF 1Z#
M'#\EE*'J(=$X?+E7K9A(G;>;REO,%DFG72/)8CISSUVXTO\ B+YN&KU?SOBB
MKJCL*ZR<2@E;5]6]EJ\V*](Q=D/6BED5O:9AL,<DF#'EY^N_%6#*5R I1'[D
M]\%N72'^S<<];'FF:YIJ18>:;.LTP>9K5).K<K9*,L)&Y'%8T?FL*3CY,T=B
M#>0MF3MR4![#%3!%P/\ V^$^D%73G:7TVHK]2:UV1V@.\*UF5BEJ)//-L()-
MH]'',,FJD@@(-/\ KT[3DC>'F01-<BW9N$)4S0,-Q9%+?7;IIP]1;J](\K\:
M+YITU1G&N/ A.][<NQ]+ZE*6\8N+_(TV2L8M$F+P/:$-K:-P)_6D&1D28Y=^
M16B99/A1%'IZNIT7=I)=Z2<JH['FJN28=U7XRJM>OZM<Q.@H,0(S0A,JQ@I5
M*&AC!:=O8L2KIZ?AX,FJD3*G?Z5(W 'E1KPKVB,<Z8\?:AOA+1+RG75$E+:\
M-7/$G=E1:H8-%8O4< BE<]%IK#HU$1D4K5_2X T""\=]/%1+".QZJ)_R+THK
MTGH>T6=M$^N6_2GY#4[HXI"(6]XXM-X-\SF9%4DI 22#U[(8+'B!V&/(7/!)
M22S:/Q,=6*NC"FY'(HF>J9WWO@8GM<6JDV[3[Y5^GV$K*/,VN 2_R!"!CDI6
MDS\^QD+R^B%-NGT2EL"'BN2T=;EN816:BXXEPSY,#VQ%[L>*^NG.^5ENDT]_
M=UO"5E/5#SF!_&BY@A7]IAY%6KCBQDA99PJ8K+J*,[(9"BXU")KO=D=CAQ5G
M'CI!MP$UVFFF-?NDM-]-W"W/9?/WMO$GHCPO!#*?$RKOSI##MQ\I0D>A(V$)
MCC^?N=?UQ% , :D>V2A<Y]08;CC;'GI[]S%AK77U;M=<"\NZ/ZO>>")]4Y*\
MA$,IZ*U/#3<PJ-2<31K P,:[;5G/+$@KY5R36+NQV@Y"63"1_IJ%%$7[S^=<
MJJ):Z?\ ?Y1.ZZYLYJKOCKT7*->@/EA0\<IQ5Z406(5ZN7?48O"Q@-Y(5>5G
MZCW<!?0($Q2<EM?1JY'L&W2J_?#='K@7EW>IBX^/ Z<'S,=(?*!D_6Z,AF36
M1LYA6)%[%FQN;/W!^4O7Z)=;;9OW8\H<J;>N>M\-C9%3I/M-TXZWV/-W;Y!;
M/\<1H.<D]=6?YX%@8? JXCTE/1:?U_R+C%;Q[LN*JH8=(CS/34-%V"QIZV"\
MN.TT-J.%4T/KUUO6$J6NQ"'>% EDULE"&7FUE;#*-].ZG'@"<#ZFFHJ8:'9,
MV(0D2U?=E'0=01(2;IBX:)=IH#GSK];KALLMKHMY5SI<+#)@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@?!SVNFV<*-4.7+E-!7MNV[6_7X<+\I]=(H=N-IJZ0Y54U
MKG??V]?;K?U^F_I],#B*&!75;7L)!I(&%D^>4'TDYESP#:Y*]^&Y]>.,!YHG
M&:;(53Z7,TA8(1'MEWPZ=N=1[7+??:NP3CC[N5#I<1'5W!PYN3\.^-.5PF5L
M;#8^C43<_CSB!O(P6F%4/I0!Z?P45Z$C"9"6Q4C;.V9)4Q&?1QC?30(K&Q(X
MJT:NAS-HA^PR7-[^5+ #O'1,/37H*H UN*B4[N>@BHV4"Z\CH9Y"2 VJJQK0
MLBF! O1,:=A3>ZTX<\-1;8#T-;OU6S)5#I%NY3)NUM \/^-IV +0*2#;_P"M
MN8S9\ELAT<"PHZD?*BY;<8:["\+:2,E;<AZ-1TC(QZS1;F6)S!/355-TW3;F
M$>BBQ=[>_1OA-:\+=5M4S>SR+1WK^$1;Q)U&%7K42O\ Y<V743YL.?)SD!&5
M^#PVV'3E%8B%(%VI3A/A![^BIV/Z)&515-4/?'H3,+R)#5] 6\@FD D$!/\
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MM(*S[TR0X53^Y3H3G,ND&&# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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M(]M15OH</E=.VO;@/M[S]>^..D^A&,SPX,: -_'XS'U\-C2GEEB-M*<%I)7
MX2QK=DVEUB(_R%>&C0-FW;(\.9:FH7<QUPO]NG6E'?0SK?WK?K]#S<[;Z9D=
M!^6^ZFJUC#(C6D6NR>R>'AVT:"1*'P1A(6-9S2R"CZ4):5#,$DBP&OUV?'?"
M3A99SVW2ZYTE]>^":SJIF,]+?'Y5XUS+A%)P2%1N%RRSRG<GB5?57]X)_P">
MF7K 20GS)A$7[D^F/Z#4)+VL>)-T-]NVY?ELAOG2CY-N:K*=%KB=S^)Y!)'T
MRD4\\^N)G HA%I.6D,I)0EO*H7#U2@20Q9\5)&NDBH <-.RD<[2X5[3_ $'I
M1MWOE)5VEM0S65<Z;=!XSY8F#"+WK7L8I$\RC8X^G$;3C<>AKKJ.#VQ0]W)V
MX>4,V6W /3 T\*:?)<*I=MW2[SE7GE11?70F9X2A^$^D*=L](W-I=1<PKVK;
M5IYU(VM[6W#X(TK>UZ2C6E56B$N,L)+(2T1 /15A.B0<--F@55^-).U4&^U/
MW44RU,?%L/=G^#@X.$/5I?YH$@^1DPF4 TZ>0 >DU&QN8C)//I!'F;C2*S#D
M'8D18NBRR7"?;<^/;[<;Y>II:T*R[M!@EJ?'[;4CC4M1#>?D)L1LNRJ^K S*
M059<RJ82&.6(80DYF D?H](.V4@L4R]516Y42<."Y!;CKCEZX43[$[NZ6* :
M>*C[HF2\QC?.9%[#5V')-_30NO\ IR!5*BR+ 6X5=Q-MRHV1(B.GC1NOKK\:
MJ*;AOQUO22O'(G=_E;2U;X\9F);(W5D\U/!YI'+UD-?#7]L-H"(D,JL6NHV'
M@;N7Q!T0<N23YL)C=OI@>">]HKM&ACMHI^))UKA45E6G"FXP)CXFG<ZF(&MQ
M/F^56)%HDI7,X&10-7I63"(.,VM7SN$'4![19ZG&1>X_T"=#U/JV;[9:8K<<
M_AY2Y$[JUNE=))<7F*J;.?5HAY(9IQB@;)J>L.[%C42HM$% IMZ!*U1+HQ_5
M(:I*Q]H/&;N72>,O2CL2$6[Y(->77VK=LMJ\%K*=;XMBNOGP;:E82 "2N6H(
M!$*N-0>%2DK"GU+*HQ_44U,Q,!KLR'FL3F\4<A!#TN;V&8J#%>6)%!TJQVBX
M;+]<"-U_%M-865XS/U;'O-23B"N*WC:S"AX37]B.HS)14X UZ0CD&AI(2BZ>
M&F$B 2$OTP2"/5]\J$GNM;0YVMS]-$F,KOF\:_J_S!4IUP"@,1$.V_ L3%D2
M]/L*\<"%0L)D=:0<+'.^ 1MFZ'#XL6NQ)%@R7123111?=-N/LWQ^:65,I1A<
M9\66I,+7/P*+><IY.^]&8;=!F/1RO3TF>(2-N]#2$)/"#5BX($!\D;CG+)[R
M[[40?_IJMU=J;;]\)U)W1&MT@FO;!\K6%T;E#KR9S"J>N.OC91'T/.JHJYE5
M-N5A7K=@[3?S0PP+%I)$XD^ ,$"L?[FP\,W*#&?"[?\ UTDD\-3&4:7K#(R6
MU_C^C$<A"#B,T<3K61EXR+BSV.Q2 F8\VE1J81?S &%\1D>@H78.6'=BI WK
MG]'EL-%J+-7*B?/?*"@K*>MO;&+Y^/RYJ_%7V:<^?TV\?/QF?DG,]:5NXEM<
MV1-1S!N%=F_]H55%6$_1B"+7A9!91PJL#_'PIWTPWI$E91--F/S/X[P$H&2"
M0FO)C290(:%)!C3O=6KR*(")QP^G0 H,(\IK$ @Z1M#[PXV<I=II*M7;I_SU
M^%1PML5E7.F!J"R/ IMQ,(!"@= 0<Q"[#L*OC5>* ZS D^S!.<-J)-$&T>&?
MDX<B;+)*BQB._M_(^8$1S==/CE=NCL3&7.THB;@\946(=P4#/Z JH,);R0Z\
MA@0Q"HHV:H")@1KZ3$U8X.49[WM*>A7(-93\.^E2S;IGK?3CG\>$K*==6XTU
M%J,*515Z-7/8K957P9VY>5%($"0B>"H[T"<2&,,DX?(4_P!U%OU"V+QZ!:*(
MJ;<LV:737M3?6E/N$W$Z\6CM)/Y8?71=-6;AD/96'$H9$+<N<R:K=J# N01H
MV2>QXV:FQD,Q#REV.*0/I^NJFX=<CU&J*JRB:NN?H76K5JZ]*> [&C%>]J4T
MQF->20=&M?R9:@AO43K.(-[PF-.5@8GK&2#&;J*1@[< TT@#33:+JH:V[>+(
M-6NW"^BUE$]V"D]V^+(F;F>YUXM<Q&7P[BLX&LC):>\^CG9A*P@LJAD.B0F3
M[G7<58)I5S%G_P"PQ)$AOZL8X1YZX_76;)*"LIYKFWK.Z;CE!E[UO.O4B\)B
M4'?R4G')-&(I*3XL=-8\K%CD>[;.R#Z*MG)L+)UPY-3HEP(VS=+Z=.],=K*Z
M,Q$W4<55'%\^*7:D!"WO0T'IMK(3LA+10E<4;H]S7O9:M834(P;)8G/8W))9
M Y,U6@L@##&;\0]=<L&\><,7FVFAND]&JRY)[+%O!S4]=2YOOS*A)!2+$[?+
MHDSKS@K]@.1!W[$C.W3AOIP0<!)GR.[UTOTJJT,[:_7['?2&MD\W=J-<V7XL
MNZOI:,@3RM8B&;V 4K%NX :@@ VRF)9U,?,<+EL,5%_O(M24S&1\B%C#W7'[
M#@>CVS_'SRFLVX$QE'%J&ZVJ#R'"27FJL81;5I3CU"M8DH(1RLTJCA4S?B ,
M*A<#F\Z[)(I4O3M;@8G'.X^*05;I,5EB;UK^))P\767PMSEK/)+FKQ\B+5=%
MX=8CZ!UO'FM>0Z9)T9>#(+$I;!XG'I"R!P[J0UG*5%'XA6/S< @Q%J\I*I*E
MF2?\>LOWRDILE97HV6$V!XX@ J2S2NY5Y[A@27R;IS+I7$",#CPF22M6OEK?
M[>2 X([:,RA7JM'"LAZ6<*]]_P 8HH[WU^/KOO9/-.DV]L'K;R1:L>E$\KZN
MZ&FT<M_I^E-I-'(9"";.P7#:1+DBR$M?-!G>SA%K+D%'#KA[OM=(FGM136E^
M/KH3.4:3>BM%.^Q?.E@0>)0J1TKNCZ0G%(RBUH+Q/]4ENJ'U10LC#6)[DZ#@
M\YE+6ON&_<^%*),3;%@FXVLHGQO;A%1+1J8F[O5-SR2^&)P>K)^1?>;97)9Y
M)',WJQZ_;P R7.3!=ZQCKF1Q]RY0<.N9.Y-15L-VM]W#M0D+2:ZWMTTX33)Y
MHZL!6<F\57!>)./5;"J6G<_HZ'QR4-[%BT7KLZC#4Y7-[+%-@8"3C>'1<.;:
M2.,F'G>D>44?_P H=JHJ]]KN-:$[HC7A*[F&3 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# _/?'*G':?>OKSWSUQUKZ[U]>>M;UO7UUO6]?76_^S_' X=4$+@4(^0Q
M[7D2>RP9'P4KLY:,ER):5F'<L.%8G+VAZI";4YZ$E&VL$@O</($!Q%6##M*.
M1K5--VGIURN9.DWMMW'PYN3%(^-ZS&V0H6B'K]&TIY#I73TA/,$G4,E,ETE1
MT@N=HV0F_#20DS"920BKT-#BB^M,6:!!-LLR9L^4NV:IN9F8UA;GTEY?%>A"
M4.*EIN0B;&)@9/'2X] .)+,9" D4WI^Q'*3OLGUQ_'+LC]*#/M6Y^_C;59SQ
MWQO??':9F)I7HS\<%<3*QE;::V=('+*:RY:9RX0@BW(1R6QU:Y7E^182)Y9E
M6P=OR.E1AQS_ "#EL5Y=,U>.TTD7:*+O@UNFJ69M:J:=]#RRC'TI-PV6LZDG
M<@L0;!WR,4EX69NC%56'6O*!(43_ '^.VXAK-UB2*R*?7?+AEQ_CKG[]X9B9
MBU7>OC KA/4G:C+!D $/(F]S,FP0#&8L*&1P=<>O9/#I@!9-6O#)DTC"/L<A
MPQ3Y2TE]H)IKKGZ*K:PNZ?'R_DQIKPS7!71PA-/1J3Z(P&;FYL\'*BH$+&P:
MU+ F5<V?;#Z6&U72[SL?+20+E0>&)K<Z#M#N_P#:.^41G34NZ?FO17E*1Z"1
M:R(>LZ7D@6S;$MF?G6I%N@U3UJW9(6D)T!QRRVGM1@VV850X5WO2RG'^MUO[
MM[WAF9M0PQ\:X7G^K=E/2,J#.H-6!'S[4$A'1"NXI-4H(48BA,4BUBSH4R'2
M>V"$<' D63'\;D1VHW6=]ZXT_7T^3-;ND-IC7QL1F/A"S#JV)&Y+KZD9*.'D
MHM&T58O*3'I6-^L!9=%H^_E=&1@&VHPW_P#(O5%OWQ7/+=VLLMSMUV-\^/A3
M6A_QI0@=8@V822[Y =ELRFSF>6,,?"A(<?8SP'>I_P!%BFL:B8LJR#@&D9F\
MP<IJ*+M3BWZ&T%-]I$4]$>AOTX+9T+YHC-"$ /\ #2EX9<A/.U-T&BS=L!0_
MMT"I@U8I1C*.T6&N>^7IEW9:_#A/G7ZZ.T>-\?ZRG?U,S-_BAXYX3@IUW<Y5
M>R2_'^>(GTE&'2FAH!7@+SZ3)4RZ/(B%E/K^XJ <4DUX;I=[WIQMRI^76]I)
M_0NZ4GU+YNA=3S<-+!<X5*/X;&/0 -T,<(A6O/*%_7NSOP\2);:=:<-%0AEG
M^HEOKZ<KH]]*J[VK_C@F9EI,\\$5'8,^M&V2:0?=H6!;=!6Y&[&7A$6(3:L7
MU"I5<D, PN6K->)&R"RE&MNTWVDG:/6D3#SCC_5[WKH1E,17)'(;XYTXL9@,
MMBU\2<9.*-$@89YX-NX-#2(^O*T ![*C2,4E,>TFS:V85<1VU"#;LPZ49ND^
MVS1=+CA7;_I^7=V8L?\ &5 X[JZ$X?<<UB\KO<7V5G$F8"8ER=6LB'2:,2SS
M]= \6V8LH\'E]"2<$NH.38,&@@@B_P"D'+7[4&^TQOGGR;&O\<=;<E.?X:P9
M(''#8O!8VR (L@Z_\<'AC2@V Y95UU^-XJX*<^>D.EE^OITHL1==ZW]W'.\&
MZ60HSXYJ;JI-3@L:-6B%8#H$%KM$V_,,W,7B-<EY2?AC!X;'R)9S)EVSJ7N-
MJ_;^D'<<\\]Z'<*J.%5R3E,M&(?&0/(<1)EKT!.!3&IJTF-/TH4CT*K\+841
MK>2P210$'$9?9;45N46"&KT2?^@9+?8W6MHZ6=?LOMZ>\%W_ )LG%_CJ$0)H
M^*ZN\TD_;2_NR$R[F*A&XD073O>B_1)'3E!Z4=.WD?U**,3:_1X^5=\#2*OY
M7:KA'EQT-]A/XVH.7!4^M&;7DH@U3=>4]$:ZD@YHFF.5U6 Z[A*4@+M8J;C#
MXKQ*8Y?95/M)J29Z0720725WK:R2HW=7\/?&I!4ZP=P"-6:7AK1O(8-)A\DU
M&8[HI&>(#YQCWG-NY!EQ*D:,Q@RA' *A-L0&/F&FKITJV52<C.UF2HWZV\_'
MQSCR>QQ=GZ(E95C&9]);KI)^XB,#)*Q2Q9W9\-MXG)Y(88-&/-J!GYB'MTN&
MJ^F>E6;YUOI;M7;)5D-W9CB_B B$@!F<5?/WMPVJ5D-96/'9(]5@\<:OI+$O
M3]V>EUI(+4:!WD4*C73[T 6:MPJ^VK%RT8M>.7[-SU_(HC=KKI"R7C2GKBI2
MKAT2M:3QDTX<I225O!8$:V15$V!8UQW!:LY55*CV(@8_8J,I\(8I)-F:""3D
M:Y42U^-?CZ&9F)G1L=F>6(-;LUL"3S8O)EQ%CT]":=.QH$8(1?K@3"+#DUBM
M";22 'C \BN2(R/]9VWTKILX:(_B4Y[355XZ$3,*N=_%W6KOFNQIZQ9?-(_"
MYW))R53GK 9+9=(5BWH!WZ*&"&]@$>M202,9S%5)N[16[(-W+9+I=LDQ)+*O
MNC6^4]&_)G#V(RL0*L!+4OEU_2>_R\JFU;P:S!I$J<3(1\+%RL2E;-9OV#A5
M>;' A;ABZ'$T40K7O;G?'3E!<F[7Y-R">;AT1\PQ_P RPFP9Q%1\3@H&%QRP
M6?0!]+67]=[9N&;YR/)A7<2(#7J[+2+P.H/_ (EP,548:0X;=:XY)=S<JMQC
MXSH2$2L!RZG2"!>RH;>42/,X+6,+KBOA'=W5U JT*&X;7(+2PF.%&HB!).GJ
MOYG"YI\Z4[=*[3X123-3F^*WQK,UIV4L!6^YPZ-I=$WD+<DH\%+.HN6YNFIK
M_ACMVH2=.61<=!; IX8V;#D&PYDY ;Z:KI]O/J2Z&_2J?2O_  H8AGH^J)\0
ME#N51B"HWO:%@25^E'@NK6NNW[8F4]@K-:!A6'X!06CN[4FKH4Z[<=*Z[D"'
M/6W*Z2KGD3EIW6=OKSES<1V+S,!,^(/-(S$Y_6SQ<I#8[8\-F-76FI%'<[@4
MW@LETDR,#21"$"7;=5-PV6;+M/MZVJV7<MUC,37P5QA_QM1.O(N.%0VV9>VD
MT55J8I Y>:C</)]1^05%9U_66$7)1L:- QXS''G?H8J+V(11'MF#!LWVPZ:N
M$TUDS6^6 )?%951<<9%$;)L!5F?JM_%"B+=$ .27MPK/G,])>@$D1K!HDQF3
MK]GH)IBWTD.1CO\ Y!/GGC_6T-\KH>=J*'^?X,2BC<\XE):1S*23Z5R-PS48
M=&)-)UT.GCE-LZ)'"?*"+-FW0XZ>D"#SOE'[E7"G6_KAF9M3L/\ %I2T4B=4
M!8*3;0.45E67,&(6#%*^@PB1V7(@ECTW;T"GME<M!J328$(;8U,,WW+,ARZ;
MNTR3]+K:?3CI7#6^>?!_'GQL-B<ECDJ(7W,GK]G8T?N&6,58V)XCYVSPEZ/;
MT?FP,?:D6XF)"Y*4?_Q3UOM(@]Y',FG3=Z@[Y>.'PW=DHTKX^E=#2\#(8O=#
MJ3"PT#IRAF@23PJ.,]BO.U(:MIW#HDW( DFSLQ..R%CM^'1IQTDDJ@-UM-JE
MVJO^8DY6O;ADP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
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M_JNB"3%7E1+2B#<0OR/3%X]O'Z)IJ2J?4Q'U_65F7*%LA^WB#3TAW*963FL
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M$B:VI1DON7^O]BQ#)9NO^1L\WRW8B''#;99VUI5NM^&# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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MDXV\Z5-I===M%UTN.GK-+L1C'&5S?=%K2VM?+,LL"J)0_$R34YHV+#9%$?\
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M%DW*!-VE4U6NOC*IJJXNS@L*EDX$049 +!A@:)(\QCD2"*6W6$?K2TID%XY
M<JCBT[6C:,A?-N.OT>I(Z?/=):V^7XZ+OF650^.BMN"\36=V)8Q&*UY.4;)K
MJ".-Q),'$YD5L:%V;81+@@UC*$C--IZ<AO2:C9Z]61&MR[_EII/?33;0FZ?F
MTY[\7M>OU(P^>W%:A K6,<K6#4LY),J[78UE JI%VS'(I&.1;6&,49GO44N8
ML/=/C';IZMRBS6TIPNBHHN7?+?AO@^*5Z!@H:J3KUDE#;D%6)PC(.!*/',??
M>9VGDB8!Q?\  Q]H+9D-5GSV88;[8=MOYY+A+KA)EW^-(F[KT_5^*C\,-*;D
M-3(@YX5/PBN[*E=RKC3+0,&3;S9Q33VB8@#A$,AH2/P>%1'B*RLT5+IL&[?E
MV?Z37X0YX64Y1$Y7\61*>!X*1ML1;B-AST46'6L2ME9J*;PYD^4)$)@.FRL=
M&S)&,<3@)$2I$;PS,#4".V9H5UTW<);[W^;!NTIB+M^.6H;QLNP[(/266B5[
M2#)MI>%'M(D09K24=61:IH_+1+Z01TL5!O0\5)\=?KME>$%G;)NKO[=;=<.1
M&4Q%-GGWA>#SR5S"6JSV<A74Z3D;.1L1R<858N1<DK[S[!'#)OI\!<N6BC3O
MS: ((K\J?D_.J[2Z^Y!7A-,;I\?/^:/3?QIUN:_&\4LNPN3X64I2:$&EVL->
M\Q329CT2]V)4$KQS^,D3/H-Z8.L/R/>.W&M-62^E/S)+;7+OEO-<>"X#5$XK
M<_"[ GXZ#U?+4;& 51MM ^8HXL;5 /?-CJ4/R#.&,Y(DV>5V[TKL6S=M!R1;
M7;A-+A+O3?@DY3,4TR0?&[!)%.;)GI&U)Z_)6*SGXURRD,<JJ8,&XF?6G [B
M5"%?[; C3V5 HY*Z^9LA31\MVD/ ;_2;Z2532=\#=-4DH_X=KB74-6OGN7S&
MR))$*[4FRG\L1D""THD'$\K:V*T)-'Q99@MMDP"B[<>*"$&_'' _3!DAK[VR
M722@W3$W#5%/C\A1J7(V+/+.L.=6"_E0^6322D&L*"<31V&D/GTH%'O <8BX
M<,%%CPGG$*,^Q@DW552=O5^U-N%4^T1NGA#5U/C(J0PRA;"<6!8\[;5]W4$9
MBR1OB$-$^*3I%C/1L1HTXD#B(M*0Q$NSL@ER=>.=;*EO]A][CC2''.#?+(PW
MXY8+ R=%EX_;5I)%:.C8\.TD"_,(_N$V*L#$SDKD[,IHSB3*3E&LLDLZ>O3P
M;IST#**<(_\ E$?]OMP6<YF^[H&&9OAX<4P)EG!\DQ&L69 Z[:L63LT^;-4D
M799RR%MV8QHX(K\=+=I-TDD$^N]\I\<\:USHPR6 P& P& P& P& P& P& P&
M P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
M P& P& P& P& P& P& P& P& P& P& P&!QDK--S&_DKDC)_8#APUF<XL=\P
MBL7EU:EU5RH^O3CU!&S! ^_)19382U .E>&_[D+%M6JXH,UZ60Y1:</#I/\
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MYWL3C47W29<US66&M2 4-2,1A,ALF:P6>VD1-69)#<<@\3@E?&H/&7BBG$;
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MA9W]>FC/??6]*J:3Y63C$=74[*P8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# XG
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MR1M#N2?(AH^1;#UF.WJR?U7YXWTDXW7;HGI<D@K8MK?Y:%[CWZ4_YC_)*?G
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MQ[T\0YV6<:AUKPP8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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M,E&_/*/?">^N.B[I2F!\WT]'8Z BS:-E2H:+6&-M>/)S"<S^>D!$_#I<(BI
MS-SB42$VGT/X3_V+;]C;-/KKKK26NN^]]$N7M;>>J4:%Y"<2KF.]DY8A9[63
M+.D%WR)UK="\/<VFT)LGKAPQ=M)NM 0^WJ726T^],>.>=<\[[UT+E%;OP=Y%
M>@HU%7%'Q?J+16NXS4H^+IO9$WC1&MH4Q[&PV'2\ W-)"9\&B3)3K@8F=1([
M8?=UTAM/K>][+NRZK.@(X(C#5XR#(.&[=^:-R!UPY(DB?7120E'1@JJFL4=O
M%F[=8@\4Z3;I]<-FW&])HIII\\\:,LY@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@<R646H(7[1?64_MVJ1U@1,M,W
M:D-B-(!8;/7+J1Q9*.$F%CVPUZ(%YX.:LWG#O\72;7I1ZBT4WWOEOM-0WKMK
MDZ;88<,NO<GJ6+\I/92H#*R&PUX\5JZ%"X5$'M9V*&<^E:<@7;CSOZ#B%E2J
M,RN-K5C8O7)'^WH"#B+QVV((-44F[MCP=-L+7,/D,:+/7#0E2TD')P&2QB'W
MXZ2ET=?<5F?G'HB<>8X?Q%F_*+=Y:8TE8U?OG"ZS5,>HV#](JZ25>]],.";6
MB63\DXZ+,Z9ES*(DFD8.U77=]3X+RX"&3SV&6W0GJ:?1&$AU_P!UBQ$GV<OH
MQCI<FX4X']M'/?6^N$N55.!LXMM1]:WVVK3T9,'U6Q!&>U9["I6@1-;DIJV<
M!QL:L5IY79FE5IW'V"VC1#3BZ"3YBLHP:*I_D;HN&W^Q[Y4&V+CX?S19"?DP
MDP.OXLE;5/DW-FSA8(VK#H&89: 63J0V'9T/3(%4  N2%Z[:BF-:N7W:?Z9=
MPX9J([33_:[4:HC9KIP6V0]EQ=> T+/U(3)Q;*](O8<D;BI"JR!%8=W6U9R:
MQCHT\B^^WE3OOB+.&::R>])[^O*__P"*WAG:KVG\GHKD4O*']#31I#G[=Z'A
MAQ.80UPYE=CMX-5\W;1109TX;ZCL>?)VDW9://%^4$'+!UVN@DVTBNL:V<KU
M:5$_DSD@:?3.M[.J P]EX&YI""/A84\Y/IUO6C:502N SI J"#$6MA&%I<;(
M/NN5-!.N!+??Y?QO?Q,EALTN$@)_(_VZZB_\G1LM@\<G7]D1CT[.RB/N _/*
M,LF5?P[OAVR9/XLA))7)X4Y5:!"A,:^=L5VOZ/!!]VY'M1M[M5;_ "@?Q<-C
MDI=43-)5'C(LJ!"R5C,*_&G)79D)@\3DDP N(8Z=C^XZS=DY+^HP?]J[:K]H
M*+=\-FJC-1R-G=M;WY,@X>7"J^,T?-DIN(D1$-;H8*2_M#>!,6MNZIY@9C9(
M%'W2,]1)%M*$OQ*<AND1B"GW;_<_"S6&SG>CXQ#V[8UF2&V"0>&LH)7XWQ60
M])5(J9) I09DFG<HGPJ,R>0-0SOA:.;7'11)1T"7_+M#:NN/VNUN7"2 VQ'Q
MMIC;Y17T7AT&#3^BI"XO*10>%SW40CLF%FP1N$'JH?66[ES>1Q85(4!)M1,&
M\9\@NVW>DWJC?>WO\<ILCP-FNG!9&W_;K.L^H@]#5-*)C'C/GJ1^I):3<'X[
M#24+J"($8(UD76XZ?6V1/3MNRG:;A .EM'A;MHLAVZ27[;\+$C&_Q0NX^4,$
MV(1IHK1%@?8??3$TIPV(-RY1M4L2N'FC^;#;#8\),\+E#TQ:OW+4&Y79+)B&
M.U5W"+M9!BH79W?8E\G@)BZ(1S=,2AO8;VPDH7 X&7-K#S$A$J"+8D>IF?;M
M(J5+ HV[C]-E%V! 8RD 0FHNV2:D5>N7^V V?@TV;?*)(E*TFTZJ_P \F-)-
MP,KXK<I9\J%QYJ>G4.JN!W(9CTKBHKE])(P+;P^8N$.76U%%%# I5MM)-%5N
M[4&SNME?WL,50,[JN"%H0]DKZ=O(.E*.@)Q-T]@H^P;-B-1Q\NL):"'SIV+4
MF$LUKIV1Z"#U$&:_*#E9[KAEV2,;A"48^1@G+I!#(6*\YR=&:V\NFXI,04L2
M&M!LRCS)_;2$E-28ZBF[;P1<6,ILB]:,NTWZY%)XR3YVDMTZ3:%V=]'C'_(&
M0A_E3R+:DP@[^?VQZ5@?,E;1:-:V&'<K Z_=6',W"ST0QF"++;(8UTV:(H)N
MD7+U=/72Z+32SM$;;F8Y0TN+_)^V;D&@PW7LMF2AZ:S"0== P!(.7@E(.;>;
MUC ER4>;C#JIR<M%W*O9-CVN/YX18+]:7Z<=MFJXV)8AWM^P[&LSS*$C-)"@
MM9>AC!DN*E\CLV-OY(\J?NL++FT2E;2&QSIX5CDD)$(%SMT/(\=-$VCGE))X
MH]X=H,1MB(FYUA@2_P @DLA4FOX++:6;F65*RZ\9$Y>Q*;CVBR7G"AH_3A"8
M3YXA)&[5,M8NR%L)_K1YHIPDN@AUKMV@I^#3H;>"9[[]M0_SW+'D5ED-DI%5
M6%1>PXHN'5;*.)G$].YN]N-Z'&N$T77+JC8'">CY5#O?U<MB#1%/?*JO^J2,
M;5JF_P FAZ '&&Y;1^HZ B<2GTVN0:E-QDODPV/I57%;'I]2 /8XA_79 3F+
MN2?QA9JZ4;\B5T_S<K+L^T';@NQ8T+[19D?/\QN0G7!6.R.&62RJ-S C)=T/
M0.SDP=B86/I14^3C(X[(A!C^ZL>T?U@/9==;2S1L.<O..$%2;=:8/SI[%F'H
MF1S-<+5P^/043YY@%I1WLU)7;>7*V$=LOT16LHAI\>J#2281YL7H[K])]M--
MWI+?:CAMSVKINV$XQ'QM5RK?DZGXJ$$K5]&U"B)KM2,UX?<GZV/#C"<3/'_"
MT?\ 6YB(C8^1VUD$J8O$!IG2)%51M^HN^8L]\+IIN7J1J<(X1XUI;..>X@;S
MSM?]\S.OI! U//3(\XDD6>J$7Z<B<LH$#GT>90TL\CP!Z?<R1"2LQ::?(_A3
M1K:C9+3CC2*ZYG;K$1S5/J+Y*Y\UI5G_ 'RO/\ZKJ@"GHOJZR<$3W3\4; //
MH2#62_E0&.62DC)-;E=76F$5#LNT=<O2&E>>UV[?ZN$S6S73@L S^0QBI.8_
M&R-+RD5%YW:QVIJXFBTKC"^I.6B'H6M?/DL+D8\WZZ?QH2W+V@R(#M*J+.'Z
M#5REVFV[TWVX,[>^K!%?DCCBLICT. 0 BX4E$FF5?=R1J=9'4XA,!\[O&O(:
MY."1 YVS; Y(3I%T\^XB0%N.VKU+3%$ATB[_ %R[>;6IY[0LZNN/CDG,B)1%
MG5MRU.4L/U81>!_U?X@0_B%+!@\P DMOOQ18+%[/N!DZ)<J<..-B-JZWUQ^+
M7>",8F^J*:1^4&=IM_X&ZZT)R6<E;0G)T@/@H0B,ZK"ACMI!(I5#!X,182!2
M6ST"+DZ:9?A1<8FKH8Z6TIRNHV9K%G".7!O37Y/#%A&X(,JNF7Z0":3=1-"7
M2\F0')$*C_I5[%E)8"X4CB0U"P&IFHD7/ 7M9^T5%O>?N=\N/SIM";.K-@/D
MU1;19@<D=*S1R$="-QV,R[F30A%S/K6'PVIY$H#7 (KMFT.CYIU:B#?1AROR
MU:+LG?2R"3;E!98;$\L?9[A2L9'*2E0E1=C!/1K/RNTK;4TCI <7M4H:CP08
MOQ8#1'8H="W*DAX<=/7#3A\FW2Z3_1Z>])L^B;=>U,Y07KO5^SL[#A-6G8RP
M@\&;GK%E)N3QE<;&YMNS;9J@A7PIN,<.W$H_C9)2AQ;HRC^(:JP_553ZZ[7[
M21$XU"!:Y^0\[<-MU-7<$J-DS$S"S 0B32 ]+G*K96JIQ1]^VI!9M!'S2.MA
M4E*OGE'N.7.F:I %VS[YVQ*//S_F;%G"HN743#!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,#F\WC59Q_P!HL)F7],4!'92XE4B%#:>"261B+6FAF60Y<<RATN&2
M3T)((J97;)_:71;C86.?=+LT.D>T4OV>7)K7;P=(<,J+C^/CAB?<_L :OY$C
MW2,L8#+$E;9_5@WAI-$)'N>CQ9@EPNDFS/.9A#>C'#;77"KHJ*Z<_:HX;==\
M&O-PU20+CWCJ;RJ#RP(.\_2R8LI?*G5>GA6H*<-\S@HFI;$N7C+UGTY<KGU^
M#>Y*YZ0ZZ6YV[T0_PVKRMT3S1U:6.CGQ\P=[98P:)\HQ=]!47QRVQZ+>KQBL
M59.QDFBC]S.FF])?Q0SD/8Q87TF]YX;HMS;AK]O/#OI/LOF[H]K6UOC\>U78
MD5 AZ0@%!-94X_M#@\I5$;K*9R8=8<KK9G).>$) XT<<$9!2G:HTN[1XV[08
M(=(+=+-%TFHK*^Z;)%&/%[F,N1TH'>>_ZDP8J1-SP74@R 48QCHA6\^P^W+A
M5-J-X @7O<M^W7:>VC179+6^$^OS83S7SMKAV3?']9,8$5=(I+Y/F,-K^.?W
M@)!")ZJRL<AD0CT<3VI)F(%1XJ- 1@=##VORN.4TFF@[[_7WMJOO[RUEQU?,
M7+?C[DH60L0\J\H'8]&(])Y3*6+$_5I(,!BQH8TK68FCK-)XLR' WXEJW!D5
M5^>$-HZ1:J_ZO2?&Q67=AA@OXX0_54#A"7D=DX776L&G&#!Q5_#\FY+O5W:\
MPAS1!;;TRN6-PCM;IZCRMTY)B/R;ZZ=-==)CS]VLE+ ^/?55^>/2#J*U4_@]
MF<B(WY]E',!$]OB#B<,)1.1$:#I.!Z*PMR\=)%%^$'.T>&A-=;?U265[ZZ$1
ME<PAJ#P3XY).<%^T'ELU:M#R(@#%PL;F9VA0T)KHE,H!#.!D"-O X5D=6-B8
M5&6.F80P<)("T4E5$./PHMNFLT6=W]JUDT)>!ATGV8GYKRTQE\#GS8BN^E)N
MLVQR*V3..T),S6?]DGG#L7*)$H#2+)\K_:NKTQ3?:U]4.%N*GFY6TJQ+*\%>
M6!U]S?@/2+*7L681E=L4KYI6G-F'4;$EXX"&!2X4N1#=\#Y!+I^EUWP6<-1Z
M:Q7MRMTG^QVIV(C*:Z-Z/U!X3@ :(T_*Z]\U0<1.Y2@7A-;G0U>1]"32[ADR
MC2*T<CSKAMR4(<#'[8-SRUX[XVU<HC]:VDLFAV+RXZM-F//Q_P!G3<3>LTL?
MS[,^J#"(5HT4*SBLS<&KMW,I9&SX']ALLNY;@Y0]/P)N@-_VZ7*G311+A+M5
M#ZI#S1I%ZLP,.>(IK2E,^A97&:=B-8JJ:EM42"T1<$CZ  C+C+B5]*B7CUTY
M%-GYTXRZ,=<-G*O"[A#E[_CVCRKP/-$US0T*L?XTS]OV5YCU!*692164/BDC
M3>16 H1>6R.'5F&NN1&VA)DY<+M6D-A5G\O%7KU(>TZ4(D>6O:_T(=:+YZW+
M#C=>%Y^$B\>#K^996 M5U.AD+ #'E<E!T^>;BC2"6./BPAHLJE(5V\+3;BBZ
M+1-7: _2:*^N4OLYPGF[OW-^O#5@2PD.L-_YHETVI*,O7)ME*B]=EY)6$3C9
M,6^?.CJ!)VL0BXF+&D63GM5UI+@8\V@M]4E>T^^B1NCA:(Y?9OQW$.V,!(#J
M-F[+JN(5-F+4</@I*-(U67N,G%1!X8<>.6@%<< M'I\JJS9.%"/#S:ND&ZKE
M722A:RXOU#;C\$WCY^JKJ3 *7AM($4:]2IZ$VLM3(8$UW*8.+D$,!Q2,C)0:
M&1TES#),DWZ&<Z;+IM'':&TNFRF_O$QE$]VP2^9?'J++PM<OKST=.B+U&UQ%
MM!1\,DC^*7C/GY,RQ%.>12;O<8,&CT)77VHY_"EHF+UWO>G#76TQ$9=^#)PE
MWX''/6DH"L_-,#FG\0+].DVW9"IA,PBC<Q$WSSFS#3P*5=(#V[6,3U[^8H@[
M4':;%W"O"_:+WI583N[T_%F$? W-62SU+-Q-"S2LXS+N9Y)[0' XI.QW$Z8K
M1NOE3;@D);E-/)*@H%%#G/UWTM_Y!MPKK>VZ7V"-UUJG9D8\[VW8G6F!2H[&
MM2FVA\3VFU>Q24SBM&4\;-1LG']I)J/3,6:RML)2;/D]Z1Y=Z;:25UUM/[=$
MUB.RFU26A\9DW*1JJZ^CE!#6)120'H$.(Q6 QH#+I'+I)9_G:: 8@**_JOC\
ME>:K<D%?M$V?2:PA9BAQM1%5%+@U,9\=5C8F'\;S.H9G H$QHV:TS#RCY><Q
M2$IQ:61@+(PSA.3.G1L7'OY+\<I:/6*;[A7OG;_:Z7"J?6^^>>L,SNO7BAOS
MG='DM:..;6AM,,_-]>HU2#D<?M:3Q6LX16TEJ2<2XS)6#45-H+*)#%@V^YD?
M7(.(R87%G63PUI50>GV[4WLLQ/6Y2.&>>"8PQ!0L(5\MAACR,JV_'8TU,5FV
M'NH8.KTO$U+$&#/V]-5HLRJKA^/_ )#CC;-, DX2UWIHDKKD>;NU ];GQW4E
M4TB&]2?SH)K2. Q%^F(;%',+-</ X0R .1VS$(F"4>/9 FQ+B1;A@0X17^S]
M5KTEWI-)'[1$93/.TB&I%XE)R:TI#(Y%YO7E8^)=B+E,FSM?)EF$+DC(5%%V
M-A/G[OA9F"+L%V U7E_URDHGVW;]_P"&TN,)YN[*,(CY ML*% "P5$6&"E@J
MRC4=%#FL-D3,T)5GD;<6N:"-FVG6G"*-FL!/9ETWU]4#B+7:W?+GA+Z#S0KK
M/3/QM5T\AO2$!\[2J3"+BK;SM'0->!*F)GH-8LTF)Y_%Q#QOI^,:P]0,>V<(
M*=J*(NT>TR*;?A5THJW5->:>O5LUV71X+B,I9><[G8U5UT AT?J\E&9@ BG$
M*@55W-$IZ5' SRTFZ9@QL E0OSLHQ<,T?S<].$!:2B'VJH]<B(SXPE3H)XJF
MED18'^IYTE%K+*+71#Q":D!,35Y_8]##ZEC!6":C@J_;&MB&1+E^GPHDOTS0
M=\];Z034X,^:N=(5?&/* ZTIM#8YY)*3)L%N""B+<MJ!4Y#"\'AET'DFAF.I
MR)=,LTGI4D!;66D]*D084H. \GUU2#AO^0CTF:C=7%L<YZ\$&JLG,=U9?G>
M140\D5>F95'))3S/J!RJ611:/FPZ?4A;FHNVD9B(115HN/?,G/#X>-506;JH
M(J\<DC=?-J54L?CQJ"@B]3]W3Y[F-5S.PI2^EBTVG=-=QZ6608?!).<1T(!\
M@84/>A_Y 4Z;M1[)O_'M_P!1U_\ A]:<]B=TS?-8R/S7R+5;Z9 8U+Z KQ]7
M<5BP"?"QLB@<74A<-C[YRSB(F4MDWC+D$"#%)NHDT2<Z320<%_MUK7;K6E">
M:>K0ZZBO@!%0+*JI%>74UT)+ WD?/P;5<\N4968=3$)6>A9 +WI9,L[<&SPX
M*BGUKO7"[YHVYUQ^=+1?-SM='#)@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,#B<V
MC%?63\A/$>3<2>$M8I9LJF?)R-3ST+R LV>(1B7I*Q45IQ&8Y6,5E(HC%3+T
MIR,*NN';8*28_1SI5Y^ Z<,7;'#FYE5-\<O-=V-&[#D5VE[%>1N25?(^$CL/
M^KTJ[J0=Z(&1EZ_)$Y>?38E7J7HE^L\_C&PX4DZ8(=#AX]/M1'9N<M*I]O+7
MC'?GZ^24B=D>MPB(4O7%354R(N(\EN8V&UBH0-<5S#XZ,5<*QI](8!6L(CWZ
MW:O3C[8Z]7UQP@YUVL,LKAY)#\<KN16E++3>7X=7*D2\JD$/;DH=_,<18L3O
MZIO1\/Y(-R,Q5CY<+")S3XUA^B/&@TBH+?2;S?9/ZE>AO\?*D=0GP//8_>4I
ME+*V!(J8Q=9.S(98KZ'14N./SFWI_P"QY%;J3ZCF,B;=CH.-$^C>AP5RY*IO
M^G[+M115TGIWR\ANBFPO/BV%[A[FJA5YR%G4&H[(V ^)$H+'C1[F12?R&AX\
M?FC,M5(-.2P="&-."J M)@SXY)*+)]K]M-H-VU-^MUK^MI8M_P"/Z(VVQLE@
MYFBP-&R;.G]D$--H@&>\M-3SRPP\M+Q[::SM'E^/&QX?P^Y[4^FU?IIIUSI'
MG76$C*8KQSMIMI_'? ;"<R0FXMM_&"#.RK/NC;H8/:C-@I//I]1%IAU9"[$2
M &96 QLGY]8<+:Y>,')!BOW]CEHHW06X4L94S$$\(U_$FVV^K00*'YT4HB;+
M%.!37MX?*4;ZBGGK L4 +&Y-))$Z&3"2V=VV7[7($G#-/7#Q5R[<K=]]$G*9
M2:[\ANG7G2@Z&_S0<)O:">03H--]1!KO<@%P6/EH6U8EXY_.\I(.B$.+]HJ.
M$'G.N'_'+GE+\?U:[&[6U>I=\9<2DRD62CMS$H[)*ZKFL:Y8(LP[Q$:E&HK3
MDII=\J: PZ=0DHLK*8Z8Z5:<]/DV;3MKV@HB]:*KM^BQE3TS+XN(4=$I#XW9
MQR+.$3MC]<J:#/NF#F$VG4M54_)8L78Q>7PIT=(M([4(S;%X\=+,>4U%FSH<
M[:]_AT(S9@U\>,99_F[=7.]!5M#3DPFD"$NHL":OX6^L&U:YMZR%9;/%2S9>
M9!'12NM-AB3A!EH4T>;VNH^Z9L>FPW3\TG>K/(:GHR6P:5*W42K\5&DHPT1C
M70?98(3/QZTX9:$;+-DT)5%VSHB^,PYN/<MR:1A!5DI]6*;%[K3O9,<J:2,^
M/1A%7-12&#VEL!-J0B,!CL'+OJ\#F(\J1AS^[?Y(S)8HF;%:,)R,%?1IO^!)
MXU68O=)/4G&U/R<=EW,V;\)=/?+U#^90ESR,&,I5FV%/)(D 2:[GXG^B2R"O
MFQ@-$ST.4#=?BEG;]HDQ?)CTG;5))RT>L=K,U2;O-.75H#SXRP9: ]5Z7N21
MJBR4&D]>21V+BX\.^(QV2^5J.\S]]B^T"ZW(,HS5H02>TI]'""FW3MCTC^)3
MA9,N]*]$^0HU2-AZMPS9#673,:,MH;+2+H>]:->RUNK4 KT2V0E\WGTM$+C(
MU18AIKAZ7?*O4W?W]*\))MT>23-Q369S\>D6FBQ![JP2 4FO:5RW P?M(D#=
M?KS&T)G6D^"[*MG;CIO(@\1D-5"^7#5SK?!ECSMNMM+6N.N1&5,&.\'CN2W,
MO?WOR1(S:5!9?-7+*'AQP:53X3Z/9^AVCB&,DI*Y2BHI5\R=".A^E2CA5'O3
MM1RH\Y<*N2[N5>*>$+\>;:MG8N71J]^P1$15@2GY06E=;0Z5 GU6#JCH:LI7
MPF%DY!:/B).8X\_#R"1)VF_8-.7CELY8/D-)[X&Z]*?.#_'&3ALN_NBGH,Y(
MS"<DI\XBZ.0Q1^Y>-Z>G=LRH8B86>3AVC^[( MSF&#S0I(0(0<IM7;(:UYX7
M:N1.=\FK\_%W%W,'6II>[GS^"#PO97D"K!HZM)&]CR'SR.\T%9<9.]%^W3^#
M&(*(=KH1M1NFGR_6^G3Y=FT;,T1OYTM3,/+X8E6'I:OM6!W&^_2=COITC(%0
MPSOF(2<R!K^.B![88L_:(25+1."MUNDNUFZSS;GM'77&_M4PD3K$]'@ICRLQ
MIRU&LO>V=N2MQ(.[ =5Q!2."8^1""+TMD/=5J;D!Y(F^*V*Y1F(IEP-6[2:?
MQS#[].-/';A5[V)FXI&+7X[8[L'. 1>RR9%&8\0@8B1;Q4:--!HS!_75@^L&
M0M GP3<JJD79&?=ANWB>F^N.62+WA'2VOQZ&[Q\F^^6O%8WS-&IG'VEDR.3N
M9+ :^JD1)D^"PV21R U8%DH6#HI$9!*9Q^22B^)8\7VNTY'B$W'7.V@MIQ]Z
M?8G*U?M_%VQ?)G2A:X&0^:NU*L(#I%6%2":4'2*45/8*5AAK#ND!6$NCREGV
M05?I=-G1=B]C2K=NX<?H\,^U-=<%W_@R@CXRV(& 6950BY54*_N2.RY6Q1;^
MK8O(C3ZS9C4\EJ4E,(]*9,4,F8W%^ALBV^Z#<=K$%'B:O.S&F[XB@Z&_6WHM
M_P"-V'SJ6W%-'%OE8A'[*6D4M3$NF)!\Q@ME'J/&T A)1/+V<,H5Q&1T1');
MY':"($E%%%$/Y;EGUPUX$9T^QSXWNI79$KG\NO E(D92_/K+ B$)V];H"I#Z
M&IGT6J#UP5FA,&V'B3U.-@S/@>-'I]AG&NGW#XBGV07&[2DR^=?.A>O+]]37
M*?9="A=CSGEC4467?C2G]4ABJ#62V0?'*C>U4Q*=T7"0(2!TR5[[<<;3;]K?
MC[WM!(DS<1",8C\?@:!'(#)"5R/G0*E",-0K5FM$00'8:MX7.Y)8>HU.3R!3
MZS:0/BYU)+L\LFSVDW:]=Z:[=/'SEP7=:;)GYC#S#TU%+O=SQ)%>/]UG(TZ[
M< !KY9V3J4#Z,B0HVS++$TW;%DLW]+NMK_1FKM)T.:[36X_(ISLEZ4@RC?C;
MC-'V)7LS'VA()&&@:L/D?$9*L"Z/+NPX=Y]8^;VDC':0FG40!AG$$'\J?I\
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MM2LROO<(&03L?#35RFXO'R$I!PN>:Y@$IL(K 2<Q\\ROD8Y)('H#*W+%VO\
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MF+9*-G,AV0%C7G[::6G^W;)MUM3]AMQV/-/5B^IOXC">D9=3<A@U*0FYF+*
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M(-&235CP4!\/GC(WTJ,Y4;K+*MB/U1ZZ1=_8*RK6Z6\PR8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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MG6D.7GX=#+*X:='OC#B@B4D906N^QI0Z*#UQ+Y4Z#@Q8D29I1ST)%@[P\0/
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MJ#2C^^L%7BO"**3+\22S%1;7WCWQ8RZI0L3P#7]DU=Y=K&>VD6C$LI*D2-)
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M#R>DTAS!HH\4T/1ZY=?D[?*/";M*IT:PR8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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M 6+M5DVO2>Q"+M!19T6\8C3H[18<S 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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M''6SQH0X28K/U&/&AC$3#S13Y%K+!"D>+&A=924F"ETAW-.8G-R8B1'(N?\
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MY7&$C9R."DSP0 ]EK,Y_"DNH1'64B,CFSHLNNQ8MG#E#2JW&^^/J(B9C3@U
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M<MT]-6(U)GREKE'7&%F)TZMBA=\^6+#F\.I2$A&)YU-H%<YA@S2JHB.C <-
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M;)PDAP0\VG0PDZ.D)</^B'C*+%)4@Q6_%J+$Q,7XX.GGH:M);ZD\;6W5Q>%
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MK6O\=X'^?AE[;]+5<8OB\), F NMO1(<=8WFI[>?*!*HH?'H1>T/IQLI%XG
M)>]GT?$3GSO8(&>/1Y1N$?NS+,GVBFIK\N^3IMCASA.$@]B>CY-!)YH.SKHM
M'8K2GJR<;LB*Q6T@?-RH5/,(Q":RD%3;$6$F1A(:6=R1RLZ7Y)%UEU!'?8M;
MILY2<HC;%_@O51TUFC:@K%F189,+)E,9M+UZJ&C7"Z7<LE ^&>A+C8PB&@%C
MSE@R3VXCX=B,$:761:)M](:^_E'6NM&)C7\$+^%[[L6;L;7#>B2,G#62\](S
M*-P@#.8>UK[C0W580RQE*]KD9KOMW(8_7C)T123?..UGSULUZ=N._O[[X3-9
M1$57"FJ>M;C-@O3M.U7"/0KBN)R20J^2-8?(BT&A52-8P]M5\,FA&:OI&W>2
MRXY9:D=%K1J-Q4"GRJ*>(J$7#EE^=NYY&,:72L,0N[T])_/OJLS$[LL#<\C/
MB]E;\R.R""@C!&A_7;-.V']D4=#H^ZC8AFP[&C8TR:\!7/!%4+PBS>_17HE]
M[DU47$3'/\EWCPN7S'U918B-VC=,<3%ULSN^XA+"3=IUJ0C8SA.&PNO^HV\
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M59ET2<8AV*PP8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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M@#U<%JY*- [((UXC:),6U*KG-:6-BE$EVS5JJ@[4+.-<]6B*_*)&OX>@G?\
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MWKKG[OJ-N76.'7DM\-\G>+/8E>O9G8OD!X+;SRTY9:YN-7G7L@KRR/\ ,<D
M$5C*I43#O"*!T0C.(9#A[%XBFJFQ-"VZ&G"*O&_IAG=EC-1*GU?W3\1GI&<P
MB[2GG;F%R>L*,)W'2T^N#SU(*TC<LHOS$NE^>4UB[=,485/AE!J$6S@<V5Y6
M?QQ-XBY8HH)]?ET:K.(J]'LD_M7XZ)S$:YN!OYPONW8[[[F-63,/((1YVL.2
MK3^Z_/I0MU6L/ES=HNU<1^X:K4H-P\3#K<(K-VP/\JFN^=?ZPB,N%\&YT<-^
M.N\O2]Q.JT\13SF>GI'Z$J.T[X*^>)* J):7-52L+] !FL]=+\1@))YJ^:.Q
M9A\-0:OCKC:B;A=;??6]DG=$:SHRWIP9\85.SQ"I+<\Y[F4MG5 5A'YDPKVC
M+"M5:%^9J4G:8JHY;8[R"B3#Z)PVM)^[WH,9U]Q4:NW[714X2:=*I#'=.L,<
M:OOXV831TA\C1^EIE-:\/V-Z(I8UYGJ*B['L:6S0C2<F'<>B)D^C,08DY(<B
M8B32-DH2DSUS]Y1\10X35<.W'"?8K.9W<VG7)Z!^'VP+D+V_:<!C$_N&GO.5
M&^KTI21J>2K&9#2<LF?(FIY2D'?,AW$Z)U_+R3=7D>79K$HJX>I*\I-E.M[Y
M$1G$5'"W1STZU\U5Z"'>Q/0T6!/._&T?LBS8;/WH5<Y)JZ1-PYS'YLM"6377
M;MV>ED=__)J35%-19XLHDDES^7?&\,Q<^6.:@E76W\2U57#0US5;7<0A5M^X
M*2N2_J?F8>MRS)X<B,=$!K%N,2P153Z%UM8$A2?_ +94.V0'/33]BYY<:6<H
M=:V:F,ZF.4(8+VY\0%MC*$IF04#87^4E1(4V/JFP$ZNM^.4]1[_VS"8'/*RB
MYVT(F5:*P5]:(J> FR_)%;EFB0>HMG"J76]8:K.-;U_DL)ZL/_&2-FT0\B^D
M8,2)&O+GE.;>L:['_K65MO#:5A TI Y3J,SX >9%RDQ=Q^.NF_\ $*/%GY%F
MCWU]%/KU]21OK='.:96L/2GQI*2/XQ8! (L.B1NVJNF5B^"H\A7AF,-:[A9&
MMG#0ZF_;H)HC*]+S.&/WS!JV*?\ F"CI%VFG][CCO>$F,]9GYICJ:_\ QMZO
MO(6_B !^?N+OS[<XL?(Y#$389PG1X_T<3HRU(M^\Z439\-BURTW]=M]\_F<-
MF2#GCK27>OJ28RQCM;GM)X?\3%*S^R/&13Q)?(UF)@PZRY8U:5G>96I6=5T8
M22E(*T(W*U)DN*"0N$2IDD@S)"]M=IDN4V_/^&M:PW><QNMMLBBGP]-#WGQ$
MO3)_^PRVG?,TEJ HV[N=,JG6'I_T+N'4H+-G&LT1?J\=7-9BSARS)+.-BDGJ
MRO?VHZWSHGGJ9Y?R6LH*R?"'K"'6UYAK.KI.0IJR-V[/3C255%9<1IR_!TPM
M0RE=$SKZ=G1K*/S5@3M8RZ[(Z:/$G'2SS3A)';53A79)C*-9XJGVE[$^**S!
M?H*2750\_(B), -R"32B<4#.F[.]$?#MEO:E>O*6DNOHG(Y?1TYF:R#3L0X8
MED$WW:Z'7:>N^^#48YQ41/B6=!7C\6<7B>JU8^7Y[%IK$&4^\HC/):GF:Q=W
MP<C?I**L[CLZ.CZD8CB#R81.U8G!/[ ?D"ZKAJMH6KV]>\./KPH2LYYZ(\YL
MKX6(K,*9M@+5I\3/BL,JU.ANX_$;KCDDFYNA[)B_E:+45'(/HN%6D-VT1,&H
M@(7B)0?LJ('_ &.7:>V/"Z_ KU."S)F1_&9[!]0P,)-J/%V3ZA"SNX*P4'2Z
MKB6Y+#7'D\D!DIY[;[3O? =Q7(4S. 3^)/3?+\8^<R-BN+^O;KKO1//C'9?;
MKRSY\[<[>;JN,_M=7\GZFVXUP]Y5_P"8-(2F!XM37?+S6]2;^&2TVWUK_8=(
M_7G:>];W]3.Z?RI/V$,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@<K+:^,
MYA;\>]01*3V")?Q?TS[>\\>LSH(E"W#Q@TBU*,?.8T[4I+A*4-5"_$[8T4NE
MT2XZ;::<%]?^65_!]53<9U,3TBE2K"^#<$O*6I6K9)Y]'P,-Z#ONYXY2]NT7
M-9Y5P@5=]-T!5JD;TPA]YUD>4+1DG2CDJB_Y?IHJ]&>DNFNOPZ[[+^YUXTN-
MZL^/F1^I('3<:(VI$H"=K?S3ZCH<HO%J\*=14@6])>=M4=_8HK'R4]=%8['H
M0\WLBW&."1)PNVYY;=/.>];<;)CE5_%"[_X@632/_(=$HC=G]>BON>D*YJJ.
M1IS">GP>B#,;U9):=%8RWXE+39:+3R?V82D7 ;G;+0X@_=\IK=)*I\I%W\.T
MMUN;XW)7/?<K3V1&I1YR)/$(=Y_B[*/W;1D_L&2PE[1DMFTFYD];2F'7W6(\
M(8D/]RU]?Y$651;N![=3[%.-*)]DC.-NV;5_??!M'FL,=CXA='4?L"4P+Y#:
M]LB:D ,OD8N4B/;J\X>1EX*@YFRW,9@Q*H'4C9;67#(LECZ;-;A11ORY4UHO
M[G;33\GDM7X/T9/(;@*P>Y(0VB=CW%Y7N2.U':-3&YO5T/=4&UO1_.X/L5&[
M2@1M[ ;5L"]"4C39M7X_H,^<.4TNU454^4I1&?U7F@7B.01\KX./&Y;4X%3Q
M@9O5]J)4[6,FA5>R@3;5=2VO XF+AY;:-AGHAJ--I(F[<J.29?\ >734^SEO
MRISI.I.7'NP?I;PK:MH69=\_HKTB'H]EZMHJ+>=_1@:25 A:KDA%X?JPV4;F
M]3%>YY"TX-9#&-VF9';Z(MCP=?E1LX[8_E;;_.(RB(J8X2@;OX9:X&V0\M*)
MV Z$RV/>C?&]MU8Z?I2\FQB-:>4ZXI"L'%5R2+\SUI!YN4G<<JAYOF0/!.G8
MMP5X523[49H]87]R>$\*E9.R/&%VK>C[0O+SMZF2H07Z,#4R%] AG-/!;*EZ
MZE(J%F(4_3$M.2D:"KZ0R>%%NP1+9<%)F:22:;QLW2=<];[)&454Q=(;2^,:
M;_R8&N''I,:Y\CP/TQ8'K>O:>YJ1-"SAMGS:3SVQ!\/D5RZGZK$]4\.M>Q'Q
MUHV2C;,VYXX;L'!'M!+OI8;^?^54K#6'P4/*TXCO.O3#8NE$ZW*UU&6B]7=-
MV8!O+O$=K>9;#<#4]SE?KA":6W:CB?+H=;W]OX=#_NZWUIYR7]SMXM8=S\2,
M;KNGO/P7S3-H] +ZIJSO.-I2>Y[;&6C>C2U"7GBM9W7P&.F \FN9A)X]"==6
M$1># PL\U&A^W"O+=#ZJ]];&^YG=PEX!?QHW2I[+6]HS:Q/(L_L23.J'(RMV
M<\SVKP7BC^GPBD8)N:1+,_4:+6%ZDX=3:B6C+22?IOM:4ZVLGK\.QOC;MU;+
M>WQ=%;=J#T+6C:TH1TXNSW_$O<39&>UB9E4(:-(JVJ5'=23"-@[&AYJ3AS/5
M8=<NGS0J*5VB^WSQQSTG]_9(SJ8GI%+4>5J;O2@FL-JHTIYY0I&*5W+.>!E*
M5G,JT8,[#,6/LV#XCHB86];!1N 2B;U_T4Y<N^^EBBJ2S=3E/I1NB3*8G76W
M,/KX5KFEM(UQ05F>PXWU!:=I^9>>:X5K&BWL.DB%4758]?G_ $ _E)J0VK-D
M3D_FE803J)BUT&K(0*3)NG:S%]UURCR:WQ=UJM#5WQ@F*L,PEHW]&R"<PNN?
MD#*^ZHHWGT3"N9QI>;47/*[LNNRIN)K1")])2&S)^^E35\Q!,$6?+A5ITT5Z
M[_:T2<[Y:U30ZS^-^\?-EN^E;_I24>4I'8-J2_U)9T%D,LH"Q-6Z.DEXESTO
MB4+D-A-_2#"$DX5%I4Z8(O/LC;1R\&->N.%4%N]*Z+.43$1-TE?W;\=$M]K'
MZ_DS>WH!6AN,0)>&=RC=+]2*TZPD+XPT-O+6\W79%+ J^RJSGS;I';9-J3=G
MXPMSPW<+">ET5-N"8Y[4;/?BIL '*IA8E7^E14:G4^F'KX=,G4LK"1R,,?HS
MUW8D(LDW#^NH;;U830!9L"DL#:.QLH$FV&G"JB_"[+\?:?X2[]*F.GY(>G?P
M<.)[5YJ(2/UC*SUF<USY,@$8O&0Q-P4G:J'GTQ:B5D_WY9]-GCR8AK^@UF;%
MDF73Q']1R.:OM*+JMT.4A'J:W75?7T-Y:N_V)0NJ6M>VQ]4,W?J!A/I$7JJ,
MM5)"<H*L+?>V#4\'9]R4I)P 6=$$XY&E"Y-PV*CEOU7/.QNN7.T$3,3&,W'1
M2C7PH[7A;^NSGIH^; 1:">OXG04Q?0H:WM2ICWI&\*F]$P&>=2,.6$1TO(::
MLF!E/HFS%"F9@4:VQ_"T;\*<+&OW-;^#(QCXC+/!LWE8/_3,(5\Y3I3P<0N*
M)L:2)M[,F#KPW6E+PT. C%@.K7<QZ&Q.R)!2C!\0UT!($6K-=5J@Y^[K]C0W
MQ=UKJFKV'\7_ %ZO]*!K^W<>H,@SC-#0(S%T89LRXD%=US.KLD-KPQT8ZD@[
MA(9<47MY,4I]&W7\?T-TMO3C\FDTR8YU%*T OA-F0U*L9(X]EREO95!Q;Q+$
MZ._K]=1QA68X=XV-K3!'J>14J].S&0]V%+Y5*%G/ F0@4D6AGA!QR^Y;Z_)%
M_<[::_FF:J?C?]$^<+-A-F41Z0IMH]$U_<E92\9:-"2^7,S,9M?V+:/JWA:-
MJ1J](*L +@DK(_A/RN=D$5]M/VOQ<?D_!Q2<XF*F/%4ME='CEY;%YV1<R%B-
MX^G//"]F>.$@7<;[(*"'M@3#F5)6%T3T<9\.T!'/'X=C?P)]+;_U_P!GC_\
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MVCR<LM9N_P [=$\,F P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
1P& P& P& P& P& P& P/_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>g337004g99b25.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g337004g99b25.jpg
M_]C_X  02D9)1@ ! @$ 8 !@  #_[0K>4&AO=&]S:&]P(#,N,  X0DE- ^T
M     !  8     $  0!@     0 !.$))300-       $    'CA"24T$&0
M    !    !XX0DE- _,       D           $ .$))300*       !   X
M0DE-)Q        H  0         ".$))30/U      !( "]F9@ ! &QF9@ &
M       ! "]F9@ ! *&9F@ &       ! #(    ! %H    &       ! #4
M   ! "T    &       !.$))30/X      !P  #_____________________
M________ ^@     _____________________________P/H     /______
M______________________\#Z     #_____________________________
M ^@  #A"24T$"       $     $   )    "0      X0DE-!!X       0
M    .$))300:      !M    !@              5@   +4    & &< .0 Y
M &( ,@ U     0                         !              "U
M5@                                             X0DE-!!$
M  $! #A"24T$%       !     (X0DE-! P     "$$    !    <    #4
M  %0  !%D   ""4 &  !_]C_X  02D9)1@ ! @$ 2 !(  #_[@ .061O8F4
M9(     !_]L A  ," @("0@,"0D,$0L*"Q$5#PP,#Q48$Q,5$Q,8$0P,# P,
M#!$,# P,# P,# P,# P,# P,# P,# P,# P,# P, 0T+"PT.#1 .#A 4#@X.
M%!0.#@X.%!$,# P,#!$1# P,# P,$0P,# P,# P,# P,# P,# P,# P,# P,
M# P,# S_P  1"  U ' # 2(  A$! Q$!_]T !  '_\0!/P   04! 0$! 0$
M         P ! @0%!@<("0H+ 0 !!0$! 0$! 0         !  (#! 4&!P@)
M"@L0  $$ 0,"! (%!P8(!0,,,P$  A$#!"$2,05!46$3(G&!,@84D:&Q0B,D
M%5+!8C,T<H+10P<EDE/PX?%C<S46HK*#)D235&1%PJ-T-A?25>)E\K.$P]-U
MX_-&)Y2DA;25Q-3D]*6UQ=7E]59F=H:6IK;&UN;V-T=79W>'EZ>WQ]?G]Q$
M @(! @0$ P0%!@<'!@4U 0 "$0,A,1($05%A<2(3!3*!D12AL4(CP5+1\#,D
M8N%R@I)#4Q5C<S3Q)086HK*#!R8UPM)$DU2C%V1%539T9>+RLX3#TW7C\T:4
MI(6TE<34Y/2EM<75Y?569G:&EJ:VQM;F]B<W1U=G=X>7I[?'_]H # ,!  (1
M Q$ /P#U586:_-SKLYU&;^S\7IC=K+AM#79 8W(LNRGV!S786+6^JM]7_AKU
M?YJGT]M[VL8Y[C#6@EQ\ %RO2&LZA@LS<UX9TG$+\W(D>V_*<Y^;D6/C=ZF%
MTRQ_IT_Z;+I_<PZ/62D;^I=6^L=>)3CDX%'4*A8UC'1;Z,#U\[(L;[J,;>[T
ML#%K_6,R[T[,KT\2O,QEU6'AX^#B4X>*P5X^.QM=3!V:T;6A8OU:-&-TB_K6
M:XT.RGW7WNR"&FFEMM[J<1W[C<5CW[_^[%F19_A59K_;'4R+Q8_I.$1--88P
MY3Q^;;D?:6758C/W<3T'Y'_<BRBSU<2M*==)4>BY=V;TO'R;]IM>T[GL&UK]
MI+/7K8=VRN_;ZU;/Y:O)*4DDDDI222S<'KV)GYGV?&98^IU;[*<R&BFT5NKK
MM^SNW^K8QKKJ]E_I?9KO^T]UJ2G222224I))))3_ /_0[KZWYMU'1<C'Q2/M
M>779763PRL,<_*R71[OU?'#]G_=C[/5_A4W6!B8N/@=,8!3A5'UKF-&C<3!;
M]H+=?\%ZS,/'?_P5JCD8K^K9'5]I$5X[NFXI.H#[&"_+L_MOLPZG?^$U0NRO
MVSDTD-+1FU8V(:S^8+#9G]:Q[/W7?9<.O$M_<N]B2FQT7'OSABTY0<W'Z6VN
MS(K=_A>H/:W+L]3]ZOI[K6V-_P"[UF_^>P%<^M/5'X/3QC8K;+>H]0=]FPJ*
M(]4N=_/75[O97]EIWWNOM_05?X55GW=7Z3A7UFNBFL76V_;WN=8'>O<ZVL58
M%+6Y&1F6/O\ 09B>K5^F_F+;?YE!Z=]7NKLS+.KOR_2S<VIM3SDM&1=14USK
M!52^M]6)7==N;;E,JH^Q59%?Z"J^K](DI&QO[ 8SJ?52[(ZC8P8G2NCXA<]E
M58 VX>%5I]HOV,:[-ZC>S^;K_P !1^C6E@]7RL<44=??33U+J-Q&)@XX+WMK
MV[MMFTV>IZ#6669.7[,9B!7T'J>-U#)R<6ZM]N4QE7[3R7ONR*ZVB;*J<0L;
MBM]3(]2_]#;C8O\ -?J-GV;]+6P^D]3JZEE/QZ'49#YH'5LES+7>C['OOK:'
M.LRLW*L_-N9BX&%35C454?JGV;)2GH'=3PF]19TSU0[-LK=<*6@N+:VD-]:W
M;_,UN>[97ZO\Z_\ FO\ "*TN8%-_U=OR[L? LS'9!QZJ<EUM8]1SW"EOVV^U
M_P!I]>S-R7^I;]GN_0>CZ7\SZ++.)TGJ]-O[3ZKU7U+ZVOL=54#3BMEKF^FZ
MM]EF[&HW;][_ -/ZE;+K;?\ !I*2VAW7,JW%((Z/C.->1_W:M:=MN+_X0QW?
MH\O_ +EY'ZI9^KT9-67/IA;E]3S.H, ^STAN#C$<'T7/=F6,_D?:7_9?_0%8
M>'U86](PNF89OPZ136W+S!3<ZYY<)O;TT4U/^T776>IZG4F?H&;_ %L7[59_
M,[>-G.IQJ\?IO2<G[/2T5TAPKH8&M&UHV9-M>2UK6_\ ==)3KI+.;D]?=J,#
M&8/Y>4Z?NKP[6_\ 33.R>O,U.!CO'_!Y3B?NMQ*6_P#324Z22S1U//:/TO2<
MD$=ZWX[Q\OUFNS_P-(=<H'\[BYE1\#C6O_'&9>U)3__1]#^KX_R8VZ/Z5;=D
MSXBZVR^O_P #>Q9?[,N?]9\OJ/2BVL8S6UWT6%[:;,FUK;+[]M1_GFXGV)MC
M_2?ZWL_T'Z2]A9S,#ZJ8>8]IL->'065M^E98YE;*:&?\)?<YE5?\MZN=)P7X
M."RFUPLR7EUN58.'W6$VY#V\>SU7_HO]'3Z=:2D.-TR]^4W-ZI<W)OJ,XU3&
MEE%,C:ZRJMSK'V9+VNV?:K7_ ,W^CQZ\;U<CUM))))2DDDDE(<K%Q\S'LQLE
MGJ4VC:]LD:?R7-A['M_,>SWL5(?5_ <YKLMUV=L(+&95CK:P1]%_V=WZNZQO
MYMME7JK3224I))))2DDDDE*22224_P#_TNLZ?ZG^13U$@=-#6MZ8&"6NLV?J
M5W47.V^ED.Q?;BXU3;L5F7OL^U/R;.GUU]2OE5))3]5)+Y5224_522^54DE/
MU4DOE5))3]5)+Y5224_522^54DE/U4DOE5))3__9 #A"24T$(0      50
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MH7*3-C*U@0'+3'HI"!0D8W M(YIU(4*PTA<:D-TH 2(CU,RIBXST3WA# 8#
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MPSO3T]?7VA_]1>@Q>R>2#R5))*E,<4H3J"BSR#R# &DGDF@T84<2:7L0#"C
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* P& P& P&!__V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
